header
string | sequence
string | class
string | mechanism
string | type
string | label
int64 |
|---|---|---|---|---|---|
MEG_8737|Drugs|betalactams|Class_B_betalactamases|VIM
|
ATGTTCAAACTTTTGAGTAAGTTATTGGTCTATTTGACCGCGTCTATCATGGCTATTGCGAGTCCGCTCGCTTTTTCCGTAGATTCTAGCGGTGAGTATCCGACAGTCAGCGAAATTCCGGTCGGGGAGGTCCGGCTTTACCAGATTGCCGATGGTGTTTGGTCGCATATCGCAACGCAGTCGTTTGATGGCGCAGTCTACCCGTCCAATGGTCTCATTGTCCGTGATGGTGATGAGTTGCTTTTGATTGATACAGCGTGGGGTGCGAAAAACACAGCGGCACTTCTCGCGGAGATTGAGAAGCAAATTGGACTTCCTGTAACGCGTGCAGTCTCCACGCACTTTCATGACGACCGCGTCGGCGGCGTTGATGTCCTTCGGGCGGCTGGGGTGGCAACGTACGCATCACCGTCGACACGCCGGCTAGCCGAGGTAGAGGGGAACGAGATTCCCACGCACTCTCTAGAAGGACTCTCATCGAGCGGGGACGCAGTGCGCTTCGGTCCAGTAGAACTCTTCTATCCTGGTGCTGCGCATTCGACCGACAACTTAGTTGTGTACGTCCCGTCTGCGAGTGTGCTCTATGGTGGTTGTGCGATTTATGAGTTGTCACGCACGTCTGCGGGGACCGTGGCCGATGCCGATCTGGCTGAATGGCCCACCTCCATTGAGCGGATTCAACAACACTACCCGGAAGCACAGTTCGTCATTCCGGGGCACGGCCTGCCGGGCGGTCTAGACTTGCTCAAGCACACAACGAATGTTGTAAAAGCGCACACAAATCGCTCAGTCGTTGAGTAG
|
betalactams
|
Class B betalactamases
|
Drugs
| 1 |
MEG_8742|Drugs|betalactams|Class_B_betalactamases|YEM
|
ATGTTAAAAACAATATTACAATTTTTTGTTTTATTCACTGTAACTCAAGGTGCTTATGCATCTAAAATAGCATTGGTAAAATTAAGTGATAATCTTTATGTTGTCGAGGACGACTATTATTACAGAGAAAACTCCATGGTTTACATTGGTAAAGACTATATTACCGTTATTGGTGCCACCTGGACACCGGATACAGCTAAAGAATTAGATGCGCAAATCAAAAAAATAAGTAAAAAACCCATCGCTGAAGTTATCAATACCAATTATCATACGGACAGGGCCGGTGGTAATTTATATTGGAAAAGTATTGGTGCTGAATTGATTTCTACCAAAATGACGTATAATTTAATGGAAAAACATTGGCAAGATATTCTTGAGACTACCCGTAAAGGGTACGATGGCTTCCCTGATATTCCCCTTGTTTTGCCGACAAAGACTTTTGATAATAACTTTGAACTACAAAATGGCGAGATAAAAGCTATCTACACAGGTGAATCTCATACTCCTGACGGAATATTTGTTTATTTTCCGAAGGAAAAAACCTTATATGGAAATTGCATAATTAAAGAGAAATTAGGTAATTTGGCCTCTGCTAATATAAAGGAGTACCCTAAGACCTTACAGAAACTTAAAAATTTAAATCTCGATATAAAGACAGTTGTCGGTGGTCATGACTCACCAATACATGGTTCCGAACTTATCGATAGCTATAAAAAACTAATCGAAGCCGCTAATAAGTAA
|
betalactams
|
Class B betalactamases
|
Drugs
| 1 |
MEG_8273|Multi-compound|Drug_and_biocide_resistance|Drug_and_biocide_MFS_efflux_pumps|NORC
|
ATGAATGAAACGTATCGCGGGGGCAACAAGTTAATCTTAGGTATTGTATTAGGTGTTATTACATTTTGGTTGTTTGCACAATCACTTGTAAATGTTGTGCCAAATTTACAACAAAGTTTTGGTGCAGACATGGGAACAATTAGTATTGCGGTAAGTCTAACCGCACTATTTTCAGGCATGTTTGTTGTTGGAGCAGGCGGCCTAGCAGATAAAATTGGACGCGTGAAAATGACAAATATCGGCTTATTATTAAGTATTATTGGTTCAGCATTAATTATTATTACAAATTTACCAGCATTGCTAATTTTAGGCCGTATTATACAAGGCGTATCAGCAGCGTGTATTATGCCTTCCACATTGGCCATTATGAAAACTTATTATGAGGGTGCTGAACGTCAGCGTGCCTTAAGCTATTGGTCTATCGGTTCTTGGGGTGGAAGTGGTATCTGTTCACTCTTCGGTGGGGCAGTTGCGACAACTATGGGTTGGAGATGGATTTTCATCTTCTCAATCATCGTTGCCGTACTTTCAATGTTACTCATCAAAGGGACGCCTGAAACGAAATCAGAAGTTACCAATACACATAAATTTGACGTTGCAGGTCTAATTGTTCTAGTAGTTATGTTATTAAGTTTAAACGTTGTCATTACTAAAGGTGCAGCACTTGGTTATACATCATTATGGTTCTTTGGTTTGATTGCAATCGTAATTGTAGCATTCTTTATTTTCTTAAATGTTGAGAAAAAAGTAGATAATCCGCTTATTGATTTTAAATTATTTGAAAATAAACCATATACAGGTGCAACGATTTCGAACTTCTTATTAAACGGTGTTGCAGGTACATTAATTGTAGCGAATACATTCGTACAACAAGGTTTAGGTTATACAGCATTGCAGGCAGGATACTTATCAATCACTTATTTAATCATGGTGTTATTGATGATTAGAGTTGGTGAAAAATTATTACAAAAAATGGGTTCTAAGCGACCAATGTTATTAGGTACATTCATTGTGATCATTGGTATTGCACTTATTTCATTAGTATTCTTACCAGGCATATTTTATGTTATCAGTTGTGTCGTAGGATATTTATGTTTTGGACTAGGCTTAGGTATTTATGCAACACCTTCTACAGATACAGCTATTTCAAATGCACCGTTAGATAAAGTTGGCGTTGCTTCAGGTATTTATAAAATGGCTTCATCACTTGGTGGTGCATTCGGTGTCGCAATTAGTGGTGCAGTATATGCCGGTGCAGTTGCTGCAACGAGCATTCATACAGGTGCGATGATTGCACTTTGGGTTAACGTATTAATGGGAATCATGGCATTTATCGCAATTTTATTTGCGATTCCTAATGATGATAAACGTGTCAAAGATGCGAAATAA
|
Drug and biocide resistance
|
Drug and biocide MFS efflux pumps
|
Multi-compound
| 1 |
MEG_8241|Multi-compound|Drug_and_biocide_resistance|Drug_and_biocide_MFS_efflux_pumps|MDE
|
ATGACGAAACATTTACAAGATTTTTTAATAACAGTTATCGCAGGTATGGGAATGTTATTATCCACCCTTGATACAGGTATTATCAATGTTGCATTATCCTTTTTGAGGGGACAATTTCAAACCACAACTAACATTGCCTCTTTTACAATAACTGGATATACTTTAGCATTAGCTATCTCTATCTTACCTTTAGGAGTATTAAGCGATAAATTTGGAAAGTTAAAGATTTCCTACTTAGGATTTGTACTTTTTGGACTGAGCTCCTTATTTTGTGGATTTGCTAATAGTATTGGCTGGCTCATTACTGGCCGGATTATTCAAGGAATGGGAGCGGCGGCTTTGCAAGCTACTTCAGCAGCTCTGATTACCACTTTAGTTTCCGAAGACCGCAAAAACAGTGCTATTAGTATTTTAGGAGTTATGATTGGCTTAGGACCTGTCCTCGGTCCTTCCTTAGGAGGCATACTACTTTCTTTAAATCTCTGGCGCTTTATTTTCTGGATTAATGTTCCCTTTGCTCTTATTGTCATCATTTGTAATCACTATCTCCTTACTAAAGTCTCCGAACAAACTAGTGAGTGGACATTAGATTCTCTTGGAACAGTTCTCAATGCTTCTATGTTGGTTTGTCTTCTCTTAGGACTATCCTTACTCAGTAAGCCTCACCTATTAGGTATCAGTCTTATTTTGATCATCATTAGTTTCTTGATCGGGATTTGGTTTTACCGTCTTGAATGCAGCAAAGAGAGTGCTCTTGTCAATGTCAAGGGGCTGAGCGAGAATCCTCGAGTACTTTCTTATCTTTTTCAAACGGTCGCTTTTGGTTTTGCCTCTGCAATGATATTCTTACTTCCACCCTTCATTTTTGAACAATTATATCATTTAGGAGTGGGGCAGACAGGCTTTCTTGTACTAGGAGCACCTGCAGGCCTGGTTCTTTTTTCAAGAATATCTGGTAAAATCAATGATGGCAGTAAAAATAAATCATTTAGCCATATTGGTTTGGGTATCATTATTTTATCCTTAATTTTCCTCCTACTTCTCACGCCTAGCTGGCCCTATTTATTCTTAACTTTAGGATTATTTATTTATGGTATTGGCGGAGGATACTTTCAGCCTGCTAATATGGCTAGTATTATGCTAGCTAGTCCTATGAAAATGCAAGGTAGCACAGGAGCATTGCAACGAATGGTACAAAACATTGCTATTTCAGCTGGTTCAGCCATTGGATCAACTTGCTTAAACCTTTGGTCAAATAATCTATTATTGGCTACCCGAATTGGCTGGGGAATTACACTCGTTCTAGTTATTCTCAGTTTAAAAGAACTAACACCATTTAAAATGACTAATAAAACAGAATAA
|
Drug and biocide resistance
|
Drug and biocide MFS efflux pumps
|
Multi-compound
| 1 |
MEG_8693|Multi-compound|Drug_and_biocide_resistance|Drug_and_biocide_RND_efflux_pumps|SEPA
|
ATGATTGTGAACTTTTTCAAGCATAAATTTTATAATTTATTAACTACAATGATTGTTCTCTTTGTGTTTGTGTTGTCCGGTGCAATTTTTTTAACATTTCTAGGTTTTGGACTTTATGGTCTTAGCAGGATACTTATATACTTTAGGTTAGGTGATTTCACGTATAATAGAAATATGTATGATAATTTATTGTATTACGGTAGTTATATCATATTTGGTTATTTTATCATTTTTGCAGTCGAACATTTAATGGATTATTTTAGAAAGATGCTTCCTGAAAATGCATATTTTAGAGGAGCAACATTCCATTTAATATCTTATACGGTTGCTACTACATTATTTTATTTCATTATTCATTTACATTATGTGTATATTAATATTGATTTTTGGGTCATCATGGTAATCATAGGCTTTCTTTATGTATGTAAACTTCAATTTTACCCTGAAAGTAAAAATCTCAATAATAGAAAATAA
|
Drug and biocide resistance
|
Drug and biocide RND efflux pumps
|
Multi-compound
| 1 |
MEG_8692|Multi-compound|Drug_and_biocide_resistance|Drug_and_biocide_MFS_efflux_pumps|SDRM
|
ATGCGATTAAAGTCAATCATAACTGTTATAGCTTTAATATTAATTATGTTTATGTCAGCGATTGAATCATCTATTATTTCGCTTGCATTACCTACAATTAAACAAGATTTAAATGCAGGAAATTTAATTTCATTAATTTTTACAGCGTATTTTATCGCATTAGTAATTGCCAATCCTATAGTGGGAGAATTACTTTCGAGATTTAAAATTATTTATGTGGCAATTGCAGGATTACTTTTATTTAGTATAGGTAGTTTTATGTGTGGTTTAAGTACTAATTTTACTATGCTAATTATATCACGCGTGATACAAGGTTTTGGATCAGGTGTATTGATGTCATTATCGCAAATTGTTCCAAAGTTAGCATTTGAAATTCCGTTACGATATAAAATTATGGGCATAGTTGGCAGTGTTTGGGGTATTTCGAGTATCATTGGACCGCTTCTAGGTGGTGGTATATTAGAATTTGCAACATGGCATTGGTTATTCTACATAAATATACCGATTGCGATCATTGCCATTATATTAGTTATATGGACATTTCATTTTCCAGAGGAAGAAACAGTTGCTAAATCAAAATTTGATACTAAAGGGCTCACGCTATTTTATGTATTTATTGGATTGATTATGTTTGCTTTATTAAACCAACAGCTATTACTTTTAAATTTCTTGAGTTTTATCTTAGCTATCGTTGTGGCAATGTGTTTATTTAAAGTAGAAAAACATGTTTCTTCACCATTTTTACCTGTGGTTGAATTTAATCGTTCGATTACTTTAGTTTTTATAACGGACCTTCTAACAGCTATTTGTTTAATGGGATTCAATTTATATATTCCAGTCTACCTTCAAGAACAACTAGGATTATCTCCATTGCAAAGTGGATTGGTTATTTTTCCTTTATCTGTAGCTTGGATTACATTGAATTTTAATTTACATCGAATTGAAGCAAAACTATCAAGGAAAGTTATTTACTTACTATCATTTACATTGTTACTAGTAAGTAGTATTATCATTTCATTTGGTATTAAATTGCCGGTACTTATAGCATTTGTGTTAATTTTGGCAGGATTAAGTTTTGGATATATTTATACGAAAGATAGTGTAATTGTCCAAGAGGAAACTAGCCCATTACAAATGAAGAAAATGATGTCATTTTATGGATTAACTAAAAATCTTGGGGCATCAATAGGTTCAACAATAATGGGATATCTTTATGCGATACAATCAGGAATCTTTGGTCCAAACTTACACAATGTGTTAAGTGCTGTTGCTGTAATTAGCATTGGGCTTATTGTTTTATGGGTCGTATTTTTTAAAGAACAGTCATCTCAATCAAAAGAATAG
|
Drug and biocide resistance
|
Drug and biocide MFS efflux pumps
|
Multi-compound
| 1 |
MEG_8628|Drugs|betalactams|Class_B_betalactamases|PFM
|
ATGAAGCTTATTAATATTCTGTCAGTCATCAGCCTGGCCTGCATTACCTCCCAGGTCTTCGCTAACAAGAGTGACTTGACCCTTACCCACTTCAAAGGCCCGCTCTACATCGTTGAAGACAAGGAATATGTGCAGGAGAACTCAATGGTCTACGTTGGCGAGCAACACATCACGGTTATTGGCGCAACCTGGACCCCAGCCACCGCTGAAAAGCTTGAGCAGGAAATCAGGAAAATCAGCCCCCTGCCCATCAAGGAGGTGATCAATACCAACTACCACACCGACCGCGCGGGAGGTAACGCCTACTGGAAGAAGCTCGGCGCCAGTATTGTCTCAACGCAGATGACCTATGACCTGGAAAAAAGCCAGTGGCGCAGTATTGTCGACTTTACCCGGCAAGGGATGGAGCACTATCCAATCCTGGAACAAAGCCTGCCAGACCAGGTATACCCGGGCAACTTCGACTTGCAAAACGGCCATGTTAGAGCACTGTATTTAGGCGCGTCTCACACCGAAGATGGGATTTTTGTGTACTTTCCAGAAGAGCGTGTGTTGTATGGAAACTGCATTCTCAAGGAAAAGCTGGGTAACATGACATTCGCGAATCGCAGCGAGTACCCGAAAACCCTGAAGAAATTGCAAGGGCTGATCCGCAGTGGTGAATTGCCCGTTGAAGCGATTATCGCAGGGCATAACTCACCGATACAGAACGTTGAGTTGATTGACCATTATCTGACCCTGCTTGAACACGGCGAGCAGTAA
|
betalactams
|
Class B betalactamases
|
Drugs
| 1 |
MEG_8267|Drugs|betalactams|Class_B_betalactamases|NDM
|
ATGGAATTGCCCAATATTATGCACCCGGTCGCGAAGCTGAGCACCGCATTAGCCGCTGCATTGATGCTGAGCGGGTGCATGCCCGGTGAAATCCGCCCGACGATTGGCCAGCAAATGGAAACTGGCGACCAACGGTTTGGCGATCTGGTTTTCCGCCAGCTCGCACCGAATGTCTGGCAGCACACTTCCTATCTCGACATGCCGGGTTTCGGGACAGTCGCTTCCAACGGTTTGATCGTCAGGGATGGCGGCCGCGTGCTGTTGGTCGATACCGCCTGGACCGATGACCAGACCGCCCAGATCCTCAACTGGATCAAGCAGGAGATCAACCTGCCGGTCGCGCTGGCGGTGGTGACTCACGCGCATCAGGACAAGATGGGCGGTATGGACGCGCTGCATGCGGCGGGGATTGCGACTTATGCCAATGCGTTGTCGAACCAGCTTGCCCCGCAAGAGGGGCTGGTTGCGGCGCAACACAGCCTGACTTTCGCCGCCAATGGCTGGGTCGAACCAGCAACCGCGCCCAACTTTGGCCCGCTCAAGGTATTTTACCCCGGCCCCGGCCACACCAGTGACAATATCACCGTTGGGATCGACGGCACCGACATCGCTTTTGGTGGCTGCCTGATCAAGGACAGCAAGGCCAAGTCGCTCGGCAATCTCGGTGATGCCGACACTGAGCACTACGCCGCGTCAGCGCGCGCGTTTGGTGCGGCGTTCCCCAAGGCCAGCATGATCGTGATGAGCCATTCCGCCCCCGATAGCCGCGCCGCAATCACTCATACGGCCCGCATGGCCGACAAGCTGCGCTGA
|
betalactams
|
Class B betalactamases
|
Drugs
| 1 |
MEG_8291|Drugs|betalactams|Class_D_betalactamases|OXA
|
ATGCCAAAAATACTAAAACATCTTAGCCTTTGCGCATCTGTAATGATTGGACTGACCTTGCTTGGTTGTCAAAATTTTCACGCCCCAACTCAAAGCGCCGTGTCAAAAAAACACGATCAAACCGAGATCGCTTCTTTATTCCAACATGCTCAAACTGTTGGCGTATTTGTTACATATGATGGGCAAACACTTCAAGCATATGGCAATGCGTTGAGTCGATCGAATACGGCTTATATTCCAGCCTCAACCTTCAAGATGTTAAATGCTCTGATTGGGATACAGCATCACAAAACTTCACCAAACGAAGTGTTTAAATGGGATGGCAAAAAGCGTGCTTTTGCGAGCTGGGAAAAAGATTTAACTTTAGCCGAGGCGATGCAGGCATCAGCAGTGCCTGTTTATCAGGAATTGGCTCGGCGTATCGGGTTAGAGTTGATGGCGAACGAAGTAAAACGCGTTGGCTTTGGCAATGCCGAGATCGGAACGCAAGTCGATGATTTTTGGTTGGTTGGCCCGCTTAAGATTACCCCAATTGAAGAGGTTAAATTTGCTTATGCTTTGGCAAATAAGCAGCTTGAATTTGACCAATCTGTGCAAAAACAAGTGAAACAGATGGTCTTCGTTGATGAAGTTCATGGAACTAAGATTTATGCCAAAAGTGGTTGGGGGATGGATGTAACACCGCAAGTGGGTTGGTGGACGGGCTGGATTGAACAACCGAATGGACAGGTGATTGCATTTTCTTTAAATCTGGAAATAAATAAGCCTGAGCACGGTGATGCGCGTAAAGCGATTGTTTATCAAGCATTACAACAATTGAAATTGTTACAGAAGCAATAA
|
betalactams
|
Class D betalactamases
|
Drugs
| 1 |
MEG_8688|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|SALB
|
ATGCTATTTTTATTTGAAGAAAAACCATTAGAAATTGAGAATAAACAGCTTATAAAACGTTTGTCATTTCATATCGAAGACCATGAGCATTTAGCCCTTATCGGTGTTAATGGTATTGGTAAATCTACGCTATTACATCATATTCATAAAAATGAATTGATTGATACAGCTATGATGGAACAAGATTTAAGTAAACATGATGATATTGATGTTATGGATTATGTCATGTCTGCATATCCAAAGTTAGTTGAATTGAGAAAAGATTTATCTGACATTGATTCTTTAAATAGTTATATAGAATTAGACGGATATAACGTTGAAAATAACATTATTATTGAAGGAAATAAATTAGGATTATCATCAACACATTTTGAGCAAAAGATAGGCACTTTAAGTGGTGGTGAGCAAACTAAAGTCTCATTTTTAAAAGTTATTTTATCAGATGCACCATTATTATTAATAGACGAACCAACTAACCATATGGATAAAGAGATGAAAGTGTGGTTAATAAAAGCTTTTAAATCAGAACAAAGAGCTATTCTATTCGTATCGCATGATAGAGAGTTTTTAAATGAAACACCAGATGCTATTTTAGAACTCACAAAAGATGGTGCAACTCGATATTCAGGTCATTATGATGATTATAAAAATCAAAAAGATATTGAAATTGAAACAGAAAAATTAAAATATGAAAAAGAACAGAAAGAACAAAAAGCAATAGAAGAAAGTATTAAGAAATACAAAGAATGGTATCAAAGGGCTGCTCAGAAAGCTTCTGTTCGTAGTCCATATGCTCAAAAACAATTAAGTAAATTAGCTAAAAGATTTAAATCAAAAGAACATCAGTTAAATCGTAAATTAGAAGAATCAAAATCTGATAATCCGTTAGAAGAAAATAAATCCTTTTCTATAGAAAATAATGAATTTAAATCACATTATTTAGTAAGATTCGAAAATGTTTCATTTTCATATAAGAGTCGTGAAATTTTTAAAGACACTTATTTTGAAATAAAGAGAAATCAAACTGTAATTATAGAAGGTAAAAATGGGTCCGGTAAATCTACATTGATACAATTAATTTTAGGTAACTTATTACCAATGAGTGGAGCTGTCAAAAAGCACCCAGACTTAGACATAGGATACTTCTCGCAAGATTTTCAAAATTTAAACCCAAACAACTCGGTATTAGAAGAAGTTATGGATATTGAGAATATGATGATAACAGACGCGAGGACTATTTTAGCGAGTTTTTATTTTGATAAGAGCAGGATGAATGATAAAGTTCGTCAGTTATCAATGGGAGAAAAGTGCAGGTTACAATTTGTAAAATTATATTTTTCTAACCCACACATCTTAATTTTAGATGAACCAACTAATTATTTTGATATTAGTATGCAAGAGAAAATCATACAATTAATCCAAAGTTTTAATGGTGCAGTAATTATTGTGTCGCATGATGAAATTTTTAAAGATGAAATAAGAGACCAAGTTTGGAAGATTGAAAACTGTAAGCTCATTCATGAAAATGTATCTATTAATACACCTATTGATGCTGAATCGATGAAGGATGAGTTAAAAATATTAGAGCAATATACAGATGAAAGAAATAAAGAAACAGACTTCTAG
|
Multi-drug resistance
|
Multi-drug ABC efflux pumps
|
Drugs
| 1 |
MEG_8689|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|SALC
|
ATGCTATTTTTATTTGAAAAAAAGTCTTTAGAGATTGACAATAAACTGCTCATACCTTCACTAACATTTATTATTGAAGAAAATGAACATTTGGCAATAGTCGGCATAAATGGTATCGGAAAATCTACACTTTTAAATAAAATCCATCATAAAGAAAATATTGAAACAGCAATGATGGAACAAGATTTAACTAAATATGGAACTTTAAATGTCATGGAGTATATTATGTTAACTTATCCACAATTATCATCGTTAAGAGAAAATCTAAGTGATTTGGATAATATAAATAGATATATTGAATTAGACGGTTACGAAATTGAGCAAAACATTATAATTGAAGGAAAAAAGTTAGGATTAACAGAAAGGCACTTTGATCAATTAATTTCTACTTTAAGTGGTGGTGAGCAAACAAAAGTTTCGTTTTTGAAAGTTAAATTAGATAAAGCACGATTATTATTAATTGATGAACCAACTAACCATATGGATGAAGAAATGAAAGTATGGTTAACTAATGCATTTAAACAAGAAAAACGTGCAATATTATTTGTTTCTCACGATAAGACTTTTTTAAATGAAACACCAGACGCAATTTTGGAACTGAGTAGTAGTGGTGCAACAAAATACTCAGGTCAGTATGACAATTACAAGCAACAAAAAGATTTAGAATATAAAACGATTAAGCTACAATACGAAAAACAAGAAAAAGAGCAACGAGCAATTGAAGAAACAATTAAAAAATATAAAGAATGGTATCAAAAAGCTTCACAAAAAGCTTCAGTAAGAAATCCTTATCAACAAAAACAACTTAGCAAGCTTGCGAAAAAGTTTAAATCGAAAGAATATCAAATGAATAAAAAACTTGAACAAACCAATTTATCAGATCCTGAAGAGGAAGGAAAAACATTTTCAATGCAACATCACGCCTTCAAATCTCATTATTTAGTTAAATTTAAAAATGTGACATTTTCATATAATGAAAAGCCTATTTTTAATGATGTCTCTTTTCATATTAAGCGAAATCAAAATGTTATCATTGAAGGTCAAAATGGCTCAGGTAAATCTACTTTGATCAAGTTGATACTAGGTCAACTGACACCTGATGAGGGAGAAGTAATCGTACATCCTGAATTAGAAATAGGTTATTTTTCACAAGATTTTAATAACTTAAATATGAAAAATACTGTGTTAGAAGAAATAATGTCTATTCAAGAAATGAAAGAAGCGGAAGCAAGAACAATTTTAGCGAATTATTATTTTAATGAAAATAGAATTAATGATGTTGTTGCCAATTTATCTATGGGTGAAAAATGTAGAATACAGTTTGTTAAATTGTATTTTTCAAATCCACATATACTCATATTAGATGAGCCAACTAACTATTTTGATATTGAAATGCAAGAAAAAATCATACAATTAATTCAATCTTTTCAAGGATCAACACTTATCATTTCACATGATAAATATTTTAAAGAAAAGCTTAAAGATCAAATTTGGACAATAAAGAATCTAGATTTGGTACATGAAAATCTTAAAATTGAGAATCCATTAAATGCTGATTCTATTAAAAATCAATTAAATGAATTAGAGCAATATACCGACGAAAGAAATAGAGAAACAGAGTTCTAG
|
Multi-drug resistance
|
Multi-drug ABC efflux pumps
|
Drugs
| 1 |
MEG_8690|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|SALD
|
ATGTCTTTTTATTTTACAGAAAAGCCATTTGAAAGGTTCGGCAAGACATTAATAGAAGAGGTTAATTTAAGTGTTGAACCAGGTGAACATATAGCAATTGTTGGTGATAACGGGGTAGGTAAATCAACATTACTCAATGCAATTTACAATAAATATAATGATTCAACGTATTTGATGGATCAAGAATTATCGAAGTATAAAAATGAAACGGCAATAAATTATATTATGTCGTGGTATCCAGAATTATTAGATATTAAACTTGCTATGCAAACTGATTATGAAAAAATTGGTGACTATATAGAACTTAATGGATATGAAATAGAAGAACAAATCATTTTACAAGCAAAGCAATTAAATTTAGAAGAGTCAGATTTAGATAAACAAATGGGGCAGTTAAGTGGCGGACAACAAACCAAAGTAGCATTAGTTCGAGCAATGATTTCAGAAAAAAATTTAATCTTGTTGGATGAACCAACAAATCACTTAGATAAACAAATGATTCATATTGTCGTGGATTATATAAAGCAAGCAAAGCAAAGTATATTATACGTGTCACATCATAGAGGATTTATCGACGAAACTGCAACGCACATTATTGAAATTACACCACAAGCTACAAGAAAATTTACTGGTAATTATAGTCAATATAAATCCATTATAGATGTTGAAAGAGAAACTCAAAAAAAGGTATACGAGAAAAAGCAAAAAGAAATAAAAGCTTTGGAAGCAACCGTAGATAGAGTTAAAAATTGGCATAAAACTGCGAATCAATCTGCAAGTGTTCGTAATCCGTTAGAGCAAAAGCGTTTGAGTAAATTAGCTCAAAAGGCAAAGGTTAAAGAATCACAAATAAATCAAAAACTTGAAAAGATTAAAGTCCAACAGCCTAAGTCGGATGATCGTCACTTCCATTTTGAGAATCAAGATGCGCTAAATAAAAAATATTTAATGCAATTATATGATTTTAGCATCACTATTGATGGTAAGAATATTTATCAAAATGCAAATTTCGAAATTAAAGATAATGAAAACATTATACTTACTGGCCCGAATGGTAGTGGCAAATCATTATTAATCTCAATTATCAAGCAGTCAATAATACCAGATGAGGGTGATATTTATATAACGCCTTCTCTAAAAATAGCTTATTTTGACCAAAAAAATGACAATTTAAATTATGACAGCACAGCATTAACAATGTTATTAAACATGGAGGGTATGGAACGTAGTCAAGCACAAACGATATTAGCGTCATTTGGATTTGATAACCAAAAAATAAACCTTCCAATTTCTCAATTATCTATGGGAGAGAAAAGTAGATTACAGTTTGTATTATTATATTTCTCAAATCCACATTTATTAATTCTCGACGAACCAACCAATTACTTCGATATTGCTACGCAAGATTTAATATTACAGATGCTAAAGCAATTTGCAGGACAAGTAATGATTGTGACGCATGATGAATACTTGAAATCTCAAATTACAGCGACACATTGGACAATTAAAGATAAAAAGTTAATGAATTTAACATTATCAGAGAAGCATTCACCCAATATGGTGGATGATACATTAAAATTATTAGATGATTATAAGTCGATAGATGAATTCGGACATTTTGAAACAGACAACTAG
|
Multi-drug resistance
|
Multi-drug ABC efflux pumps
|
Drugs
| 1 |
MEG_8691|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|SALE
|
ATGTCTTTTTATTTTGCCCAAAAACCTTTTGAAATGTTTGGAAAAACACTGATTCAGTCAGTGGATTTACAATTTGAAAAGGGTGAACATATTGCTGTGATTGGTAATAATGGCGTTGGGAAAACGACTTTATTAAAAGCATTAAATAATAAGTATAAAGAAGATACTTATTTGATGGACCAAAACATGACTACCTTTGGAAACATGACGGGGATAGACTATGTAATAAGCTTAAACACAGAATTGTTTCATTTAAAACAAGCGTTAATGGATAACTATGAAAAAGTTTCAGATTATATCGCTTTAAATGGCTATGAATTTGAACAAACCATTATAACTAAAGCGAAGCAAATGGCTCTAACGGAAGCAGATCTTGACAAACCAATTAAAGTATTAAGCGGCGGCCAACAAACTAGGCTTGCTTTATTGAGAGCATTTATTTCAAACAAACCATTGATATTGCTGGACGAACCAACCAATCATTTAGACCAAGAAATGATAGACCAATTGATTAACCATATACAACAATCAAAACGCACAATCATATATGTGTCGCATCATAGAGGATTTATAGATCAGACCGCGAGTCATGTTATAGAAATAACACCCGAAAGTACAAGAAAATTTAATGGCAATTATAAGCAATACAAAGAGATAAAAGATTTAGAAAGTCAAACAGAACAACGTATATATAATAAACAACAAAAAGAAATACAAGACCTCGAACGTACGATCAAACGCGTACAAACATGGCATCATTCTGCTCAGCAAAAAGCAAGTGTACGTAATCCGATTGAACAGAAAAAGTTGAGCAAATTAGCGCAAAGGGCAAAGGTGAAGGAAAAACAATTAAACCAAAAATTACAAGAAAAACATATTCAAGAACCGAGTAAAGAAACAAAGTCATATTACTTTAGTCATCAGACTAGCCTTCCTAAACGTTTCTTAATTCGTTTTGAAGATGTTAGCGTTAATATTGATGGACAAGCTATATATAAACACGCTCATTTTGAAATGAAACAAAATGAAAATATATTACTTACTGGTCCAAATGGAAGTGGTAAATCGCTTTTCATCGCTTTGATTAGACAGCATTTATCACCAGACGAAGGTATTATAGAGATTACGCCATCGTTAAAGATAGGTTACTTTGATCATACAAATAACAATCTAAATGAAGCAGAATCTCCATTATCAATGTTGTTAGTAAGAACTAACATAACGCGTAGCCAAGCGCAGACATTACTTGCTTCATTTAATTTTGATAAGGATCAAATCAAAAAACCAATTCGCTATTTGTCTATGGGGGAAAAAAGTCGTTTACAATTTGTATTATTATATTTTTCAGGTGCTAATTTATTAGTATTGGATGAGCCTACGAACTATTTTGATATTGTAACTCAAGATTTAATTTTAAGTATGATTCAAAGTTTTACCGGTCAAGTATTGATTGTTACACATGATTCATATTTACAATCTCAATTTAAAGCTGTACATTGGGAAATAAAAAATCAACAACTTTATAATGTATCTTTAACTCATACGCGTGAATCAAACTTAGATGAAACCCTTAAGTTACTAGGTGAATATAAATTTATAGATGAAAATGGTCATTTTGAAACAGACAACTAG
|
Multi-drug resistance
|
Multi-drug ABC efflux pumps
|
Drugs
| 1 |
MEG_8083|Drugs|MLS|23S_rRNA_methyltransferases|ERM52
|
ATGAAAAATCTTGGATATTCACAAAATTTTTTGGTTAATAAAAAGTTGGTAGAACGTTTAATAAGCAAGTCAAATATTGATGTAACAGATTATGTTATTGAAATTGGTCCTGGAAAAGGGATAATAACAGATGTACTTTCTCAGCATGCTGGAGAGGTTGTTGCAGTTGAATATGATCAAGAATTATATAATAATTTAGTAAGATATCACAGTCATGATAATGTTACATATATATTTGGTGATTTTTTAAAATATAAGTTGCCTTTAAATCGCAGATATAAAATATTCTCCAATATTCCTTTTCAGATAACAGCGGATATTATTAGGAAATTAACAGACGATGTAAATCCACCATCAGATATAAATATCATAATTCAAAGAGAGGCAGCTAAAAAGAATTGCGGTATTCCATTACAAAAATATGAAGGTTTTCGTGCTGCTATAATAAAGGCACAATATAAGGTAGAAATTACACATAGTTTTAAAAGGAGCGATTTTTTTCCTTCGCCTAATGTTGATACAGTTATGCTTCATATGCAGTTATGGGATGATAGATTGAGTGGTGATGATCTTCAAAATTATAAAGATTTAGTGGCTTTTTTTTACACTAATATTAAAGGAGAGACTGCTAAAGAGAGACTTTCTATTTTATTTTCTAATGAGCAAATCAAAAGATTGGGAAAAGCCAATAGAATTAGTCTTTCAAATTCATATACGTTAATCACGGCCGAGCAGTGGATGAATATTTATTATTACTCCAAAATTGGATTGACAGATGAAAAGAAAAAAAAGTTTCAAGATGCATATAAAAAACTTCAAAAAATGAATAAAAAATTGAAAAAGCAAAACAGAACATCTTTACGAAAGTCTAGTAGCAATAAGAAATGTAGAACAAGGATTGATACTTCTAATGGTACAAAAAATAGATAG
|
MLS
|
23S rRNA methyltransferases
|
Drugs
| 1 |
MEG_8259|Drugs|MLS|MLS_resistance_ABC_efflux_pumps|MSRG
|
ATGGAACAAATCTGTTTTGAATTAGAAAATGTAGAAGTGACATATCTAGATAAAGAGGTTTTAAAGATTGAAAGATTAGCTGTACACCAATTTGACCGTATCGGCATAGTCGGTAAAAATGGTGCAGGTAAAAGCACGTTACTAAAATTACTGGCGGGTATCATTAAGCCAACAACGGGAAAGGTGAATCGGCTTGTTGAGAATGGCTATTTTGAGCAACTTGAAACTCCATCAGTACGTGATGCTGATCCAGTGTTACTTGGAAAATTAGACGTACCAAAAGACTCTAATCAGCTAAGCGGTGGGGAACAAACAAGGATGAAACTCGCTAAATTGTTTACTCATTATTATGAAGCTTTATTAATTGATGAGCCGACTACTCACTTAGACCAAGAGGGGATTTCGTTTTTGCTCGATGAACTTAGGTATTACTATGGAGCGCTTGTATTAATTAGTCATGACCGTTCTGTATTAGATGAACTAGTTACGACAATTTGGGAAGTTCATGAAGGTAAGGTACGAATCTATTCAGGAAATTACAGCGACTACATGGCACAAAAGAAGTTAGAACGTGAACAGCAGAGTCAAGCACATGAACAGTTCATAAAAGAAAAGAGCAGGTTAGAAAAAGCAGCACAAGAAAAAATGAAGAAAGCTGAAAAAGTTGCACAAGCAGGTCGATTGTCAAAAAAAGATGCGAATGCAAAGCCGGATAAGTCCTTTATGACAAAATCCAAAGGTACGAGCCAAAAAGCTATGCAGCGTGCAGCAAAGGCCATTGAGCAACGAATGGAAAAACTTCAGGAAGTCGATGCTGTAAAAGAGGATAGGCAAATAAACTTCCATCAATCGAGAAATTTAGAGCTGCATAATAAATTTCCGATAATGGCAGACCGATTTACTCTTCAAGTGGATAACAAAGTATTATTAAATGAAGTAAGTTTTCAAATGCCGCTTGGTAAAAAAATTGCAATTTCGGGTAAAAATGGTGCTGGCAAAAGTACTTTACTCCACCATATTGCTATCAATGCGCCAGGTTTAACAATTTCACCAAAAGCAAAAATTGGATACTTTCGTCAAATGAGCTATCAATATACAAGGGATGAAACGGTATTGGAATTTCTGAAAAATCGTTCTGAATACGATGAGAGATTTTTACGAAGCGTTCTACATTCCATGTTGTTTGTCGGCACAGATATATTAAAAAGTGTAAAATCATTAAGTGGTGGTGAAGCGATTCGTCTACAATTATGTCAATTATTTTTAGGAGAGTATAATATTTTATTGTTAGATGAACCAACCAATTTTTTAGATATCTATGCTATTGAAGCGTTAGAAAGATTTATTACAGCATATAAAGGCACTATTATCTTCGTATCACATGATCGCAGGTTTATTGATTGTGTAGCAGATTGTATATATTTCATTGAAGATCAACAGCTAAAATTAAGGGGTTGA
|
MLS
|
MLS resistance ABC efflux pumps
|
Drugs
| 1 |
MEG_8262|Drugs|MLS|MLS_resistance_ABC_efflux_pumps|MSRL
|
ATGGAACAAATTTGTTTTGAATTAGAAAAAATTGAAGTAACTTATTTAGATAAAAAAGTATTAGAGATAGATCGTTTAGCAGTTCATCAATTTGATAGAATTGGTATTGTTGGAAAAAATGGTGTTGGTAAGAGTACTCTGCTAAAATTACTTGCAGGTCATATTCAACCTACAGTTGGAAAAGTAAAGCGTCAAGTAGAATATGGTTATTTTGAACAGGTAGAAGGTCCTAAAGATATATCAACAGATCCTAAGTTACTTAGCCAATTACATGTTGATGAGAATTCGAAAGGGCTAAGTGGTGGTGAACAAACAAGATTAAAACTTGCACAGTTATTTACGGACTATTATGAATCTTTATTAATTGATGAGCCAACTACACATTTGGACCAAGAAGGTATATCATTTTTAATAGAAGAGTTGAAATACTATTATGGGGCACTGGTATTAATAAGTCATGACCGATATGTTTTAGATGAACTTGTGACTACAATTTGGGAAGTTGATGATGGGAAAGTAAAAGTATATTCAGGAGATTACAGTGAATATATCGAGCAAAAGAAACTTGAAAGATCAAAACAAACTCAGGCTCATGAACAGTTCTTAAAGGAAAAAAAACGTTTAGAAAAAGCAGCAGAAGAAAAAATGAAAAAAGCAGAAAAAATTGCTAAATCTTCTGCTAAATCAAAAGACTCTAAAGTAAAAGCAAATCGTATGTTTGAATCAAAATCAAAGGGTACAACTCAAAAAGCGTTACAACGTGCTGCTAAGGCTGTTGAACAAAGAGTAAAAAAACTTGAAGTTATAGATGCGCCTAAAAAAGAACAAACTATCCGTTTTCATCAAACAAATATCATACTTGAGTTACATAACAAGTTTCCAATTATGGCTGATCAATTAACGATTACAGTAGGAAATAAGATACTTTTAAACAATGTTAACTTTCAATTTGCATTAGGTGAAACGATTGCTATTACTGGTAAAAATGGTTCTGGGAAATCAACATTAATTCACCACATATTACAACGTGAAAAAGGAATTACTATTTCTCCAAAGGCTGTTATAGGCTCTTATGAGCAGATGGGATATCAATTTAAAACTGATGAAACTGTAATGGACTTTATGAAAAATAGAAGCGATTATGGAGAAAGTAAAATACGTTCTGTACTATATGCTATGAGTTTTACTGGGAATGATTTAAAAAAGAGTGTTCAAAAATTAAGTGGTGGCGAGGCGACTCGTTTAGTCCTATGTCAATTATTTCTAGGAAGATACAACGTTTTGATTTTAGATGAACCTACTAACTTTTTAGATGTTTTTTGTATTGAAGCTTTAGAAACATTTTTAAAAGGCTATGAAGGAACAGTTATACTAATATCACATGATAAAACATTTTTAGATCGTGTAGCTGATAGTGAATACGTTCTAGAAAATCAGAACCTTAAAAAAAATAGATAG
|
MLS
|
MLS resistance ABC efflux pumps
|
Drugs
| 1 |
MEG_8244|Drugs|MLS|MLS_resistance_MFS_efflux_pumps|MEFF
|
ATGAATAATATGAATTGGAAACGGAAATTTATTGCGATTTTTACAGGGCAGTTCTTTTCACTATTAAGCAGTGCTGCTGTTCAATTTAGTATCATTTGGTGGTTAACAGATACATCAGGAGGTTCTCCACTGATTTTAACATTAGCAGGACTGGCTGGATTTATGCCACAAGCATTGTTAGGTCCTTTTGCAGGAACTATTACTGATCGTTATTCACGAAAAGTGATTATGATAATTGCAGATATGACGGTTGCACTTGGAAGTTTAGCTTTATTTGTATCAATGTATTTTTATGATCCGAGTATTATATTGGTGATAATTGTATTGATCGTTCGTTCATTAGCAACTGCATTCCATATGCCGGCTATGCAAGCGTCTATTCCACTAATAGCCCCAAAAGAGCATTTGACAAAAGTTTCTGGATGGGGACAGACAGTGGCTTCTATATCAAATATTGTTGGTCCAGCAGCGGGGATGTCATTACTAGCGATAAGCTCCGTTGAGTGGGTTCTATTACTAGATGTCTTTGGGGCAGTAATTGCTAGTAGTATTTTGCTATTTATTCACATTCCAAATGTACAGAGTTCAGAAACTGTTGATTCTTCTAGTTTTATCAGCGATATGAAAGAAGGATATCATGCACTTGTAAAACATCCTGTTTTATTAAGGTTAACAGTCACGATTACGATTGTTTCGGTGCTGTATATTCCGCTAGGCACTTACTTTCCGCTTATGACACGAAATCATTTCGAGAAGGGCGTAGTTGAAGCTGGAATAATCGAAATTGTTTTTGCTGTTGGCCTCATCTTTGGTGGTATATTAATGGGGATTTTCGGAGATCGATTTGAAAAATTGAAACTCATTGTTAGCGGAATGATACTGATGGGGATTGCCTTATTCATTTCTGGCACACTTCCATCAACTTTATTCTATGGATTTATCGTAATGGCTGGTCTAGTGGGATTGTCTGGTCCATTATTTTCAGCTCCGTTTTATGCTCTTATCCAAACCGAAATTGAACCTCATTTACTTGGGAGAGTGTTTAGTTTTGTTGGAAGTTTGGCATTACTTGCAACACCGTTGGGTTACGCATTTGCTGGGGTTCTGATCCACTTAACAAATGTGGCCGTATTATTTTTGATTACAGGTATATTAATTGTATTAAATGCTGTTATCGTAAGGAAAGCAAAATAG
|
MLS
|
MLS resistance MFS efflux pumps
|
Drugs
| 1 |
MEG_8082|Drugs|MLS|23S_rRNA_methyltransferases|ERM51
|
ATGCCTACCTACAGGCCGAACAAGGGCCGTCACGAGAACGGCCAGAACTACCTCGTCAACAAGTCAATGATTAAGAAGGTCGTTGACCTTGTCCCTGTCAGTGCGTCCGTCCCGGTCATAGAGATCGGCCCGGGACACGGGGCGCTGACCTTTCCCCTCCAGGACCGTGTCCTGGCTACCGGTGGATCGTTGACCGCCGTCGAGATCGACCCGGCCTCCGTCCGGTGGCTGGAGGAGCGGCTGCGCCCGGAGGTTCACCTGTACGAGCAGGACGTCCTTGATTTTGTGCTGCCGGACGGCCCGCACGTCCTGGTGGGGAACCTGCCGTTTCACCTGACCACCGCGATCCTGCGGCACGTCCTTCACTCACCGGGGTGGACTCACGCGGTCTTCCTGGTGCAGTGGGAGGTCGCGCGTCGCCGCGCCGGCGTCGGTGGTGCCACGATGATGACAGCCCAGTGGTGGCCCTGGTTCGACTTCGAACAGCACGGGCGAATACCATCCACACATTTCCGTCCCCGCCCCACCGTCGACGCCGGTGTCCTGGTGATGCGTCGCCGGGAAGAGCCTCTCGTCAACTGGTCGGAGCGTGCGCGGTACGCGTCGTTCGTCCATGCCGTGTTCACCGGCAAGGGCCGAGGCATCGCCGACATCGTGTCCCGGGTCGTGGGGCGTCGGCGTGAACGACGGTGTGCTGAGGTCCTGCGTGAGGCCGGTGTTCCGGCAAACGCACTGCCGAAACAGTTGGACGCGGGGCAGTGGGCCACACTGTTTAAGGCCGTGGGGCGCTAA
|
MLS
|
23S rRNA methyltransferases
|
Drugs
| 1 |
MEG_8246|Drugs|MLS|MLS_resistance_MFS_efflux_pumps|MEFJ
|
ATGGAAAACAACAAATGGAAGCAGAAGTTTTTTGCAATATATACAGGACAATTCTTTTCACTATTAAGTAGTGCGGCCGTTCAATTTGGTATTATTTGGTGGCTAACTGATAAAACTGGTGGTTCACCATTGCTTCTAACACTAGCAGGACTTGCAGGTTTTTTACCACAAGCATTAGTAGGACCTTTTGCTGGCACGATTACAGACCGTTATTCACGGAAGTTTTTGATGATTTCAGCAGATATGACTGTTGCGTTAGGTAGTTTAATTTTATTTTTAATATTGCATTTCTATGAGGCTAATATCATTTTTGTAATTCTGATTTTAGCACTTAGATCATTAGCAACTGCTTTTCATATGCCAGCAATGCAAGCATCAATTCCTTTACTTGCCCCTGAAGAAGCATTGACAAAGGTCGCTGGTTGGGGGCAAATGGTAGCATCCGTTTCTAATATAGTAGGACCAGCTGTAGGGATGTCAATTCTTTCAGTGAGCTCAATTAAATGGGTACTACTTTTAGATATACTTGGAGCTGTAGTTGCAAGTGGGATTTTACTTTTTATAAATATACCTAAAATACAAAAAACTGAATCTGTTGAACTTACAAGTTTTTTTGTAGAAATGAAAGAAGGGTATAATGCCCTTGTTAATCATCCTATCTTGTTGAAACTTACAATACTTATGACAATCGTAGCAGTCCTATACATACCACTTGGAACTTACTTCCCACTTATGACAAGAAATCATTTTGGGAAAGGTGTTGTTGAAGCTGGTACAGTAGAGATTGCATTTGCTATCGGTTTAATAGTAGGCGGTTCATTGTTAGGTATAATAGGTGATAAATTTGAAAAAGTGAAGACAATGGCAATTGGAATGCTATTGATGGGACTGGCACTATTTTTCTCTGGTCTTCTCTCACCATCACTTTTCTTTATCTTTATAATTTTGTCCGGATTGGTTGGATTTTCAGGACCTTTATTTTCTGCACCATTCTATGCTTATATTCAAACTGAGATTGAGCCACAATTATTAGGAAGAATTTTCAGTTTTGTAACAAGTCTCTCACTTTTAGCCACGCCAATTGGATATGCATTATCTGGTTTACTAATTGAATTTACTAGTGTTTCTATATTGTTTTCAATCATTGGTGTATTAGTAATACTAAGTGGTCTTATTACTTTAAAAGTGAAATAG
|
MLS
|
MLS resistance MFS efflux pumps
|
Drugs
| 1 |
MEG_8724|Drugs|betalactams|Class_B_betalactamases|VAM
|
ATGAATTTTCTGATAAAAAATATTCTGCTCATTACTCTTTTTGTTCCTTTTGTAACAGCAGCAAACAATACAGACACTAAAACGCTGGAGGTTAAACAATTAACCGATAATATCTATCAGCATATCTCATATAAACATGTTGAGCCTTGGGGGTTTATTGGCGCGTCTGGCTTAATTGTAGTCGATGGAGATGCGGCATACCTGATTGACACTCCTTGGACGACCAAAGCAACCAATCAACTTATTGAATGGATTGAAGATAGAGGTCTCGTACTAAAAAGCGCAATAGTAACTCACTTTCATGAAGATGCGAGTGGTGATTTACCACTTTTAAATGATTTAAAAGTTAACACTTATGCCACTTCACTCACTAATCAACTTCTTAAACTCAATAACAAAGAAATTTCGAATACTGAAATATCGAGCAATGAACTCAAAATTTTCAACGGCATTGCGACAGTGTATTATCCTGGCCCAGGCCATACTGAAGATAACATCGTTGTTTGGTTACCGAATGAAAAGCTATTATTTGGCGGTTGCTTTGTTAAAAGCCTCCGTAATAAAAGTCTAGGTTACACTGGAGATGCAAATATAGGCGAATGGTCGAACTCTATTCAAAGAGTGCTGCAACGCTATCCAGATATAGTCACTGTAGTGCCTGGGCATGGTCAGGTTGGAGACGTTAGTTTACTCCTTCATACACAAAAATTAGCATCATCCGATAAGACTTCTGACAAATAG
|
betalactams
|
Class B betalactamases
|
Drugs
| 1 |
MEG_8236|Drugs|Lipopeptides|Colistin_phosphoethanolamine_transferase|MCR
|
ATGATGCAGCATACTTCTGTGTGGTACCGACGCTCGGTCAGTCCGTTTGTTCTTGTGGCGAGTGTTGCCGTTTTCTTGACCGCGACCGCCAATCTTACCTTTTTTGATAAAATCAGCCAAACCTATCCCATCGCGGACAATCTCGGCTTTGTGCTGACGATCGCTGTCGTGCTCTTTGGCGCGATGCTACTGATCACCACGCTGTTATCATCGTATCGCTATGTGCTAAAGCCTGTGTTGATTTTGCTATTAATCATGGGCGCGGTGACCAGTTATTTTACTGACACTTATGGCACGGTCTATGATACGACCATGCTCCAAAATGCCCTACAGACCGACCAAGCCGAGACCAAGGATCTATTAAACGCAGCGTTTATCATGCGTATCATTGGTTTGGGTGTGCTACCAAGTTTGCTTGTGGCTTTTGTTAAGGTGGATTATCCGACTTGGGGCAAGGGTTTGATGCGCCGATTGGGCTTGATCGTGGCAAGTCTTGCGCTGATTTTACTGCCTGTGGTGGCGTTCAGCAGTCATTATGCCAGTTTCTTTCGCGTGCATAAGCCGCTGCGTAGCTATGTCAATCCGATCATGCCAATCTACTCGGTGGGTAAGCTTGCCAGTATTGGGTATAAAAAAGCCAGTGCGCCAAAAGATACCATTTATCACGCCAAAGACGCGGTACAAGCAACCAAGCCTGATATGCGTAAGCCACGCCTAGTGGTGTTCGTCGTCGGTGAGACGGCACGCGCCGATCATGTCAGCTTCAATGGCTATGAGCGCGATACTTTCCCACAGCTTGCCAAGATCGATGGCGTGACCAATTTTAGCAATGTCACATCGTGCGGCACATCGACGGCGTATTCTGTGCCGTGTATGTTCAGCTATCTGGGCGCGGATGAGTATGATGTCGATACCGCCAAATACCAAGAAAATGTGCTGGATACGCTGGATCGCTTGGGCGTAAGTATCTTGTGGCGTGATAATAATTCGGACTCAAAAGGCGTGATGGATAAGCTGCCAAAAGCGCAATTTGCCGATTATAAATCCGCGACCAACAACGCCATCTGCAACACCAATCCTTATAACGAATGCCGCGATGTCGGTATGCTCGTTGGCTTAGATGACTTTGTCGCTGCCAATAACGGCAAAGATATGCTGATCATGCTGCACCAAATGGGCAATCACGGGCCTGCGTATTTTAAGCGATATGATGAAAAGTTTGCCAAATTCACGCCAGTGTGTGAAGGTAATGAGCTTGCCAAGTGCGAACATCAGTCCTTGATCAATGCTTATGACAATGCCTTGCTTGCCACCGATGATTTCATCGCTCAAAGTATCCAGTGGCTGCAGACGCACAGCAATGCCTATGATGTCTCAATGCTGTATGTCAGCGATCATGGCGAAAGTCTGGGTGAGAACGGTGTCTATCTACATGGTATGCCAAATGCCTTTGCACCAAAAGAACAGCGCAGTGTGCCTGCATTTTTCTGGACGGATAAGCAAACTGGCATCACGCCAATGGCAACCGATACCGTCCTGACCCATGACGCGATCACGCCGACATTATTAAAGCTGTTTGATGTCACCGCGGACAAAGTCAAAGACCGCACCGCATTCATCCGCTGA
|
Lipopeptides
|
Colistin phosphoethanolamine transferase
|
Drugs
| 1 |
MEG_8233|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|LSAD
|
ATGTCGAATATTAAAATAAATAATTTAACATTTGGTTATACCGATCAGCTTATTTTTGACAATGTAAATATCAATATTGATGACCAATGGAAGCTGGGATTGGTTGGCCGTAACGGGAGAGGGAAAACTACACTTTTAAAAATCCTTCTTGGAGAAGTGGATGTACATCTTGAAATTAAAACCAATAAGAGCTTTGTGTATTTTCCTCAGACGATTAATGATAAAGACCAGTTGACCTTATTTGTCTTGCAAGAGTTAGCTGACTTTGAGCAGTGGGAACTTGAGCGTGAATTGACACTAATGGGCGTAGATTTAGATACTTTATGGCGTCCTTTCAATAGTCTTTCTGGTGGAGAGCAAACAAAGACACTCTTAGCACTTTTATTCTTGGATGAGCATAATTATCCGCTCATCGATGAGCCAACCAATCATCTTGATAAAGCTTCACGTGAGAAAGTTGCAGCCTACTTGTCAGAAAAAAAGGGATATATTTTAATCTCACATGACCGTAATTTTCTCAATAAGACGACAGATCATACACTTGCGATAGAGCGTGCGGACTTACAAGTATATGCAGGTAATTTTGCTATCTACGAGGAGGAAAAAAGATTGCGAGATCTCACGGAAAAGGCACAAGATGATAAACTCAGGAAAGAAATCGGTAGATTGAAACAAACGGCGCGTGAAAAAGAAGCGTGGTCGCGTAACTTAGAAGCAACAAAATCCCGTAAGAAACGAGGTTTTGATTCGGAAACAAAACGTGTTGATAAAGGTTTTATTGGACGAAAAGCAGCAAATATGATGCAAAAGTCTAAAAATCTCGAAAAGCGCATGAAAGAGGATATCGCTGACAAGGAACTACTTCTAAAAAATTGGGAAGAAGTACCTGGATTGGAAATGAGTGTCTTAGAGAGTCATCAAAAACGCTTACTGACAGTGGAAAATTTAGCGGCTGGATTTGAAGACTTTCTTTTTGAACCTGTGTCTTTTACACTTGAACAAGGTCAGGTGCTTGCACTAACAGGAGAAAATGGTAGAGGAAAATCTTCTCTAATGAAAGTCCTCACAGGTGAATTTACTGGCCGTTATGTTGGAACATTTGAGTTGGCCCATAACTTGGTCATTTCCGAAGTAAGACAACTTGCAGATAATAGAGGGTTTCTGAACGAGTTTGCCAAAAAAGAAAACTTAGAATTAGAACTTTTTCTCAACAATTTGCGCAAATTAGGCGTAGAGCGCAAAGTTTTTGAGCAAAAAATCGAAAATATGAGTCAGGGACAGCAGCGTAAAGTCGAACTGGCCCGCGCCTTAAGTCAGCCGGCGCATATTTATCTTTGGGATGAACCCCTCAACTATCTTGATGTTTTTAATCAAGAACAAATTATTCAAATGATAAAGAGAAGCAAGCCTAGTATGCTTGTCATTGAGCACGATCAGTATTTTGTTGATCAAGTAGCAGATGCCCAAATCGAACTCATAAAAAGCAGCGTTTAA
|
Multi-drug resistance
|
Multi-drug ABC efflux pumps
|
Drugs
| 1 |
MEG_8640|Drugs|betalactams|Class_C_betalactamases|PRC
|
ATGCGCCACCTGTACCGCCCTCTGTTCGTCGCCCTGGCGCTGCTGGCCGCCAGCCACGCGCCGGCCGCACCTTCACTGGAAACACAGGTGGACGCCGCTGCGAAGTCGATGATGCAGACCCATGCCATTCCCGGCATGGCCATCGCCATCAGCCACAAGGGGCAGTCGCATTTCTTCGAATACGGCGTCGCATCCCTTGAAAACGGCCAGACGGTGGATCGCCATACCCTTTTCGAGCTGGGCTCGATCAGCAAACTCTTCACCGCCACCCTCGGCGCCTACGCCGAAGCGCGCGGCACGCTGAACCTCAGTGACAACGCCAGCCAGTATCTGCCGGCCCTGCAGGGCAGCGCCTTCGATCACATCAGTTTGCTGGATCTGGCCACTTACACCTCGGGCGGCCTGCCACTGCAGTTCCCGGACACGGTCAGCAACGAACGGCAGATGCTCGATTACTACCGCAACTGGCAGGCGGTGTATCCGCCGGGTACGCAGCGGCTGTATTCCAACCCCAGCATCGGCCTGTTCGGCCACCTGGCAGCAGCCAGTCTGGCCAAGCCGTTTCAGCAGTTGATGGAGAAGGATCTGCTGCCGCAACTGAGCATGCAGGAAAGCTACGTCCGTATACCGACCGAGCAGATGGAGCACTATGCCTGGGGCTACCGCGACGACAAGGCGGTGCGCGTGACGCCCGGCGCGCTGGATGCCGAAGCCTACGGGTTGAAATCTACTGCCGCCGACGTGCTACGCTTCATCGACGCCAATCTGCACCCGGATCAACTACCCGCACCACTGCGCCAGGCGATCAGCGCAACACATCGTGGCTACTACCAGGTCGGCGACATGACTCAGGCGCTGGGCTGGGAGCGCTACGCCTACCCCATCAGCCTAGAAAAACTGCAGGCTGGCAACTCAGCAGAAATGGCGCTGCAACCGCAGACCGTGGCGCGTTTCGCTGCGCCCAAGCCTGCCGAAGGTGACCTGCTGCTGAACAAGACCGGCTCGACCAACGGCTTCGGCGCCTACATCCTACTGCTGCCGGCGCGCGATACCGGCCTGGTGATACTCGCCAACCGCAATTACCCCAATGCCGAACGCGTGCGCCTGGCCTTGCAATTGCTGGACGCGATCGAGCCGTAG
|
betalactams
|
Class C betalactamases
|
Drugs
| 1 |
MEG_8185|Drugs|betalactams|Class_A_betalactamases|KPC
|
ATGTCACTGTATCGCCGTCTAGTTCTGCTGTCTTGTCTCTCATGGCCGCTGGCTGGCTTTTCTGCCACCGCGCTGACCAACCTCGTCGCGGAACCATTCGCTAAACTCGAACAGGACTTTGGCGGCTCCATCGGTGTGTACGCGATGGATACCGGCTCAGGCGCAACTGTAAGTTACCGCGCTGAGGAGCGCTTCCCACTGTGCAGCTCATTCAAGGGCTTTCTTGCTGCCGCTGTGCTGGCTCGCAGCCAGCAGCAGGCCGGCTTGCTGGACACACCCATCCGTTACGGCAAAAATGCGCTGGTTCCGTGGTCACCCATCTCGGAAAAATATCTGACAACAGGCATGACGGTGGCGGAGCTGTCCGCGGCCGCCGTGCAATACAGTGATAACGCCGCCGCCAATTTGTTGCTGAAGGAGTTGGGCGGCCCGGCCGGGCTGACGGCCTTCATGCGCTCTATCGGCGATACCACGTTCCGTCTGGACCGCTGGGAGCTGGAGCTGAACTCCGCCATCCCAGGCGATGCGCGCGATACCTATACCTCATCGCCGCGCGCCGTGACGGAAAGCTTACAAAAACTGACACTGGGCTCTGCACTGGCTGCGCCGCAGCGGCAGCAGTTTGTTGATTGGCTAAAGGGAAACACGACCGGCAACCACCGCATCCGCGCGGCGGTGCCGGCAGACTGGGCAGTCGGAGACAAAACCGGAACCTGCGGAGTGTATGGCACGGCAAATGACTATGCCGTCGTCTGGCCCACTGGGCGCGCACCTATTGTGTTGGCCGTCTACACCCGGGCGCCTAACAAGGATGACAAGCACAGCGAGGCCGTCATCGCCGCTGCGGCTAGACTCGCGCTCGAGGGATTGGGCGTCAACGGGCAGTAA
|
betalactams
|
Class A betalactamases
|
Drugs
| 1 |
MEG_8183|Drugs|betalactams|Class_A_betalactamases|KPC
|
ATGTCACTGTATCGCCGTCTAGTTCTGCTGTCTTGTCTCTCATGGCCGCTGGCTGGCTTTTCTGCCACCGCGCTGACCAACCTCGTCGCGGAACCATTCACTAAACTCGAACAGGACTTTGGCGGCTCCATCGGTGTGTACGCGATGGATACCGGCTCAGGCGCAACTGTAAGTTACCGCGCTGAGGAGCGCTTCCCACTGTGCAGCTCATTCAAGGGCTTTCTTGCTGCCGCTGTGCTGGCTCGCAGCCAGCAGCAGGCCGGCTTGCTGGACACACCCATCCGTTACGGCAAAAATGCGCTGGTTCCGTGGTCACCCATCTCGGAAAAATATCTGACAACAGGCATGACGGTGGCGGAGCTGTCCGCGGCCGCCGTGCAATACAGTGATAACGCCGCCGCCAATTTGTTGCTGAAGGAGTTGGGCGGCCCGGCCGGGCTGACGGCCTTCATGCGCTCTATCGGCGATACCACGTTCCGTCTGGACCGCTGGGAGCTGGAGCTGAACTCCGCCATCCCAGGCGATGCGCGCGATACCTCATCGCCGCGCGCCGTGACGGAAAGCTTACAAAAACTGACACTGGGCTCTGCACTGGCTGCGCCGCAGCGGCAGCAGTTTGTTGATTGGCTAAAGGGAAACACGACCGGCAACCACCGCATCCGCGCGGCGGTGCCGGCAGACTGGGCAGTCGGAGACAAAACCGGAACCTGCGGAGTGTATGGCACGGCAAATGACTATGCCGTCGTCTGGCCCACTGGGCGCGCACCTATTGTGTTGGCCGTCTACACCCGGGCGCCTAACAAGGATGACAAGCACAGCGAGGCCGTCATCGCCGCTGCGGCTAGACTCGCGCTCGAGGGATTGGGCGTCAACGGGCAGTAA
|
betalactams
|
Class A betalactamases
|
Drugs
| 1 |
MEG_8008|Drugs|betalactams|Class_A_betalactamases|BLAZ
|
ATGTTCGTTTTAAACAAGTTCTTTACCAATTCACATTACAAAAAAATTGTACCTGTCGTATTACTTTCATGCGCGACACTGATAGGGTGTTCTAATAGTAATACGCAATCAGAATCAACTAAACAAACAAATCAAACCAATCAAGTTAAGCAAGAAAATATAGGTAATCATGCTTTTGCTAAACTTGAAAAAGAATATAACGCTAAACTTGGTATTTACGCACTGGACACAAGTACGAATCAGACTGTTGCTTACCATGCAGATGATCGTTTTGCATTTGCCTCTACATCTAAATCATTAGCAGTGGGAGCTCTTTTACGTCAGAATTCAATAGAAGCTCTTGATGAAAGAATTACGTATACACGTGAAGACCTATCTAATTATAATCCAATTACTGAAATGCATGTGGATACAGGAATGACGTTAAAAGAACTTGCAGATGCTTCTGTTCGATATAGTGACAGTACGGCACATAATTTAATTCTTAAAAAGTTAGGTGGTCCATCCGCATTTGAAAAAATCTTGAGGAAAATGGGTGATACTGTTACTAACTCCGAGCGATTTGAACCTGAATTAAATGAAGTAAATCCAGGAGAAACACATGATACGAGTACACCAAAAGCAATCGCTAAGACGCTTCAATCTTTTACATTAGGAACTGTACTACCATCTGAGAAACGTGAACTGTTAGTAGATTGGATGAAGAGAAATACGACTGGGAATAAATTAATTCGTGCGGGTGTACCAAAAGGATGGGAAGTAGCTGATAAAACAGGTGCAGGATCTTATGGAACAAGGAATGATATCGCAATTATTTGGCCACCAAATAAAAAGCCGATTGTTCTTTCCATCCTTTCTAATCATGATAAAGAAGATGCAGAATACGATGATACACTTATTGCAGACGCTACGAAAATCGTGTTAGAAACTCTAAAAGTTACGAATAAATAA
|
betalactams
|
Class A betalactamases
|
Drugs
| 1 |
MEG_8184|Drugs|betalactams|Class_A_betalactamases|KPC
|
ATGTCACTGTATCGCCGTCTAGTTCTGCTGTCTTGTCTCTCATGGCCGCTGGCTGGCTTTTCTGCCACCGCGCTGACCAACCTCGTCGCGGAACCATTCGCTAAACTCGAACAGGACTTTGGCGGCTCCATCGGTGTGTACGCGATGGATACCGGCTCAGGCGCAACTGTAAGTTACCGCGCTGAGGAGCGCTTCCCACTGTGCAGCTCATTCAAGGGCTTTCTTGCTGCCGCTGTGCTGGCTCGCAGCCAGCAGCAGGCCGGCTTGCTGGACACACCCATCCGTTACGGCAAAAATGCGCTGGTTCCGTGGTCACCCATCTCGGAAAAATATCTGACAACAGGCATGACGGTGGCGGAGCTGTCCGCGGCCGCCGTGCAATACAGTGATAACGCCGCCGCCAATTTGTTGCTGAAGGAGTTGGGCGGCCCGGCCGGGCTGACGGCCTTCATGCGCTCTATCGGCGATACCACGTTCCGTCTGGACCGCTGGGAGCTGGAGCTGAACTCCGCCATCCCAGGCGATGCGCGCGATACCTCATCGCCGCGCGCCGTGACGGAAAGCTTACAAAAACTGACACTGGGCTCTGCACTGGCTGCGCCGCAGCGGCAGCAGTTTGTTGATTGGCTAAAGGGAAACACGACCGGCAACCACCGCATCCGCGCGGCGGTGCCGGCAGACTGGGCAGTCGGAGACAAAACCGGAACCTGCGGAGTGTATGGCACGGCAAATGACTATGCCGTCGTCTGGCCCACTGGGCGCGCACCTATTGTGTTGGCCGTCTACACCCGGGCGCCTAACAACCGGGCGCCTAACAAGGATGACAAGCACAGCGAGGCCGTCATCGCCGCTGCGGCTAGACTCGCGCTCGAGGGATTGGGCGTCAACGGGCAGTAA
|
betalactams
|
Class A betalactamases
|
Drugs
| 1 |
MEG_8667|Drugs|betalactams|Class_A_betalactamases|ROB
|
ATGTTAAATAAGTTAAAAATCGGCACATTATTATTGCTGACATTAACGGCTTGTTCGCCCAATTCTGTTCATTCGGTAACGTCTAATCCGCAGCCTGCTAGTGCGCCTGTGCAACAATCAGCCACACAAGCCACCTTTCAACAGACTTTGGCGAATTTGGAACAGCAGTATCAAGCCCGAATTGGCGTTTATGTATGGGATACAGAAACGGGACATTCTTTGTCTTATCGTGCAGATGAACGCTTTGCTTATGCGTCCACTTTCAAGGCGTTGTTGGCTGGGGCGGTGTTGCAATCGCTGCCTGAAAAAGATTTAAATCGTACCATTTCATATAGCCAAAAAGATTTGGTTAGTTATTCTCCCGAAACCCAAAAATACGTTGGCAAAGGCATGACGATTGCCCAATTATGTGAAGCAGCCGTGCGGTTTAGCGACAACAGCGCGACCAATTTGCTGCTCAAAGAATTGGGTGGCGTGGAACAATATCAACGTATTTTGCGACAATTAGGCGATAACGTAACCCATGCCAATCGGCTAGAACCCGATTTAAATCAAGCCAAACCCAACGATATTCGTGATACGAGTACACCCAAACAAATGGCGATGAATTTAAATGCGTATTTATTGGGCAACACATTAACCGAATCGCAAAAAACGATTTTGTGGAATTGGTTGGACAATAACGCAACAGGCAATCCATTGATTCGCGCTGCTACGCCAACATCGTGGAAAGTGTACGATAAAAGCGGGGCGGGTAAATATGGTGTACGCAATGATATTGCGGTGGTTCGCATACCAAATCGCAAACCGATTGTGATGGCAATCATGAGTACGCAATTTACCGAAGAAGCCAAATTCAACAATAAATTAGTAGAAGATGCAGCAAAGCAAGTATTTCATACTTTACAGCTCAACTAA
|
betalactams
|
Class A betalactamases
|
Drugs
| 1 |
MEG_8668|Drugs|betalactams|Class_A_betalactamases|ROB
|
ATGTTAAATAAGTTAAAAATCGGCACATTATTATTGCTGACATTATTATTGCTGACATTAACGGCTTGTTCGCCCAATTCTGTTCATTCGGTAACGTCTAATCCGCAGCCTGCTAGTGCGCCTGTGCAACAATCAGCCACACAAGCCACCTTTCAACAGACTTTGGCGAATTTGGAACAGCAGTATCAAGCCCGAATTGGCGTTTATGTATGGGATACAGAAACGGGACATTCTTTGTCTTATCGTGCAGATGAACGCTTTGCTTATGCGTCCACTTTCAAGGCGTTGTTGGCTGGGGCGGTGTTGCAATCGCTGCCTGAAAAAGATTTAAATCGTACCATTTCATATAGCCAAAAAGATTTGGTTAGTTATTCTCCCGAAACCCAAAAATACGTTGGCAAAGGCATGACGATTGCCCAATTATGTGAAGCAGCCGTGCGGTTTAGCGACAACAGCGCGACCAATTTGCTGCTCAAAGAATTGGGTGGCGTGGAACAATATCAACGTATTTTGCGACAATTAGGCGATAACGTAACCCATGCCAATCGGCTAGAACCCGATTTAAATCAAGCCAAACCCAACGATATTCGTGATACGAGTACACCCAAACAAATGGCGATGAATTTAAATGCGTATTTATTGGGCAACACATTAACCGAATCGCAAAAAACGATTTTGTGGAATTGGTTGGACAATAACGCAACAGGCAATCCATTGATTCGCGCTGCTACGCCAACATCGTGGAAAGTGTACGATAAAAGCGGGGCGGGTAAATATGGTGTACGCAATGATATTGCGGTGGTTCGCATACCAAATCGCAAACCGATTGTGATGGCAATCATGAGTACGCAATTTACCGAAGAAGCCAAATTCAACAATAAATTAGTAGAAGATGCAGCAAAGCAAGTATTTCATACTTTACAGCTCAACTAA
|
betalactams
|
Class A betalactamases
|
Drugs
| 1 |
MEG_8153|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation
|
ATGGGTAAAAACGAGGCCAGAAGATCGGCCCTGGCGCCCGATCACGGTACAGTGGTGTGCGACCCCCTGCGGCGACTCAACCGCATGCACGCAACCCCTGAGGAGAGTATTCGGATCGTGGCTGCCCAGAAAAAGAAGGCCCAAGACGAATACGGCGCTGCGTCTATCACCATTCTCGAAGGGCTGGAGGCCGTCCGCAAACGTCCCGGCATGTACATTGGCTCGACCGGTGAGCGCGGTTTACACCATCTCATTTGGGAGGTGGTCGACAACGCGGTCGACGAGGCGATGGCCGGTTATGCAACCACAGTGAACGTAGTGCTGCTTGAGGATGGCGGTGTCGAGGTCGCCGACGACGGCCGCGGCATTCCGGTCGCCACCCACGCCTCCGGCATACCGACCGTCGACGTGGTGATGACACAACTACATGCCGGCGGCAAGTTCGACTCGGACGCGTATGCGATATCTGGTGGTCTGCACGGCGTCGGCGTGTCGGTGGTTAACGCGCTATCCACCCGGCTCGAAGTCGAGATCAAGCGCGACGGGTACGAGTGGTCTCAGGTTTATGAGAAGTCGGAACCCCTGGGCCTCAAGCAAGGGGCGCCGACCAAGAAGACGGGGTCAACGGTGCGGTTCTGGGCCGACCCCGCTGTTTTCGAAACCACGGAATACGACTTCGAAACCGTCGCCCGCCGGCTGCAAGAGATGGCGTTCCTCAACAAGGGGCTGACCATCAACCTGACCGACGAGAGGGTGACCCAAGACGAGGTCGTCGACGAAGTGGTCAGCGACGTCGCCGAGGCGCCGAAGTCGGCAAGTGAACGCGCAGCCGAATCCACTGCACCGCACAAAGTTAAGAGCCGCACCTTTCACTATCCGGGTGGCCTGGTGGACTTCGTGAAACACATCAACCGCACCAAGAACGCGATTCATAGCAGCATCGTGGATTTTTCCGGCAAGGGCACCGGGCACGAGGTGGAGATCGCGATGCAATGGAACGCCGGGTATTCGGAGTCGGTGCACACCTTCGCCAACACCATCAACACCCACGAGGGCGGCACCCACGAAGAGGGCTTCCGCAGCGCGCTGACGTCGGTGGTGAACAAGTACGCCAAGGACCGCAAGCTACTGAAGGACAAGGACCCCAACCTCACCGGTGACGATATCCGGGAAGGCCTGGCCGCTGTGATCTCGGTGAAGGTCAGCGAACCGCAGTTCGAGGGCCAGACCAAGACCAAGTTGGGCAACACCGAGGTCAAATCGTTTGTGCAGAAGGTCTGTAACGAACAGCTGACCCACTGGTTTGAAGCCAACCCCACCGACGCGAAAGTCGTTGTGAACAAGGCTGTGTCCTCGGCGCAAGCCCGTATCGCGGCACGTAAGGCACGAGAGTTGGTGCGGCGTAAGAGCGCCACCGACATCGGTGGATTGCCCGGCAAGCTGGCCGATTGCCGTTCCACGGATCCGCGCAAGTCCGAACTGTATGTCGTAGAAGGTGACTCGGCCGGCGGTTCTGCAAAAAGCGGTCGCGATTCGATGTTCCAGGCGATACTTCCGCTGCGCGGCAAGATCATCAATGTGGAGAAAGCGCGCATCGACCGGGTGCTAAAGAACACCGAAGTTCAGGCGATCATCACGGCGCTGGGCACCGGGATCCACGACGAGTTCGATATCGGCAAGCTGCGCTACCACAAGATCGTGCTGATGGCCGACGCCGATGTTGACGGCCAACATATTTCCACGCTGTTGTTGACGTTGTTGTTCCGGTTCATGCGGCCGCTCATCGAGAACGGGCATGTGTTTTTGGCACAACCGCCGCTGTACAAACTCAAGTGGCAGCGCAGTGACCCGGAATTCGCATACTCCGACCGCGAGCGCGACGGTCTGCTGGAGGCGGGGCTGAAGGCCGGGAAGAAGATCAACAAGGAAGACGGCATTCAGCGGTACAAGGGTCTAGGTGAAATGGACGCTAAGGAGTTGTGGGAGACCACCATGGATCCCTCGGTTCGTGTGTTGCGTCAAGTGACGCTGGACGACGCCGCCGCCGCCGACGAGTTGTTCTCCATCCTGATGGGCGAGGACGTCGACGCGCGGCGCAGCTTTATCACCCGCAACGCCAAGGATGTTCGGTTCCTGGATGTCTAA
|
Fluoroquinolones
|
Fluoroquinolone-resistant DNA topoisomerases
|
Drugs
| 1 |
MEG_8287|Drugs|betalactams|Mutant_porin_proteins|OMP36|RequiresSNPConfirmation
|
ATGAAAGTTAAAGTACTGTCCCTCCTGGTACCAGCACTGCTGGTAGCGGGCGCAGCAAATGCGGCTGAAATTTATAACAAAGACGGCAACAAATTAGACCTGTACGGTAAAATCGACGGTCTGCACTACTTCTCTTCCGACGACAGCGTCGACGGCGACCAGACCTACATGCGTATCGGCGTGAAAGGCGAAACCCAGATCAACGACCAGCTGACCGGTTACGGCCAGTGGGAATACAACGTTCAGGCGAACAACACTGAAAGCTCCAGCGACCAGGCATGGACTCGTCTGGCCTTCGCGGGTCTGAAATTCGGCGACGCGGGTTCTTTCGACTACGGTCGTAACTACGGCGTTGTTTACGACGTAACTTCCTGGACCGACGTTCTGCCGGAATTCGGCGGCGACACCTACGGTTCCGACAACTTCCTGCAGTCCCGTGCTAACGGTGTTGCCACCTACCGTAACTCTGACTTCTTCGGTCTGGTTGACGGCCTGAACTTTGCTCTGCAGTACCAGGGTAAAAACGGCAGCGTGAGCGGCGAAGATCAGACCAACAACGGTCGTGACTTCCAGAAACAGAACGGCGAAGGCTTCGGCACCTCCGTAACTTATGATATCTGGGACGGCATCAGCGCTGGTTTCGCGTACTCCAGCTCTAAACGTACCGACGAGCAGAACAACTCTACCTTCGTGTCTAAGACCGATGGTGGTCGTTACGGTGTTCTGGGTGAAGGCGATCACGCTGAAACCTACACCGGTGGTCTGAAATACGACGCCAACAACATCTACCTGGCGACTCAGTACACCCAGACTTACAACGCAACCCGCACCGGTAACATCGGTTTTGCTAACAAAGCGCAGAACTTCGAAGTCGTTGCTCAGTACCAGTTCGACTTCGGTCTGCGTCCGTCCGTGGCTTACCTGCAGTCTAAAGGTAAAGACATGGGCCGTTACGGCGACCAGGACATCCTGAAATATGTTGACCTGGGTGCGACCTACTACTTCAACAAAAACATGTCCACCTACGTTGATTACAAAATCAACCTGCTGGACGACAACAAGTTCACTAAAGATGCAAGCATCTCTACTGACAACGTTGTGGCTCTGGGCCTGGTTTACCAGTTCTAA
|
betalactams
|
Mutant porin proteins
|
Drugs
| 1 |
MEG_8448|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|PARC|RequiresSNPConfirmation
|
ATGACCAGCCTTGCGCATCATGCGACAGAAAACCGCTCTGTAGCCGAATTTACTGAACAGGCTTACTTGAATTATGCCATGTACGTCATTATGGACCGTGCATTGCCGCATATCAGTGATGGCTTAAAGCCCGTACAGCGCCGTATTGTCTATGCTATGAGCGAGCTAGGCTTAAAAAGCAGTGGCAAGCCAAAAAAATCAGCGCGTACAGTGGGTGATGTACTTGGTAAATACCACCCACATGGTGACTTGGCATGTTATGAAGCCATGGTACTCATGGCTCAGCCATTTAGTTACCGCTATCCTTTAATCGAAGGTCAGGGGAACTGGGGTTCACCAGATGATCCTAAATCTTTTGCTGCGATGCGTTATACCGAAGCCAAACTCTCGGCTTATAGTGAATTATTGCTGAGCGAATTAGGTCAGGGCACTAGCGAATGGCAAGATAACTTTGATGGTTCTTTAAAAGAACCGATCACTTTACCTGCACGTGTACCTAATATTCTTCTTAATGGTACGACAGGTATTGCTGTCGGGATGGCAACTGATATCCCGCCACATAATTTGCGTGAAGTTGTAAAAGGCACAATTGCTTTAATCCGTAATCCGCAAACCTCGGACGAAAAATTAGCTGAATATATTCCGGCTCCGGATTTACCAACCAAAGCTGAAATTATTACCCCGCCAGAAGAATTACTCAAAATCCAGACCACTGGTCGTGGTAGTTACCGTATGCGAGCGGTATATACCATTGAGAAAAATGAAATCGTAATTACTGAGCTGCCATATCAAGTCTCTGGTTCTAAGGTAATTACTCAAATTGCTGACCAGATGCAGGCTAAAAAGCTGCCATTAGTCGTTGATGTGCGTGATGAATCGGATCATGAAAACCCGACACGACTCGTGATTGTACTGCGCTCTAACCGTATTGATGCGGAAGCAGTAATGAGTCACTTATTTGCGACCACCGATTTAGAATCAAGCTATCGTGTCAATTTAAACATGATTGGCGAAGATGGCCGTCCTCAGGTGAAATCAATTCGTCGTATTTTGCTTGAATGGATCGAGATCCGTAAAAAAACGGTAACTCGTCGTTTGCAGTACCATTTAAACCGTATTGAAAAGCGCCTGCATATTTTGGCAGGTCTTTTAATTGCTTATCTCGATATTGATACAGTCATTCGTATTATTCGTGAAGAAGACCAGCCTAAGCCAGTCTTGATGGAACACTTTAATATTGATGAGATACAGGCCGAGGCGATTTTAGAGCTTAAATTACGTCATTTGGCAAAGCTTGAAGAGATGGAAATTCGTCATGAACAAGATGAGCTTTCCGCGAAAGCTGCCATTATTCGTGAACAACTCGAAAATCCTGAATCTTTAAAAAATTTGATTATTGGCGAATTAAAAGAAGATGCGAAAAAGTTCGGTGATGAGCGCCGTTCTCCAATTGTTGCACGTGCTGAAGCGGTTCAAATTAAAGAACAGGATTTAATGCCAGCTGAAACGGTAACAGTCGTGTTGTCTGAAGCAGGCTGGGTTCGTGCGGCAAAAGGTGCGGATGTGGATGCTGAAAATCTGAACTACCGTGCTGGGGACCAATATTTAAGTCATGCTGTCGGGAAAACCAATCAGCGAGTTTACTTCCTTGATGAAACAGGGCGCAGCTATGCCTTGCCAATTAGTAACTTACCTTCAGCGAGAGGCTTGGGGGATCCATTAAGTTCTAAATTATCACCAGCAAGTGGCGTATCGTTTATTCAGGTTTATTTAGATGATGATGAGTCTGAGTTGATTGCTGCAAGTTCGGCAGGTTATGGTTTTAAAACGCAAACCAAGCAATTAGATACCAATGCGAAAGCCGGTAAGACATTCTTAACGGTTCCGGATAAGGCAAAGGCTTTACCACTTATTTCTGCCCAAAACATGACGCATTTGGCTGTACTGAGCTCAGCAGGGCGTTTGTTAATTTTAGATTTGGCAGAACTACCAAATTTAAATAAAGGTAAAGGTAATAAGTTGATACAACTTGAAGGCAAAGAGCAAATTTTATCCATGACAACCCTGAACTTAGATGAAATAATTCAGGTGGTTGCAGGTCAACAACATCTCAAATTAAAAGGTGATGATCTACAAAAATACATGGGTAAACGTGCTTCGAAAGGTCAGCTCTTACCACGTGGATATCAAAAAGCAAATAAACTGTTGATTCAGAGATAA
|
Fluoroquinolones
|
Fluoroquinolone-resistant DNA topoisomerases
|
Drugs
| 1 |
MEG_8148|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation
|
ATGGATCAATTCGCCAAAGAGACCCTGCCCACCTCCCTCGAGGAGGAAATGCGCCGTTCGTATCTCGATTACGCGATGAGCGTGATCGTCGGACGTGCCCTTCCGGATGTCCGCGATGGCCTGAAGCCCGTGCACCGGCGCGTACTGTTCGCGATGCACGAACTGAACAACGACTGGAACCGCGCGTACAAGAAATCGGCGCGTATCGTCGGCGACGTGATCGGTAAGTACCACCCGCACGGCGACACGGCGGTCTACGACACGATCGTGCGGATGGCGCAGGACTTCTCGCTGCGCTACATGCTGATCGACGGGCAGGGCAACTTCGGCTCGATCGACGGCGACAATGCGGCGGCGATGCGGTACACCGAAATTCGCATGGCGAAGATCGGGCACGAGCTGCTCGCCGACATCGACAAGGAAACGGTCGATTTCGAGCCGAACTACGACGGCAACGAAACGCAGCCGTCGGTCCTGCCGTCGCGGATCCCGAACCTGCTGATCAACGGCTCGTCGGGCATCGCCGTCGGCATGGCGACCAACATTCCGCCGCACAACCTGAACGAAGTCGTCGACGCGTGCCAGCACCTGCTGAGCAACCCCGACGCGACGGTCGACGAACTGATCGAGATCATCCCGGCGCCGGATTTCCCGACGGCCGGCATCATCTACGGCGTCGCCGGCGTGCGCGACGGCTACCGCACCGGCCGCGGCCGCGTCGTGATGCGCGCGGCCACGCACTTCGAGGAGATCGACCGCGGCCAGCGGATGGCGATCATCGTCGACGAGCTGCCGTACCAGGTCAACAAGCGCTCGCTGCTCGAGCGGATCGCCGAGCTCGTCAACGAGAAGAAGCTCGAAGGCATTTCCGATATCCGCGACGAATCCGACAAGAGCGGCATGCGGGTCGTGATCGAGCTCAAGCGCGGCGAAGTGCCGGAAGTGGTGCTGAACAACCTGTACAAGGCGACGCAGCTGCAGGACACGTTCGGCATGAACATGGTCGCGCTCGTCGACGGCCAGCCGAAGCTGCTGAACCTGAAGGAAATCCTGCAGTGCTTCCTGTCGCACCGGCGCGAAGTGCTGACGCGCCGCACGATCTACGAACTGCGCAAGGCGCGCGAGCGCGGCCACGTGCTCGAAGGTCTCGCGGTCGCGCTCGCGAACATCGACGAGTTCATCGCGATCATCAAGGCCGCGCCGACGCCGCCGATCGCGAAGCAGGAGCTGATGACGAAGTCGTGGGATTCGTCGCTCGTACGCGAGATGCTGACGCGCGCCGAATCCGAGAACGCGGCGGCGGGCGGCCGTGCCGCGTACCGTCCGGAAGGGCTGAATCCGGCGTACGGGATGCAGGCCGACGGGCTGTACAGGTTGTCCGACACGCAGGCGCAGGAAATCCTGCAGATGCGTCTGCAGCGCCTGACCGGCCTCGAGCAGGACAAGATCATCGGCGAGTATCGCGAAGTGATGGCGCAGATCGCCGATCTGCTCGACATCCTCGCGCGCCCGGAGCGCATCACGACGATGATCGGCGACGAGCTGACGACGGTGAAGGCCGAATTCGGCGATGCGCGCCGCTCGCGGATCGAGCTGAACGCGACCGAACTGAATACCGAAGACCTGATCACGCCGCAGGACATGGTCGTCACGATGTCGCATGCCGGCTACGTGAAGTCGCAGCCGCTGTCGGAGTACCGCGCGCAGAAGCGCGGCGGCCGCGGCAAGCAGGCGACGCAGATGAAGGAAGACGACTGGATCGAGACGCTCTTCATCGCGAATACGCACGACTACATGCTGTGCTTCTCGAACCGCGGTCGCGTGTACTGGATCAAGGTCTACGAGGTGCCGCAAGGTTCGCGCAACTCGCGCGGCCGTCCGATCGTCAACATGTTCCCGCTGCAGGAAGGCGAGAAGATCAACGTCGTGCTGCCGGTGAAGGAATTCTCGGCCGACAAGTTCGTGTTCATGGCGACGTCGCTCGGCACGGTCAAGAAGACGCCGCTCGAAGCGTTCAGCCGTCCGATGAAGAAGGGCATCATCGCGGTCGGCCTCGACGAGGGCGACTATCTGATCGGCGCGTCGATCACCGACGGCGCGCACGACGTGATGCTGTTCTCCGATTCGGGCAAGGCCGTGCGCTTCGACGAGAACGACGTGCGTCCGATGGGCCGCGAAGCGCGCGGCGTGCGCGGCATGCAGCTCGAGGACGGGCAGCAGGTCATCGCGCTGCTGGTCGCGGGCAGCGAGGAGCAGTCCGTGCTCACCGCAACCGAGAACGGCTTCGGCAAGCGTACGCCGATCACCGAGTACACGCGTCACGGCCGCGGCACGAAGGGTATGATCGCGATCCAGACCTCCGAGCGTAACGGCAAGGTCGTCGCTGCGACGCTCGTCGATCCGGAAGATCAGATCATGCTGATCACGACGGCCGGCGTGTTGATTCGCACGCGCGTTTCCGAGATCCGCGAGATGGGACGGGCGACGCAAGGTGTTACACTCATCAGTCTCGATGAGGGTACGAAGCTTTCGGGTCTGCAGCAGATTGCCGAGGCCGAAGAGGGCGATGGCGAAGCCGACGAGGCGTCGGACGGCGAAGCCTGA
|
Fluoroquinolones
|
Fluoroquinolone-resistant DNA topoisomerases
|
Drugs
| 1 |
MEG_8455|Drugs|betalactams|Penicillin_binding_protein|PBP1|RequiresSNPConfirmation
|
ATGATTAAAAAGATTTTAACGACTTGTTTTGGTTTGGTTTTTGGGTTTTGTGTATTTGGAGTGGGTTTGGTTGCCATTGCTATTTTGGTAACGTATCCGAAACTGCCGTCTTTGGATTCTTTGCAGCATTACCAGCCTAAAATGCCGTTGACTATTTATTCGGCGGATGGGGAAGTCATCGGTATGTATGGGGAGCAGCGGCGCGAATTTACAAAAATCGGCGATTTCCCAGAGGTGTTGCGGAATGCGGTTATCGCCGCCGAGGATAAACGCTTTTACCGGCATTGGGGGGTGGATGTTTGGGGTGTTGCCCGCGCTGCCGTCGGCAATGTCGTGTCCGGCAGCGTGCAGTCGGGTGCGAGTACGATTACGCAGCAGGTGGCGAAAAATTTTTATTTGAGCAGTGAAAAAACGTTCACACGCAAATTCAATGAGGTGTTGCTTGCCTATAAAATCGAGCAGTCTTTAAGCAAAGACAAAATCCTCGAGTTGTATTTCAATCAGATTTACCTCGGTCAGCGCGCCTATGGTTTTGCATCTGCCGCGCAAATCTATTTCAATAAGAATGTCCGAGATTTGACTTTGGCGGAAGCCGCCATGCTTGCGGGACTGCCCAAGGCTCCGTCTGCCTATAATCCGATTGTTAATCCAGAACGTGCCAAGTTGCGCCAGAAGTATATTTTGAACAATATGCTCGAGGAGAAGATGATTACCGTGCAACAGCGCGATCAGGCGTTGAATGAGGAACTGCATTACGAGCGGTTTGTTCGGAAAATCGATCAGAGTGCTTTATATGTGGCGGAAATGGTGCGTCAGGAACTGTATGAGAAATACGGTGAAGATGCCTATACGCAGGGTTTTAAGGTTTATACCACGGTCCGCGCCGATCATCAGAAGGTGGCAACCGAGGCATTGCGCAAGGCTCTACGGAATTTCGATCGCGGCAGCAGCTACCGCGGTGCGGAAAACTATATCGATTTGAGTAAGAGTGAAGATGTCGAGGAGACTGTCAGCCAGTATCTGTCGGGACTCTATACCGTCGATAAAATGGTTCCCGCCGTTGTGTTGGATGTGACTAAAAAGAAAAATGTCGTCATACAGCTGCCCGGCGGCAGGCGGGTTACGCTTGACAGGCGCGCCTTGGGTTTTGCGGCCCGCGCGGTCAATAATGAAAAAATGGGGGAGGACCGTATCCGCAGGGGCGCGGTCATCCGTGTCAAAAACAACGGCGGGCGTTGGGCGGTGGTTCAAGAGCCGTTGCTGCAGGGGGCTTTGGTTTCGCTGGATGCAAAAACCGGAGCTGTGCGCGCGCTGGTCGGCGGTTATGATTTTCACAGCAAAACATTCAATCGTGCCGTTCAGGCAATGCGGCAGCCGGGTTCGACCTTTAAGCCGTTTGTCTATTCGGCGGCATTATCTAAGGGGATGACCGCGTCCACAGTGGTTAACGATGCGCCGATTTCCCTGCCGGGGAAAGGGCCGAACGGTTCGGTTTGGACACCTAAAAATTCAGACGGCAGATATTCCGGCTACATTACTTTGAGACAGGCTCTGACGGCTTCCAAGAATATGGTTTCCATCCGTATTTTGATGTCTATCGGTGTCGGTTACGCGCAACAGTATATCCGGCGTTTCGGCTTCAGGTCGTCCGAGCTGCCGGCAAGCCTGTCTATGGCTTTAGGTACGGGCGAGACAACGCCGTTGAAAGTGGCGGAGGCATATAGCGTATTTGCGAACGGCGGATATAGGGTTTCTTCGCACGTAATCGATAAGATTTATGACAGAGACGGCAGGTTGCGCGCCCAAATGCAACCTTTGGTGGCCGGGCAAAATGCGCCTCAGGCAATCGATCCGCGCAATGCCTATATTATGTATAAGATTATGCAGGATGTGGTCCGTGTTGGTACGGCAAGGGGGGCAGCTGCGTTGGGAAGAACGGATATTGCCGGTAAAACGGGTACGACCAATGACAATAAGGATGCGTGGTTTGTCGGTTTTAACCCTGATGTGGTTACTGCCGTATATATCGGCTTCGACAAACCTAAGAGTATGGGGCGTGTCGGCTACGGCGGTACGATTGCGGTGCCGGTTTGGGTGGACTATATGCGTTTTGCGTTGAAAGGAAAGCAGGGCAAGGGGATGAAAATGCCTGAAGGTGTGGTCAGCAGCAATGGCGAATACTATATGAAGGAACGTATGGTAACCGATCCGGGCTTGACGCTGGACAACAGCGGTATTGCGCCGCAACCTTCCCGACGGGCAAAAGAAGATGACGGGGGCGCGGCAGAAGGCGGACGGCAGGCGGCGGATGACGAAGTCCGCCAAGATATGCAGGAAACGCCGGTGCTTCCGAGTAATACTGGTTCCAAACAGCAGCAGTTGGATTCCCTGTTTTAA
|
betalactams
|
Penicillin binding protein
|
Drugs
| 1 |
MEG_8633|Drugs|betalactams|Penicillin_binding_protein|PILQ|RequiresSNPConfirmation
|
ATGAATACCAAACTGACAAAAATCATTTCCGGTCTCTTTGTCGCAACCGCCGCCTTTCAGACGGCATCGGCAGGAAACATTACAGACATCAAAGTTTCCTCCCTGCCCAACAAACAGAAAATCGTCAAAGTCAGCTTTGACAAAGAGATTGTCAACCCGACCGGCTTCGTAACCTCCTCACCGGCCCGCATCGCCTTGGACTTTGAACAAACCGGCATTTCCATGGATCAACAGGTACTCGAATATGCCGATCCTCTGTTGAGCAAAATCAGTGCCGCACAAAACAGCAGCCGTGCGCGTCTGGTTCTGAATTTGAACAAACCGGGCCAATACAATACCGAAGTACGCGGGAACAAAGTTTGGATATTCATTAACGAATCGGACGATACCGTGTCCGCCCCCGCCCGCCCAGCCGTAAAAGCCGCGCCTGCCGCACCGGCAAAACAACAGGCTGCCGCACCGTTTACCGAGTCCGTAGTATCCGTATCCGCACCGTTCAGCCCGGCAAAACAACAGGCAGCGGCATCGGCAAAACAACAGGCGGCGACACCGGCAAAACAAACCAATATCGATTTCCGCAAAGACGGCAAAAATGCCGGCATTATCGAATTGGCGGCATTGGGCTTTGCCGGGCAGCCCGACATCAGCCAACAGCACGACCACATCATCGTTACGCTGAAAAACCATACCCTGCCGACCGCGCTCCAACGCAGTTTGGATGTGGCAGACTTCAAAACACCGGTTCAAAAGGTTACGCTGAAACGCCTCAATAACGACACCCAGCTGATTATCACAACAACCGGCAACTGGGAACTCGTCAACAAATCCGCCGCGCCCGGATACTTTACCTTCCAAGTCCTGCCGAAAAAACAAAACCTCGAGTCAGGCGGCGTGAACAATGCGCCCAAAACCTTCACAGGCCGGAAAATCTCCCTTGACTTCCAAGATGTCGAAATCCGCACCATCCTGCAGATTTTGGCAAAAGAATCCGGGATGAACATTGTTGCCAGCGACTCCGTCAACGGCAAAATGACCCTCTCCCTCAAAGATGTGCCTTGGGATCAGGCTTTGGATTTGGTTATGCAGGCGCGCAACCTCGATATGCGCCAGCAAGGGAACATCGTCAACATCGCGCCCCGCGACGAGCTGCTTGCCAAAGACAAAGCCTTCTTACAGGCGGAAAAAGACATTGCCGATCTGGGCGCGCTGTATTCCCAAAACTTCCAATTGAAATACAAAAATGTGGAAGAATTCCGCAGCATCCTGCGTTTGGACAATGCCGACACGACCGGAAACCGCAACACGCTTGTCAGCGGCAGGGGCAGCGTGCTGATCGATCCCGCCACCAACACCCTGATTGTTACCGATACCCGCAGCGTCATCGAAAAATTCCGCAAACTGATTGACGAATTGGACGTACCCGCGCAACAAGTGATGATTGAGGCGCGTATCGTCGAAGCGGCAGACGGCTTCTCGCGCGATTTGGGCGTTAAGTTCGGCGCGACAGGCAGGAAAAAACTGAAAAATGAGACGAGCGCATTCGGCTGGGGCGTGAACTCCGGCTTCGGGGGCGGCGATAAATGGGAGGCCCAAACCAAAATCAACCTGCCGGTTGCCGCTGCCGCAAACAGCATTTCGCTGGTGCGCGCGATTTCCTCCGGCGCGTTGAATTTGGAATTGTCCGCATCCGAGTCGCTTTCAAAAACCAAAACGCTTGCCAATCCGCGCGTGCTGACCCAAAACCGCAAAGAGGCCAAAATCGAATCCGGTTACGAAATTCCTTTTACCGTAACTACAGCCTCGGGCGGCGGCAACTCTACCAACACGGAACTCAAAAAAGCCGTCTTGGGGCTGACCGTTACGCCGAACATCACGCCCGACGGACAAATCATCATGACCGTCAAAATCAACAAAGACTCGCCTGCACAATGTGCTTCAGGCAACAACACAATCCTATGTATTTCGACCAAAAGCCTGAATACGCAGGCTATGGTTGAAAACGGCGGCACTTTGATTGTCGGCGGTATTTATGAAGAAAACAACGGCAATACGCTGACCAAAGTCCCCCTGTTGGGCGACATCCCCGTTATCGGCAACCTCTTTAAAACACGCGGGAAAAAAACCGACCGCCGCGAACTGCTGATTTTCATTACCCCGAGGATTATAGATACGGCCGGCAACAGCCTGCGCTATTGA
|
betalactams
|
Penicillin binding protein
|
Drugs
| 1 |
MEG_8149|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation
|
ATGCAAGATAATTCAGTCAATGAAACAAAAAATATTGTAGAAGTGGGGATTGATTCTTCTATTGAAGAGAGCTATTTAGCTTATTCCATGAGCGTGATCATAGGGCGCGCTTTACCGGACGCTAGAGATGGCTTAAAGCCCGTGCATAGGCGTATTTTGTATGCGATGCATGAATTAGGCCTTACTTCAAAAGTCGCTTACAAAAAAAGCGCTAGGATCGTGGGTGATGTGATTGGTAAATACCACCCCCATGGCGATAATGCGGTTTATGATGCGCTAGTGAGAATGGCGCAAGATTTTTCCATGCGTTTGGAATTAGTGGATGGGCAGGGCAACTTTGGCTCTATTGATGGCGATAACGCCGCAGCGATGCGTTACACTGAAGCCAGAATGACTAAGGCGAGTGAAGAAATTTTAAGGGATATTGATAAAGACACCATTGATTTTGTGCCTAATTATGACGATACCTTAAAAGAGCCAGATATTTTACCAAGCCGTCTGCCTAACCTTTTAGTCAATGGGGCTAATGGGATCGCTGTGGGGATGGCGACTTCTATCCCCCCTCACAGGATGGATGAAATCATAGACGCTTTAGTGCATGTCTTAGAAAACCCTAACGCTGGATTAGATGAAATCTTAGAATTTGTCAAAGGGCCTGATTTTCCCACTGGTGGGATCATTTATGGCAAGGCGGGTATTATTGAAGCCTATAAAACGGGGCGAGGACGCGTGAAAGTGCGGGCCAAAGTGCATGTGGAAAAAACAAAAAATAAAGAAATCATCGTTTTAGATGAAATGCCTTTTCAAACCAATAAAGCCAAATTAGTGGAACAAATCAGCGATTTAGCGCGAGAAAAGCAAATTGAAGGCATTAGTGAAGTGCGCGATGAGAGCGATAGAGAGGGCATTAGAGTGGTGATTGAATTAAAAAGAGACGCGATGAGTGAAATTGTCTTAAACCACCTCTACAAACTCACCACTATGGAAACCACTTTTAGCATCATTTTACTCGCTATTTACAATAAAGAGCCTAAGATTTTCACGCTTTTAGAGTTGTTGCACCTTTTCTTAAACCACAGAAAAACCATTATTATAAGACGCACGATTTTTGAATTAGAAAAGGCTAAGGCCAGAGCGCATATTTTAGAGGGCTATTTGATCGCACTAGACAATATTGATGAAATCGTGCGACTCATTAAAACAAGCCAAAGCCCAGAAGCGGCTAAAAACGCCTTAATGGAGCGTTTCACTTTGAGCGAGATTCAAAGCAAGGCCATTTTAGAAATGCGTTTGCAACGCTTAACAGGCCTTGAAAGGGATAAGATCAAAGAAGAATACCAAAACTTGTTGGAGCTTATTGATGATCTCAATGGCATTTTAAAGAGCGAAGATCGCTTGAATGGAGTCGTCAAAACAGAGCTTTTAGAAGTCAAAGAGCAATTTTCTTCTCCAAGGCGCACTGAAATTCAAGAATCTTATGAAAATATTGACATAGAAGATTTGATCGCTAATGAGCCTATGGTAGTGAGCATGAGTTATAAAGGCTATGTGAAAAGAGTGGATTTAAAAGCTTATGAAAAGCAAAATCGTGGTGGTAAAGGCAAGCTTTCAGGCAGCACTTATGAAGACGATTTCATTGAAAACTTTTTTGTGGCTAACACGCATGATATTTTGCTCTTTATCACCAATAAGGGGCAATTGTATCATTTGAAAGTCTATAAAATCCCAGAAGCGAGCCGGATCGCTATGGGTAAAGCCATTGTAAATTTAATCTCGCTCGCTCCGGATGAAAAGATCATGGCGACTCTAAGCACCAAAGACTTTAGCGATGAACGCTCTTTGGCCTTCTTCACGAAAAATGGCGTGGTGAAGCGCACCAATTTGAGCGAATTTGAAAGCAACAGGAGTTGTGGTATCAGAGCGATTGTTTTAGATGAAGGCGATGAATTAGTGAGCGCAAAAGTTGTGGATAAAAACGCTAAGCATTTGCTCATCGCATCGCATTTGGGCATTTTCATTAAATTCCCTTTAGAAGAGGTGCGCGAGATCGGAAGAACTACTCGTGGGGTTATAGGCATCAAGCTGAATGAAAACGATTTTGTTGTCGGTGCGGTCGTTATTAGCGATGATGGCAACAAGCTTTTGAGCGTGAGTGAAAACGGGCTTGGCAAGCAAACTTTAGCCGAAGCGTATAGAGGGCAATCTCGTGGAGGTAAGGGGGTCATTGGCATGAAGCTCACTCAAAAAACCGGCAATCTAGTGGGCGTTATCAGCGTGGATGATGAAAATTTGGATTTGATGATCCTTACTGCAAGCGCAAAAATGATCAGAGTTTCTATTAAAGATATTAGAGAAACCGGAAGAAACGCTAGTGGGGTAAAGCTCATAAACACCGCCGATAAAGTCATGTATGTCAATTCTTGCCCTAAAGAAGAAGAGCCAGAAAATTTAGAAACCTCTTCGGCACAAAATTTGTTTGAGTGA
|
Fluoroquinolones
|
Fluoroquinolone-resistant DNA topoisomerases
|
Drugs
| 1 |
MEG_8152|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation
|
ATGCAAAATTACCAGAGCCATAGTATTAAGGTTTTAAAAGGCTTAGAGGGGGTTAGGAAACGCCCTGGAATGTATATTGGTGATACCAATGTGGGTGGGTTGCACCACATGGTGTATGAAGTCGTGGATAACGCTGTAGATGAGAGCATGGCGGGTTTTTGCGATACGATTAATATCACTTTGACCGATGAGGGTTCATGCATCGTAGAAGATAACGGGCGAGGCATTCCTGTAGATATTCACCCCACGGAAAAAATCCCCGCTTGCACCGTGGTTTTAACGATTTTGCATGCGGGGGGCAAGTTTGATAACGATACTTATAAAGTTTCAGGCGGTTTGCATGGCGTGGGCGTTTCGGTTGTGAACGCTTTGAGCAAACGCTTGATTATGACCATTAAAAAAGAGGGTCAAATTTATCGCCAAGAGTTTGAAAAGGGTATTCCTACTAGCGAGCTTGAAATCATTGGCAAAACCAAAAGCGCTAAAGAAAGCGGCACGACTATTGAATTTTTCCCTGATGAAAGCGTGATGGAAGTCGTTGAATTTCAAGCGGGTATTTTACAAAAACGCTTTAAAGAAATGGCGTATCTTAACGATGGCTTAAAAATTTCTTTCAAAGAAGAAAAAACCCAACTGCAAGAGACTTATTTCTATGAAGACGGCTTGAAACAATTCGTTAAAGACAGCGCTAAAAAAGAATTGCTCACCCCCATTATTTCGTTTAAAAGCATGGATGAAGAAACGCGCACTTCTATAGAAGTCGCTCTAGCGTATGCTGATGATTATAATGAAAACACTTTAAGCTTTGTGAATAACATTAAAACTTCTGAAGGTGGCACGCATGAGGCGGGCTTTAAAATGGGCTTGTCTAAAGCAATTTTGCAATATATTGGCAATAATATTAAAACCAAAGAGTCACGCCCCATCTCTGAAGATATTAAAGAGGGGTTGATCGCTGTTGTGAGCTTGAAAATGAGCGAGCCTTTGTTTGAAGGGCAGACTAAATCCAAACTCGGCAGTTCGTATGCGCGCGCGTTGGTTTCAAAATTAGTCTATGATAAAATCCATCAATTTTTAGAAGAAAACCCTAACGAAGCCAAAATCATTGCCAATAAAGCCCTACTAGCTGCAAAAGCCAGAGAAGCCAGTAAGAAAGCCAGAGAGCTTACAAGGAAAAAAGATAATTTGAGTGTCGGCACTTTGCCTGGAAAATTAGCCGATTGCCAGAGTAAAGACCCCTTAGAGAGTGAAATCTTTTTAGTGGAGGGCGATAGTGCGGGCGGGAGCGCTAAACAAGGGCGCGATAGGGTTTTCCAAGCGATCTTGCCCCTAAAAGGTAAGATTTTAAATGTGGAAAAAAGCCATTTATCAAAAATCCTAAAATCAGAAGAAATTAAAAACATGATCACGGCTTTTGGGTGCGGCATTCAAGAGAGTTTTGATATAGAAAGATTGCGCTATCATAAAATCATTATCATGACCGATGCTGATGTGGATGGGAGCCATATCCAAACCTTGCTGATGACTTTTTTCTATCGTTATTTGCGCCCGCTGATTGAACAAGGGCATGTTTATATCGCTCAAGCCCCTCTTTACAAATACAAGAAGGGCAAGACAGAAATTTATCTTAAAGACAGCGTCGCTTTGGATCATTTTTTAATTGAGCATGGCATCAATTCGGTGGATATTGAAGGGATTGGCAAGAACGATTTGATGAACTTGTTAAAAGTGGCACGCCATTACCGCTATGCGCTTTTGGAATTAGAAAAACGCTACAATTTGCTAGAAATTTTACGCTTTCTCATTGAAACTAAGGACGCCTTAAGCCTTGATATGAAAGTTTTAGAAAAAAGCATTTTAGAAAAATTAGAGGGCTTGAATTATCAGATCTTACGCTCTTTTGCCACTGAAGAAAGCTTACATTTGCACACGCAAACCCCTAAAGGCTTGGTGGAATTTAACCTAGATGACAATCTCTTTAAAGAAGTGTTGTTTGAAGAAGCGAATTACACTTACCAAAAGCTTATGGAGTATAATTTAGACTTCTTAGAAAATAAGGATATTTTGGCGTTTTTAGAAGAAGTGGAAAATCACGCTAAAAAGGGAGCGAATATCCAGCGCTATAAGGGGCTAGGCGAGATGAACCCTAATGATTTGTGGGAAACGACCATGCATAAAGAAAACCGCAGCTTGATCAAACTCAAAATTGAAGATTTAGAAAAAACCGATGCAGTCTTTTCGCTTTGCATGGGCGATGAAGTAGAGCCTAGAAGAGCCTTTATCCAAGCGCATGCTAAAGATGTGAAACAACTAGATGTGTAA
|
Fluoroquinolones
|
Fluoroquinolone-resistant DNA topoisomerases
|
Drugs
| 1 |
MEG_8458|Drugs|betalactams|Penicillin_binding_protein|PBP3|RequiresSNPConfirmation
|
ATGGATAATAAAAACATTGATCCCAACTTCAACCCAGAACGATTTTTAGAAACCCAAAAATACAAGGGCTCTATTACGGCTTTAATCTTTTTATTGCTTTTTTTTATTTTTTTAATGGTGGCTTTTAAAAAAGCTTTTTTTGCCCAAGCCAACATGCCTAATCTAGTGATGAGCAAACAAGACACTGCGGCTAGGGGGACTATCTATAGTCAAGACAACTACAGCCTAGCCGCTTCGCAAACCCTTTTCAAACTGGGCTTTGATACAAGGTTTTTAAACCCGGATAAAGAAGATTTTTTCATTGATTTCCTTTCTATTTATAGCAATATCCCTAAAAAGTCCTTAAAAGACGCCATCAATACGAAAGGCTATATTATTCTAGCCTATGATCTCACGCCCAATATGGCCGCTAACATTAGAGACTTGAATAAGAAATTTTTAGCCTTTGGGGTTTTTCAAAATTTCAAAGACGCGCACGATAAGGTGTGGCAAAAGCAAGGGCTAAACATTGAAGTGAGCGGCGTTTCCAGGCATTACCCTTATCAAAATAGCCTAGAGCCAATCATTGGCTATGTGCAAAAACAAGAAGAAGACAAGCTCACTTTAACTACCGGTAAAAAAGGCGTTGAAAAATCTCAAGATCACTTGCTTAAAGCCCAACAAAATGGCATAAGAACAGGCAAAAGAGATGTGAGTTTTAATTTTATTCAAAACCACTCTTACACAGAGGTTGAGCGCCTTGATGGCTATGAGGTGTATTTGAGCATTCCTTTAAAACTCCAAAGAGAAATTGAAACCCTATTGGATAAAACCAAAGACAAACTCAAGGCTAAAGAAATCCTAGTGGGTATCATTAACCCTAAAAGCGGGGAAATCTTATCGCTAGCTTCAAGCAAGCGCTTCAATCCTAACGCCATTAAAACCAGCGATTATGAAAGCTTGAATTTGAGCGTTGCCGAAAAGGTTTTTGAGCCAGGCAGCACGATCAAACCCATTGTTTATTCCTTGCTGTTAGACAAGAATTTGATCAACCCTAAAGAACGCATTGATTTAAACCATGGCTATTACCAATTAGGAAAATACACCATTAAAGACGACTTTATCCCTAGTAAAAAAGCCGTTGTGGAAGATATTTTGATCCAATCTAGCAATGTGGGCATGATAAAAATCAGCAAAAATCTCAACCCGGAGGATTTCTATAATGGGCTTTTAGGCTATGGATTTTCTCAAAAAACCGGCATTGATTTATCCTTAGAAGCCACAGGAAAGATCCCTCCTTTGTCCGCTTTCAAGCGTGAAGTGTTAAAGGGGAGCGTCTCTTATGGCTATGGGCTGAACGCGACTTTTTTGCAGCTTTTAAGGGCTTATGCGGTGTTTTCTAATGAAGGCAAATTGACTACCCCCTATTTAGTGCAACGAGAGACCGCCCCTAATGGCGATATTTACATCCCTAGCCCCAAACCCACTTTTCAAGTCATTAGCCCCAAAAGCGCCAGGAAAATGAAAGAAACCTTAATCAAAGTGGTGCGTTATGGCACAGGCAAAAACGCTCAATTTGAAGGGTTATACATAGGGGGCAAAACAGGCACGGCTAGGGTTGCTAAAAACGGGAGTTACAGCGCGGAATCCTACAACAGCTCTTTTTTTGGGTTCGCTGAAGATGAAAGGCAGGTTTTTACTATCGGCGTGGTTATCTTAGGCTCGCACGGCAAGGAAGAATATTATGCTAGCAAGATTGCAGCCCCTATTTTTAAAGAAATCACCGAAATTTTAGTGCGTTACAATTACCTATCGCCCTCTATTGCGATTCAAAACGTGCTCGAGAAAAACCGCTTTAAGATAAAATAA
|
betalactams
|
Penicillin binding protein
|
Drugs
| 1 |
MEG_8457|Drugs|betalactams|Penicillin_binding_protein|PBP2|RequiresSNPConfirmation
|
ATGAAAAATCTTCGCTATAAGCTTTTGCTCTTTGTTTTTATAGGGTTTTGGGGGTTATTGGTTTTAAATTTATTTATTTTAAGCGTTAAAAATCAAGAATACTATGAAAAATTGGCCGAACGCAACATGACCAAAAAGGAATTTCTAGTCCCTACAAGGGGCGATATTACAGACAGAAATGATGAGTTTTTAGCCACTAACGAATTGGTGTTTGGCGTGTTTTTGCCTAGTAGACTGAAACAAAAAGAACTTTTGGAAAAAATTGAAATCATCCAAAAGTTTTTCCCTAACTTTTCCAAAGAAACGCTTTTAAACAATTACCAAAAAGAAAATTCGCTTTATAACCACAACCTCATTAAAGTGGTGGGATTCATTCCTTATATCGCCATGCAACCTCTTTATGCCAAACTCATCCAAACTCAAGGCATTTTTGCTCTTCCCTTAGACAAGCGCTACTACCCTAATAACGCTTTAGCTTCACATGTTTTAGGCTATGTGGGGGTGGCAAGCTTGCAAGATCTAAAAGACGATGAAGAAAATCAATACAGCCAGATTGTAGGCAAAACCGGCATTGAAAAAGAATATAACAAGCTTTTACAAGGCAAGGTGGGCTATAAAATCATGCGTGTCAATGCACTCAATCAAGAATTAGCCACTTTAGAAGTAGTGCCGCCAAGCACCAACAACCACTTGCAATTGAGTTTAGACAAACGCTTGCAAAAAGAAGCGGACAAGCTCTTTGAAAATAAGAGAGGGGCTATTTTAGTGATGAACGCAGAAAATGGGGAATTGCTCGTTGCAGGAAGTTACCCTGAATACAATTTGAACGATTTTGTAGGCGGGATCAGTCAAGACAAATGGCAAAAACTTCAAGATGATATTTATAACCCCTTATTAAACCGCTTCGCTAACGCTTTGTATCCGCCGGGATCTGTGGTTAAAATGGGCGTGGGCTTGAGCTTTTTAGAAAACCTTCATATCACAGAAAACACCACCATACCCACCCCGCCTTTTATTGAAGTGGGCAAGCGCAAATTCAGGGACTGGAAAAAAACAGGGCATGGCAATTCTAATTTGTATAAAGCGATTAGGGAGTCCGTGGATGTGTATTTTTATAAGTTTGGGCTTGAAATCTCTATAGAAAAACTCTCTAAAACCTTAAGAGAAGTGGGCTTTGGGGAAAAAACAGGCGTTGATTTGCCGAATGAATTTGTGGGGATTGTGCCGGATAATTTGTGGAAACTCAAACGATTCAATCAAGATTGGCGCGTTGGGGACACGCTCATTACTGCTATTGGGCAAGGCTCTTTTTTAGCCACGCCCTTACAAGTGCTAGCCTATACGGGACTCATTGCGACAGGCAAACTGGCAACGCCTCATTTTGCTATCAATAATAAACAGCCGCTCAAAGACCCCCTGAATAGTTTTCAAAAAAAGAAGCTCCAAGCCTTGCGCGTGGGCATGTATGAAGTGTGTAACCATAAAGACGGCACCGCTTATCATTCCACAAGGGGTTCTAAGGTTACTTTAGCGTGTAAAACCGGCACCGCGCAAGTCGTGGAAATCGCTCAAAACATCGTCAATCGCATGAAAGAAAAGGATATGGAGTATTTCCATCGATCCCATGCGTGGATTACCGCATTTTTGCCTTATGAAAAACCCAAATACGCTATCACTATTTTAGTAGAACATGGGGAAGGGGGGTCAAAACTAGGGGGCTTGTTAGTGAAAATGAGCAATAAACTCTATGAGCTTGGCTATCTTTAA
|
betalactams
|
Penicillin binding protein
|
Drugs
| 1 |
MEG_8454|Drugs|betalactams|Penicillin_binding_protein|PBP1|RequiresSNPConfirmation
|
ATGCTAAAAAAGATTTTTTATGGTTTTATCGTTTTATTTTTGATTATCGTAGGGTTGTTAGCCATTCTTATCGCTCAAGTTTGGGTAACTACGGATAAGGATATTGCTAAAATTAAAGATTATCGCCCGGGCGTCGCTTCACAGATTTTAGACCGAAAAGGGCGTTTGATCGCTAATATCTATGATAAGGAATTTCGTTTTTATGCGCGTTTTGAAGAAATCCCCCCACGATTTATTGAAAGCCTTTTAGCGGTAGAAGACACCCTCTTTTTTGAACATGGGGGGATCAATTTAGACGCTATCATGCGCGCTATGATTAAAAACGCTAAAAGCGGTCGTTACACCGAGGGGGGTAGCACCCTAACCCAACAACTCGTTAAAAACATGGTGCTCACACGAGAAAAAACCCTAACCAGAAAACTCAAAGAAGCTATCATTTCCATACGCATTGAAAAAGTCTTAAGCAAAGAAGAAATTTTAGAGCGCTATTTGAACCAAACTTTTTTTGGGCATGGGTATTATGGCGTGAAAACCGCAAGTTTAGGGTATTTTAAAAAACCCCTTGACAAACTCACGCTTAAAGAAATCGCCATGTTAGTCGCCTTGCCTAGGGCTCCGAGTTTTTATGATCCTACCAAAAATTTAGAATTTTCACTTTCTAGGGCTAATGATATTTTAAGGCGGTTGTATTCTTTAGGCTGGATTTCTTCTAACGAGCTCAAATCCGCTCTCAATGAAGTGCCAATCGTCTATAACCAAACTTCCACGCAAAATATCGCTCCCTATGTCGTGGATGAAGTATTGAAGCAATTGGATCAATTAGACGGGTTAAAAACTCAAGGCTATATTATAAAGCTCACGATAGATTTGGATTACCAACGCTTAGCGTTAGAGTCCTTGCGTTTTGGGCATCAAAAAATCTTAGAAAAAATCGCTAAAGAAAAGCCAAAAACTAACGCGTCTAATGAAGATGAAGACAACTTGAACGCTAGCATGATAGTTACAGACACGAGCACCGGTAAGATTTTAGCTTTAGTGGGAGGGATTGATTATAAAAAAAGCGCTTTCAATCGCGCCACGCAAGCCAAACGGCAATTTGGGAGCGCGATCAAGCCTTTTGTGTATCAAATCGCTTTTGATAATGGCTATTCCACGACTTCTAAAATCCCTGATACCGCGCGAAACTTTGAAAATGGCAATTATAGTAAAAACAGCAAACAAAACCATGCATGGCACCCCAGCAATTATTCTCGCAAGTTTTTAGGGCTTGTAACCTTGCAAGAAGCTTTGAGCCATTCATTAAATCTAGCCACGATCAATTTAAGCGATCAGCTTGGCTTTGAAAAAATTTATCAATCTTTAAGCGATATGGGGTTTAAAAACCTCCCTAAAGACTTGTCTATTGTGTTAGGGAGCTTTGCTATCTCACCCATTGAAGCGGCTGAAAAGTATTCTTTATTTTCTAATTACGGCACTATGCTCAAACCCATGCTCATTGAAAGCATCACTAACCAACAAAACGATGTCAAAACTTTCACGCCTATGGAAACCAAAAAGATCACCTCCAAAGAACAGGCTTTTTTAACCATTTCAGTGCTGATGAATGCGGTAGAAAACGGCACAGGGAGTTTGGCTCACATTAAAGGTTTAGAAGTCGCCGGTAAAACCGGAACTTCTAACAACAATATTGACGCTTGGTTCATTGGCTTTACCCCCACCTTGCAAAGCGTGATCTGGTTTGGGAGGGACGATAACACGCCTATTAGCAAAGGAGCGACAGGAGGCGTTGTGAGCGCGCCTGTGTATTCGTATTTCATGCGTAATATTCTAAGCATTGAACCTTCTTTAAAAAGAAAGTTTGATGTCCCCAAAGGCTTGCGTAAAGAAATTGTGGATAAAATCCCCTACTATTCAACCCCCAATTCCATCACCCCCACCCCCAAAAGAACAGACGATAGCGAAGAACGCTTGTTGTTCTAA
|
betalactams
|
Penicillin binding protein
|
Drugs
| 1 |
MEG_8671|Drugs|MLS|Macrolide-resistant_50S_rRNA_mutation|RPLD|RequiresSNPConfirmation
|
ATGGAATTGAAAGTAATTGACGCTAAAGGACAAGTTTCAGGCAGCCTGTCTGTTTCTGATGCTTTGTTCGCCCGCGAATACAATGAAGCGTTGGTTCACCAGCTGGTAAATGCCTACTTGGCAAACGCCCGCTCTGGTAACCGTGCTCAAAAAACCCGTGCCGAAGTAAAACACTCAACCAAAAAACCATGGCGTCAAAAAGGTACCGGCCGCGCCCGTTCCGGTATGACTTCTTCTCCGCTGTGGCGTAAAGGCGGTCGCGCGTTCCCGAACAAACCCGACGAAAACTTCACTCAAAAAGTAAACCGTAAAATGTACCGTGCCGGTATGGCGACTATCCTGTCCCAATTGGCGCGTGACGAGCGTTTGTTTGTGATTGAGGCGTTGACTGCCGAAACTCCCAAAACCAAAGTTTTTGCCGAACAAGTAAAAAATTTGGCTCTGGAGCAAGTGCTGTTTGTAACCAAACGGCTCGACGAGAATGTTTACTTGGCTTCACGCAACTTGCCAAACGTATTGGTTTTGGAAGCTCAACAAGTTGATCCTTACAGCTTGCTGCGTTATAAAAAAGTAATCATCACTAAAGATGCGGTTGCACAATTAGAGGAGCAATGGGTATGA
|
MLS
|
Macrolide-resistant 50S rRNA mutation
|
Drugs
| 1 |
MEG_8254|Drugs|MLS|Macrolide-resistant_23S_rRNA_mutation|MLS23S|RequiresSNPConfirmation
|
TGAAATGATAGAGTCAAGTGAATAAGTGCATCAGGCGGATGCCTTGGCGATGATAGGCGACGAAGGACGTGTAAGCCTGCGAAAAGCGCGGGGGAGCTGGCAATAAAGCAATGATCCCGCGGTGTCCGAATGGGGAAACCCACTGCATTCTGTGCAGTATCCTAAGTTGAATACATAGGCTTAGAGAAGCGAACCCGGAGAACTGAACCATCTAAGTACCCGGAGGAAAAGAAATCAACCGAGATTCCGCAAGTAGTGGCGAGCGAACGCGGAGGAGCCTGTACGTAATAACTGTCGAGGTAGAAGAACAAGCTGGGAAGCTTGACCATAGCGGGTGACAGTCCCGTATTCGAAATCTCAACAGCGGTACTAAGCGTACGAAAAGTAGGGCGGGACACGTGAAATCCTGTCTGAATATGGGGGGACCATCCTCCAAGGCTAAATACTCATCATCGACCGATAGTGAACCAGTACCGTGAGGGAAAGGCGAAAAGAACCCCGGGAGGGGAGTGAAACAGAACCTGAAACCTGATGCATACAAACAGTGGGAGCGCCCTAGTGGTGTGACTGCGTACCTTTTGTATAATGGGTCAACGACTTACATTCAGTAGCGAGCTTAACCGGATAGGGGAGGCGTAGGGAAACCGAGTCTTAATAGGGCGATGAGTTGCTGGGTGTAGACCCGAAACCGAGTGATCTATCCATGGCCAGGTTGAAGGTGCCGTAACAGGTACTGGAGGACCGAACCCACGCATGTTGCAAAATGCGGGGATGAGCTGTGGGTAGGGGTGAAAGGCTAAACAAACTCGGAGATAGCTGGTTCTCCCCGAAAACTATTTAGGTAGTGCCTCGAGCAAGACACTGATGGGGGTAAAGCACTGTTATGGCTAGGGGGTTATTGCAACTTACCAACCCATGGCAAACTCAGAATACCATCAAGTGGTTCCTCGGGAGACAGACAGCGGGTGCTAACGTCCGTTGTCAAGAGGGAAACAACCCAGACCGCCGGCTAAGGTCCCAAATGATAGATTAAGTGGTAAACGAAGTGGGAAGGCACAGACAGCCAGGATGTTGGCTTAGAAGCAGCCATCATTTAAAGAAAGCGTAATAGCTCACTGGTCGAGTCGTCCTGCGCGGAAGATGTAACGGGGCTCAAATCTATAACCGAAGCTGCGGATGCCGGTTTACCGGCATGGTAGGGGAGCGTTCTGTAGGCTGATGAAGGTGCATTGTAAAGTGTGCTGGAGGTATCAGAAGTGCGAATGTTGACATGAGTAGCGATAAAGCGGGTGAAAAGCCCGCTCGCCGAAAGCCCAAGGTTTCCTACGCAACGTTCATCGGCGTAGGGTGAGTCGGCCCCTAAGGCGAGGCAGAAATGCGTAGTCGATGGGAAACAGGTTAATATTCCTGTACTTGATTCAAATGCGATGTGGGGACGGAGAAGGTTAGGTTGGCAAGCTGTTGGAATAGCTTGTTTAAGCCGGTAGGTGGAAGACTTAGGCAAATCCGGGTTTTCTTAACACCGAAGAAGTGATGACGAGTGTTTACGGACACGAAGCAACCGATACCACGCTTCCAGGAAAAGCCACTAAGCTTCAGTTTGAATCGAACCGTACCGCAAACCGACACAGGTGGGCAGGATGAGAATTCTAAGGCGCTTGAGAGAACTCGGGAGAAGGAACTCGGCAAATTGATACCGTAACTTCGGGAGAAGGTATGCCCTCTAAGGTTAAGGACTTGCTCCGTAAGCCCCGGAGGGTCGCAGAGAATAGGTGGCTGCGACTTGTTTATTAAAAACACGAGCACTCTTGCCAACACGAAAGTGGACGTATAGGGTGTAACGCCTGCCCGGTGCCGGAAGGTTAATTGAAGATGTGCAAGCATCGGATCGAAGCCCCGGTAAACGGCGGCCGTAACTATAACGGTCCTAAGGTAGCGAAATTCCTTGTCGGGTAAGTTCCGACCCGCACGAATGGCGTAACGATGGCCACACTGTCTCCTCCCGAGACTCAGCGAAGTTGAAGTGGTTGTGAAGATGCAATCTACCCGCTGCTAGACGGAAAGACCCCGTGAACCTTTACTGTAGCTTTGCATTGGACTTTGAAGTCACTTGTGTAGGATAGGTGGAAGGCTTGGAAGCAAAGACGCCAGTCTCTGTGGAGTCGTCCTTGAAAATACCACCCTGGTGTCTTTGAGGTTCTAACCCAGACCCGTCATCCGGGTCGGGGACCGTGCATGGTAGGCAGTTTGACTGGGGCGGTCTCCTCCCAAAGCGTAACGGAGGAGTTCGAAGGTTACCTAGGTCCGGTCGGAAATCGGACTGATAGTGCAATGGCAAAAGGTAGCTTAACTGCGAGACCGACAAGTCGGGCAGGTGCGAAAGCAGGACATAGTGATCCGGTGGTTCTGTATGGAAGGGCCATCGCTCAACGGATAAAAGGTACTCCGGGGATAACAGGCTTGATTCCGCCCAAGAGTTCATATCGACGGCGGAGTTTGGCACCTCGATGTCGGCTCATCACATCCTGGGGCTGTAGTCGGTCCCAAGGGTATGGCTGTTCGCCATTTTAAAGTGGTACGTGAGTTGGGTTTAAAACGTCGTGAGACAGTTTGGTCCCTATCTGCAGTGGGCGTTGGAAGTTTGACGGGGGCTGCTCCTAGTACGAGAGGACCGGAGTGGACGAACCTCTGGTGTACCGGTTGTAACGCCAGTTGCATAGCCGGGTAGCTAAGTTCGGAAGAGATAAGCGCTGAAAGCATCTAAGCGCGAAACTCGCCTGAAGATGAGACTTCCCTTGCGGTTTAACCGCACTAAAGGGTCGTTCGAGACCAGGACGTTGATAGGTGGGGTGTGGAAGCGCGGTAACGCGTGAAGCTAACCCATACTAATTGCCCGTGAGGCTTGACTCT
|
MLS
|
Macrolide-resistant 23S rRNA mutation
|
Drugs
| 1 |
MEG_8020|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CML
|
ATGCCTTTTGATAACAAACAAACTCCACGCTGGAGTTATTCCCTGCCATTTGCGCTCGCGTTGATGGCTCCCTTCGACATTCTCGCCTCGCTGGCCATGGACATCTACTTGCCGGTCGTACCGTCCATGCCTGCGATCCTGCAAACGACACCCGCCATGGTGCAGCTGACGCTCAGCCTCTACATGGTGATGCTGGGTGTCGGGCAGCTTCTTTTCGGCCCGTTGTCCGACCGTTTCGGACGCAGGCCCATCCTGCTTGGCGGTGGACTGGTGTTCGCCCTTTCGTCCTTCGCTCTGGCGATTACCGACAATGCCACCGTTTTCGTATTGCTTCGTTTCGTACAGGCAACAGGTGCCTCGGCAGCACTTGTCGCCACTTTCGCAACGGTCCGCGACGTCTATGCGACGCGCCCCGAAGGCGCGACGATCTACGGCCTTTTCAGCGCCATGGTTTCCTTCGTCCCTGCGCTTGGGCCGATTGCAGGCGCCCTGATTGCAAAAGGGTTCGGATGGCGGACAATCTTCGCATTGCTGGGCGTTTTCAGTCTCGTCGCAACATGGCGCGCCTTGCGCCACTGGCACGAGACACGACCGACCAGCAGCGCGCCGGGCACAGGCGGTCTGGGGCGGATCATGAAGGATTTTCCCTTCTGGACCTATACGCTCGGTTTTGCGACGGCGATGGGCACGTTCTTCGTGTTCTTTTCCACCGCACCGCGCATTCTGATCGAACGCGGCGGTTTCCCGGAAACCGGCTTCAGTCTTGCCTTCGCAAGCGTTGCCATCGTCATGATCGCCGCCACGTGCATCCTGCCTCGCCATACGCAGAAATGGGGTGCCCGTAAAAGCGTGGCCCTTGGCATGACCGTGCTCCTTGCCAGCGCGCTCCTGCTTCTGGCGGGTGAGAAACTACTACAACCATCGTTCACAAGCCTCATCGTCCCGATGTGGCTTGCTGCTGTCGGGATTGTTTTCACTGCATCGATGACGGCAAATGGAGCGCTTGCAGCCTTTGATGACAATGCAGGCATGGCGGTCGCAGTCTATTTCTGCATTCAAAGCCTGATCGTCAGTCTCGCAGGAACCGCACTGGTCATTTTCCTGCCGGGCGATACTGCCTGGCCATTGATCGTTTTCTGCACAATCATGCCATTGCTGGTTCTGGCCATGCTCGTGAGGCTACGAAAGAACTGA
|
Phenicol
|
Phenicol resistance MFS efflux pumps
|
Drugs
| 1 |
MEG_8013|Drugs|Phenicol|Chloramphenicol_acetyltransferases|CATA
|
ATGGAGAAAAAAATCACTGGATATACCACCGTTGATATATCCCAATGGCATCGTAAAGAACATTTTGAGGCATTTCAGTCAGTTGCTCAATGTACCTATAACCAGACCGTTCAGCTGGATATTACGGCCTTTTTAAAGACCGTAAAGAAAAATAAGCACAAGTTTTATCCGGCCTTTATTCACATTCTTGCCCGCCTGATGAATGCTCATCCGGAATTCCGTATGGCAATGAAAGACGGTGAGCTGGTGATATGGGATAGTGTTCACCCTTGTTACACCGTTTTCCATGAGCAAACTGAAACGTTTTCATCGCTCTGGAGTGAATACCACGACGATTTCCGGCAGTTTCTACACATATATTCGCAAGATGTGGCGTGTTACGGTGAAAACCTGGCCTATTTCCCTAAAGGGTTTATTGAGAATATGTTTTTCGTCTCAGCCAATCCCTGGGTGAGTTTCACCAGTTTTGATTTAAACGTGGCCAATATGGACAACTTCTTCGCCCCCGTTTTCACCATGGGCAAATATTATACGCAAGGCGACAAGGTGCTGATGCCGCTGGCGATTCAGGTTCATCATGCCGTCTGTGATGGCTTCCATGTCGGCAGAATACTTAATGAATTACAACAGTACTGCGATGAGTGGCAGGGCGGGGCGTAA
|
Phenicol
|
Chloramphenicol acetyltransferases
|
Drugs
| 1 |
MEG_8436|Drugs|betalactams|Class_D_betalactamases|OXA
|
ATGCGTAGAACCCGGGTCCTCGTGTTGAGTTTTACACTCCTCCTGGCTTTACTGGCAGCTTGCAACCCACTCCAGACCGCCACGTCCCAACCCTTGCCGAACACAACCGTTCAGACGGAAACCGACCTTCCGGTTTCCGAAGAAAAACCGGAACTGGAAAATTTCTTCGAGGGAATGAAGGGCGCCTTTGTGTTGTACGACTTGAATGGTCAGAAAACGATCCGTTTCAATACACAGCGCTGCGCCGAACCCTTCCTGCCGGCGTCCACCTTCAAAATTCTAAACGCCCTAATTGGTTTGGAGACCGGCGTTATCTCGGACGAAAATTACAAGATTGCGTGGGACGGCACGAACTACGAGATCGCCTCCTGGAATCAGGATCAGACCCTCGCGACGGCGTTCCAAAATTCGGTCGTCTGGTATTACCAGGAACTCGCCCGGCGCGTCGGGGAAGAGAGAATGCGGCATTATGTGGAATTGGCCGATTATGGCAACCGGGACATCTCTGGCAAGATCGATACATTCTGGCTGGAAGGCGGCCTTCGAATATCAGCCGACCAACAGGTGGATTTTCTGAAGCGGTTCTATCAAAATGATCTGCCGTTTTCCACCTCATCGATCGACATCGTGAAGAAGATCATGATTTTGGAGTCGACCGATTCCTATACCTTTCGCGGAAAAACCGGATCGGTTCAACGTGTTCCCATCCACACCGGCTGGTTCGTGGGTTACCTGGAACGGGATGGGAATGTGTATTTCTTCGCGACCAACATTGAAAGCACCGATCCGGATGGATTTGCAAGCGGTGCGGCCGCGAGGGAAATTACAGAGAATATCCTGGTCGAGGAGGGTCTGCTGCCGCCCCGCTGA
|
betalactams
|
Class D betalactamases
|
Drugs
| 1 |
MEG_8415|Drugs|betalactams|Class_D_betalactamases|OXA
|
ATGTCCCGCCTGCTTCTCTCCAGCCTGCTGGCTGCCGGTCTGCTCGCCGCTCTGCCTGCCTCCGCCGCCAGCGGCTGTTTTCTCTATGCTGACGGCAACGGCCAGACCCTCTCCAGCGAAGGGGACTGCTCCAGCCAGCTGCCGCCCGCATCCACCTTCAAGATCCCGCTGGCACTGATGGGCTATGACAGCGGCTTTCTGGTGGATGAAGAGCATCCAGCACTGCCCTTCAAACCGGGTTACGACGACTGGCTGCCCGCCTGGCGCGAAACCACTACCCCGCGCCGCTGGGAAACCTACTCGGTGGTCTGGTTCTCCCAGCAGATCACCGAATGGCTGGGGATGGAGCGCTTCCAGCAATACGTCGACCGCTTCGACTACGGCAACCGGGATCTCTCCGGCAATCCGGGCAAGCATGACGGCCTGACCCAGGCCTGGCTAAGCTCCAGCCTCGCCATAAGCCCGGAGGAGCAGGCCCGCTTCCTCGGCAAGATGGTGAGCGGCAAGCTGCCGGTCTCGGCGCAGACCCTGCAGTACACCGCCAATATCCTCAAGGTGAGCGAGATCGATGGCTGGCAAATCCACGGCAAGACCGGCATGGGCTACCCGAAGAAGCTGGATGGCAGCCTCAACCGCGATCAGCAGATCGGCTGGTTCGTCGGCTGGGCCAGCAAACCGGGCAAGCAGCTGATCTTCGTCCATACCGTGGTGCAAAAGCCCGGCAAGCAGTTCGCCTCCCTCAAGGCGAAAGAAGAGGTGCTGGCCGCCCTGCCCGGGAAGCTGAAGACCCTGTAA
|
betalactams
|
Class D betalactamases
|
Drugs
| 1 |
MEG_8005|Drugs|betalactams|Class_B_betalactamases|BLAB
|
ATTATGAAGAATATAATGCGGGCACTGATCCTTGTTTTTGGTTTTATGAGTTTTTTTATGTTTGGACAGGAGAATCCTGACGTCAAAATTGAAAAGCTAAGAGATAATCTGTATGTATACACAACCTACAATACATTTAACGGGACTAAATATGCCGCTAATGCAGTATATCTGGTAACTGATAAGGGTGTTGTGGTTATAGACTGTCCGTGGGGAGAAGACAAATTTAAAAGCTTTACGGACGAGATTTATAAAAAACACGGAAAGAAAGTTATTATGAATATTGCAACACATTCTCATGATGATCGTGCCGGAGGTCTTGAATATTTTGGTAAAATAGGTGCAAAAACTTATTCTACTAAAATGACAGATTCTATTTTAGCAAAAGAGAATAAGCCAAGAGCACAATATACTTTTGACAATAATAAATCTTTCAAAGTAGGAAAATCCGAGTTTCAGGTTTACTATCCCGGAAAAGGACATACAGCAGATAATGTGGTGGTATGGTTTCCAAAAGAAAAAGTATTGGTTGGAGGTTGTATTATAAAAAGCGCTGATTCAAAAGACCTGGGGTATATTGGAGAAGCATATGTAAATGACTGGACGCAGTCTGTACACAATATTCAACAGAAGTTTTCCGGTGCTCAGTACGTTGTTGCGGGGCATGATGATTGGAAAGATCAAAGATCAATACAACGTACACTAGACTTAATCAATGAATATCAACAAAAACAAAAGGCTTCAAATTAA
|
betalactams
|
Class B betalactamases
|
Drugs
| 1 |
MEG_7870|Drugs|Aminoglycosides|Aminoglycoside_N-acetyltransferases|AAC3-PRIME
|
ATGAGCATCATTGCAACCGTCAAGATCGGCCCTGACGAAATTTCAGCCATGAGGGCTGTGCTCGATCTCTTCGGCAAAGAGTTTGAGGACATTCCAACCTACTCTGATCGCCAGCCGACCAATGAGTATCTTGCCAATCTTCTGCACAGCGAGACGTTCATCGCGCTCGCTGCTTTTGACCGCGGAACAGCAATAGGTGGGCTCGCCGCCTACGTTCTACCCAAGTTCGAGCAAGCGCGAAGCGAGATCTACATTTATGACTTGGCAGTCGCTTCCAGCCATCGAAGGCTAGGAGTCGCAACTGCCCTGATTAGCCACCTGAAGCGTGTGGCGGTTGAACTTGGCGCGTATGTAATCTATGTGCAAGCAGACTACGGTGACGATCCGGCAGTCGCTCTCTACACAAAGCTTGGAGTTCGGGAAGACGTCATGCACTTCGACATTGATCCAGGAACCGCCACCTAA
|
Aminoglycosides
|
Aminoglycoside N-acetyltransferases
|
Drugs
| 1 |
MEG_8006|Drugs|betalactams|Class_B_betalactamases|BLAB
|
ATAATGAAAGGATTAAAAGGGCTATTGGTTCTGGCTTTAGGCTTTACAGGACTACAGGTTTTTGGGCAACAGAACCCTGATATTAAAATTGAAAAATTAAAAGATAATTTATACGTCTATACAACCTATAATACCTTCAAAGGAACTAAATATGCGGCTAATGCGGTATATATGGTAACCGATAAAGGAGTAGTGGTGATAGACTCTCCATGGGGAGAAGATAAATTTAAAAGTTTTACAGACGAGATTTATAAAAAGCACGGAAAGAAAGTCATCATGAACATTGCTACACATTCTCATGACGATAGAGCCGGAGGTCTTGAATATTTTGGTAAACTAGGTGCAAAAACTTATTCTACTAAAATGACAGATTCTATTTTAGCAAAAGAGAATAAGCCAAGAGCAAAGTACACTTTTGATAATAATAAATCTTTTAAAGTAGGAAACACTGAGTTCCAGGTCTATTATCCGGGAAAAGGTCATACAGCAGATAATGTGGTGGTATGGTTCCCTAAAGACAAAGTATTAGTAGGAGGCTGCATTGTAAAAAGCGGTGATTCGAAAGACCTTGGGTTTATTGGGGAAGCTTATGTAAACGACTGGACACAGTCCATACACAACATTCAGCAGAAATTTCCCGATGTTCAGTATGTCGTTGCAGGTCATGACGACTGGAAAGATCAAACATCAATACAACATACACTGGATTTAATCAGTGAATATCAACAAAAACAAAAGGCTTCAAATTAA
|
betalactams
|
Class B betalactamases
|
Drugs
| 1 |
MEG_8441|Drugs|betalactams|Class_D_betalactamases|OXA
|
ATGCCAAAAATACTAAAACATCTTAGCCTTTGCGCATCTGTAATGATTGGACTGACGTTGCTAGGTTGCCAAAATTTGCACGCCCCAACTCAAAGCGCCGTGTCAAAAAAACACGATCAAACCGAGATCGCTTCTTTATTCCAACATACTCAAACTGTTGGCGTATTTGTTACATATGATGGGCAAACATTTCAAGAATATGGCAATGCGTTGAGTCGATCGAATACGGCTTATATTCCAGCCTCAACCTTCAAGATGTTAAATGCTCTGATTGGGATACAGCATCACAAAAGTTCGCCCAACGAAGTGTTTAAATGGGATGGCAAAAAGCGTGCTTTTGCGAGCTGGGAAAAAGATTTAACTTTAGCCGAGGCGATGCAGGCATCAGCAGTGCCTGTTTATCAGGAATTGGCTCGGCGTATCGGGTTAGAGTTGATGGCGAACGAAGTAAAACGCGTTGGCTTTGGCAATACTGAGATCGGAACGCAAGTCGATGATTTTTGGTTGGTTGGCCCGCTTAAGATTACCCCCGTTGACGAAGTGAAATTTGCTTATGCTCTGGCAAATAAGCAGCTTGCATTTGACCAATCTGTGCAAGAACAAGTGAAACAGATGGTCTTCGTTGATGAAGTTCATGGAACTAAGATTTATGCCAAAAGTGGTTGGGGTATGGATGTAACACCGCAAGTGGGTTGGTGGACGGGCTGGATTGAACAACCGAATGGACAGGTGATTGCATTTGCTTTAAATCTGGAAATAAATAAGCCTGAGCACGGTGATGCGCGTAAAGCGATTGTTTATCAAGCATTACAACAATTGAAATTGTTACAGAAGCAATAA
|
betalactams
|
Class D betalactamases
|
Drugs
| 1 |
MEG_8721|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_pumps|TOPR
|
ATGACCTCTCACTTCATGCTCCGTCGCGCTCTGCTGCCCCTGGCCATCGCCGCCCTGGCGGGTTGTTCGCTGGCCCCGACCTACGAGCGCCCGCAGGCACCGGTCGCGTCGCACTGGCAAGCCGCCGACGCGGAGGGCACCCGTGCCCAGGCGCTGGACTGGCAGACCTTCATCGTCGATGCCGACTTGCGCCGCGCGGTGGATACGGCGCTGAGCAACAACCGCAGCCTGCGCCAGGCGCTGCTGGATATCGAAGCTGCGCGTGCCCAGTACCGCATCCAGCGTGCTGATCGCCTGCCTTCGATCAACGCCAATGCCAGCGGCAACCGCCAGCGCCTGCCTGCCGATCTGTCGCAGACCGGGCGCTCGGAAGTGACCAGCAACTATCAGGTCGGCCTCGGCCTCGCGGAGTACGAAGTCGACCTGTTCGGCCGCGTGCGCAACCTCTCCGAGGCCGCGCTGGAGACCTACCTGGCGACCGAGGAGGCGACCCGTGCCACGCAGATCAGCCTGGTTGCCGAGGTCATCCAGGCCTACCTGACCCGCGATGGTGCGCTACGCCGCATGGCCCTGGTCGAACAAACCCTGGACAGCCGCATGGCCTCGCTGGAGCTGGTCAGCCAGCGCCGTGCAGCGGGGGCCGCCACCGCCCTGGATTACCAGGAAGCGGTCGGCCTTGCCGAACAGGCTAGGGCCGAGCGCGAGAGCACCGAACGCCAGTTACGCCAGGCGGACAACGCCCTGGTCCTGTTGCTCGGCACGCCAGATGCCGCTCGCCTGCTGCCCGCGACGCCCCGCGACGACCTGATGGTGCTGCAGGACATCGCCCCCGGCACCAGCTCGGAACTGATCGAACGGCGCCCGGACATTCTCGCCAGCGAGCACCGCCTCAAGGCGCGCAATGCCGATATCGGTGCAGCTCGCGCCGCGTTCTTTCCCCGGATCAGCCTGACCGGTTCGGTGGGCAGCTCCAGTGCCGAGTTGTCCGGATTGTTCGATGGCGGCTCGCGGGCCTGGAGCTTTGCCCCGACGCTGTCGCTGCCGATCTTCGCCGGTGGCCGCAACCGCGCCAACCTGGACCTCGCCGAAGTGCGCCAGGACGCGGCGGTGGCCGACTACGAAGGCACCATCCAGACCGCCTTCCGCGAAGTGGCCGATGCCCTGGCCGCCACCGACACCCTGCGCCGCGAGGAGGCTGCCCGCCAGGCTCTGGCCGGTTCCAGCGAGGCTGCGATGGCCCTGGCTAAGGCGCGTTACGAGGGCGGCGTGGACGACTACCTGCGTTATCTTGACGCCCAGCGCAGCACCTTTAGCAACCAGACCACACTAATTCAAATCAGCACGGAACGGCAGATTGCGCTGGTTGACCTGTTCAGGTCTCTGGGCGGTGGCTGGGGCCAAACTGAACCGATGGCCGGGATCGGCGCTGAGTGA
|
Multi-drug resistance
|
Multi-drug RND efflux pumps
|
Drugs
| 1 |
MEG_8260|Drugs|MLS|MLS_resistance_ABC_efflux_pumps|MSRG
|
ATGGAACAAATCTGTTTTGAATTAGAAAATGTAGAAGTGACATATCTAGATAAAGAGGTTTTAAAGATTGAAAGATTAGCTGTACACCAATTTGACCGTATCGGCATAGTCGGTAAAAATGGTGCAGGTAAAAGCACGTTACTAAAATTACTGGCGGGTATCATTAAGCCAACAACGGGAAAGGTGAATCGGCTTGTTGAGAATGGCTATTTTGAGCAACTTGAAACTCCATCAGTACGTGATGCTGATCCAGTGTTACTTGGAAAATTAGACGTACCAAAAGACTCTAATCAGCTAAGCGGTGGGGAACAAACAAGGATGAAACTCGCTAAATTGTTTACTCATTATTATGAAGCTTTATTAATTGATGAGCCGACTACTCACTTAGACCAAGAGGGGATTTCGTTTTTGCTCGATGAACTTAGGTATTACTACGGAGCGCTTGTATTAATTAGTCATGACCGTTCTGTATTAGATGAACTAGTTACGACAATTTGGGAAGTTCATGAAGGTAAGGTACGAATCTATTCAGGAAATTACAGCGACTACATGGCACAAAAGAAGTTAGAACGTGAACAGCAGAGTCAAGCACATGAACAGTTCATAAAAGAAAAGAGCAGGCTAGAAAAAGCAGCACAAGAAAAAATGAAGAAAGCTGAAAAAGTTGCACAAGCAGGTCGATTGTCAAAAAAAGATGCGAATGCAAAGCCGGATAAGTCCTTTATGACAAAATCCAAAGGTACGAGCCAAAAAGCTATGCAGCGTGCAGCAAAGGCCATTGAGCAACGAATGGAAAAACTTCAGGAAGTCGATGCTGTAAAAGAGGATAGGCAAATAAACTTCCATCAATCGAGAAATTTAGAGCTGCATAATAAATTTCCGATAATGGCAGACCGATTTACTCTTCAAGTGGATAACAAAGTATTATTAAATGAAGTAAGTTTTCAAATGCCGCTTGGTAAAAAAATTGCAATTTCGGGTAAAAATGGTGCTGGCAAAAGTACTTTACTCCACCATATTGCTATCAATGCGCCCGGTTTAACAATTTCACCAAAAGCAAAAATTGGATACTTTCGTCAAATGAGCTATCAATATACAAGGGATGAAACGGTATTGGAATTTCTGAAAAATCGTTCTGAATACGATGAGAGATTTTTACGAAGCGTTCTACATTCCATGTTGTTTGTCGGCACAGATATATTAAAAAGTGTAAAATCATTAAGTGGTGGTGAAGCGATTCGTCTACAATTATGTCAATTATTTTTAGGAGAGTATAATATTTTATTGTTAGATGAACCAACCAATTTTTTAGATATCTATGCTATTGAAGCGTTAGAAAGGTTTATTACAGCATATAAAGGCACTATTATCTTCGTATCACATGATCGCAGGTTTATTGATTGTGTAGCAGATTGTATATATTTCATTGAAGATCAACAGCTAAAATTAAGGGGTTGA
|
MLS
|
MLS resistance ABC efflux pumps
|
Drugs
| 1 |
MEG_8245|Drugs|MLS|MLS_resistance_MFS_efflux_pumps|MEFF
|
ATGGATAATATGAATTGGAAACGGAAATTTATTGCGATTTTTACAGGGCAGTTCTTTTCACTATTAAGCAGTGCTGCTGTTCAATTTAGTATCATTTGGTGGTTAACAGATACATCAGGAGGTTCTCCACTGATTTTAACATTAGCAGGACTGGCTGGTTTTATGCCACAAGCATTGTTAGGTCCTTTTGCAGGAACTATTACTGATCGTTATTCACGAAAAGTGATTATGATAATTGCAGATATGACGGTTGCACTTGGAAGTTTAGCTTTATTTGTATCAATGTATTTTTATGATCCGAGTATTATATTGGTGATAATTGTATTGATCGTTCGTTCATTAGCAACTGCATTCCATATGCCGGCTATGCAAGCGTCTATTCCACTAATAGCCCCAAAAGAGCATTTGACAAAAGTTTCTGGATGGGGACAGACAGTGGCTTCTATATCAAATATTGTTGGTCCAGCAGCGGGGATGTCATTACTAGCGATAAGCTCCGTTGAGTGGGTTCTATTACTAGATGTCTTTGGGGCAGTAATTGCTAGTAGTATTTTGCTATTTATTCACATTCCAAATGTACAGAGTTCAGAAACTGTTGATTCTTCTAGTTTTATCAGCGATATGAAAGAAGGATATCATGCACTTGTAAAACATCCTGTTTTATTAAGGTTAACAGTCACGATTACGATTGTTTCGGTGCTGTATATTCCGCTAGGCACTTACTTTCCGCTTATGACACGAAATCATTTCGAGAAGGGCGTAGTTGAAGCTGGAATAATCGAAATTGTTTTTGCTGTTGGCCTCATCTTTGGTGGTATATTAATGGGGATTTTCGGAGATCGATTTGAAAAATTGAAACTCATTGTTAGCGGAATGATACTGATGGGGATTGCCTTATTCATTTCTGGCACACTTCCATCAACTTTATTCTATGGATTTATCGTAATGGCTGGTCTAGTGGGATTGTCTGGTCCATTATTTTCAGCTCCGTTTTATGCTCTTATCCAAACCGAAATTGAACCTCATTTACTTGGGAGAGTGTTTAGTTTTGTTGGAAGTTTGGCATTACTTGCAACACCGTTGGGTTACGCATTTGCTGGGGTTCTGATCCACTTAACAAATGTGGCCGTATTATTTTTGATTACAGGTATATTAATTGTATTAAATGCTGTTATCGTAAGGAAAGCAAAATAG
|
MLS
|
MLS resistance MFS efflux pumps
|
Drugs
| 1 |
MEG_8418|Drugs|betalactams|Class_D_betalactamases|OXA
|
ATGTGGATGCTAAAAGCGATATCTTGTTCAGTTTTAAGCTGGATGCTGTTAAGTGCATGCAGTCAGCAACCTCTTAAGGACCAAATGCAGCAGCCATTGATGATGCAACAACCACGGTTAGCTGAGTTGAATCATATGTTTCAAGCAGTGGGCAGTGCGGTAGTTTTTGTTACTTATGATGGGGAAAAATTGCAGCGTTTTGGCAATGATTTGCAAAGAGCTGAAACTGCCTATATACCTGCTTCAACTTTTAAAATGTTAAATGCTTTAATTGGTTTACAGCAGCGTAAAACCACGACCACTGAAGTATTTTTATGGGATGGAAAAGCACGCGCAATGAAAAGTTGGGAACGGGATATGACTTTGGCTGAGGCGATGCAAGTCTCAGCAGTTCCCATCTATCAAACCTTGGCTCGACGCATTGGTCTGCCGTTGATGCAAAAAGAGCTTCATCGAGTTGGTTATGGAAATGCTCAGATTGGTACACAGGTTGATCGCTTTTGGTTAGATGGACCCTTAAAAATTACACCGCAACAAGAAGCTGAATTTGCTTACAGACTTGCGACCCAGACCTTACCTTTTGATGCACATGTGCAACAAGAGGTGAAACAAATGCTTTATGTGGAGCGTCGTGGTGTTGCTAAGTTGTATGCTAAGTCAGGATGGGGAGCCGATGTAAAACCTCAGGTGGGTTGGTATGTGGGATGGGTGGAACAGCCCAATGGCAAAATTTTGGCCTTTGCTTTAAATATGCAGATACAGAATGAGCAGCAATTGGCAATGCGTAAACAGCTCACCCTAGATGCTTTAGATAAACTTAGTATCTTTCCTTATTTATAA
|
betalactams
|
Class D betalactamases
|
Drugs
| 1 |
MEG_7878|Drugs|Aminoglycosides|Aminoglycoside_N-acetyltransferases|AAC6-PRIME
|
ATGAGTACCAACCATGGCTCAGTCACACTGCGCCTCATGACCGAGCAGGACCTTCCCATGCTCTATGAGTGGCTAAATCGATCTCATATCGTCGAGTGGTGGGGCGGAGAAGAAGCACGCCCGACACTTGCTGACGTACAGGAACAGTACTTGCCAAGCGTTTTAGCGCAAGAGTCCGTCACTCCATACATTGCAATGCTGAATGGAGAGCCGATTGGGTATGCCCAGTCGTACGTTGCTCTTGGAGGCGGGGACGGATGGTGGGAAGAAGAAACCGATCCAGGAGTACGCGGAATAGACCAGTCACTGGCGAATGCATCACAACTGGGCAAAGGCTTGGGAACCAAGCTGGTTCGAGCTCTGGTTGAGTTGCTGTTCAATGATCCCGAGGTCACCAAGATCCAAACGGACCCGTCGCCGAGCAACTTGCGAGCGATCCGATGCTACGAGAAAGCGGGGTTTGAGAGGCAAGGTACCGTAACCACCCCAGATGGTCCAGCCGTGTACATGGTTCAAACACGCCAGGCATTCGAGCGAACACGCAGTGATGCCTAA
|
Aminoglycosides
|
Aminoglycoside N-acetyltransferases
|
Drugs
| 1 |
MEG_8021|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CML
|
GTGCCCAATCGTAAATCACCAACCTGGACCTATTCGGTGCCGGCAGCGTTGCTGCTGATGGCACCCTTCGACATCCTCGCCTCGCTGGCGATGGATATCTACCTTCCGGTCGTGCCGGCCATGCCCGGTATTCTCGGCACCACCCCGGCAATCATCCAGCTGAGCCTGAGCCTCTATATGATCGTTCTCGGCGTCGGGCAGATCGTCTTCGGACCCATTTCCGATCGCATCGGTCGGCGTCCCGTCCTCATCGGCGGGGCGCTCGCCTTTGCGGCCGCGTCATTGCTGATCGCCGCGACATCGTCGGCCCCGACCTTCCTTGCCCTGCGCCTCCTTCAGGCGATCGGCGCATCGGCAGCGCTTGTCGCCACCTTTGCGACGGTCCGCGACGTCTATGCGGAGCGGCCGGAGGGCGTGACCATCTACGGGCTCTTCAGCGCGATGCTCGCCTTCGTCCCGGCCCTCGGGCCGATCGCCGGCGCGCTTCTGGCCGATTACTTCGGCTGGCAGGCGATCTTCCTGACACTCGGTGTGCTGGCAATCGCCGCCACGGCAAACGCCCTGCCGCGATGGCGGGAAACGCGACCCGTCGGCGCCGAGGAGCAAAGGCGGGCTTTCGCCCCGATCCTTAAGGATGGAGCGTTCTGGACCTACACTCTCGGCTTCAGCGCCGCGATGGGCTCGTTCTTCGTGTTCTTCTCGACCGCACCACGCGTGCTGATCGACCGGGCGGGTTACTCCGAGCTCGGCTTCAGCCTGGTCTTTGCAACGGCAGCGGTGGTGATGATCGTCACCACCCGTTTCGCCAAACGCTTCGTCGCGCTTTGGGGCATCGCCGGCAGTTTTGCCCGCGGGATGGGGCTACTTCTCCTCGGCGCGATGCTGCTTGTCGTCGGGGAAAGCGTGTCCCCACCATCGTTCTGGACCTTCATTCTGCCGATGTGGGTCATTGCCGTCGGCATCGTCTTTACCGGCTCGGTCACCGCCAATGGAGCGCTGCAAGCCTTCGGCCACGTGGCGGGTACCGCAGTCGCGCTCTACTTCTGCATCCAAAGCCTGATCGTCGGGGTGCTCGGCACTGTGGCCGTGGTGCTGCTCGGCGGCGATACCGCCTTTCCATTAGCCGGCTATTCGTCGATCATGGCGATCGGCACGCTGATCGCTCTCGGTCGTTTGACACGGCAACGAGCGGCGGACGCCTGA
|
Phenicol
|
Phenicol resistance MFS efflux pumps
|
Drugs
| 1 |
MEG_8247|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_pumps|MEXC1
|
ATGAACAAATTCCGCGAATGGATCACTTTTTCCGTGATCTCCTGTTTGGTCGCCGTGACCCTGGTTGGCTGCGACAAGCCCGAAGAGCAACGGGAAGAGGCGCCAGCGCGTGAAGTCGATGTGCTCAGCGTGAAGACCGAGCCCTTCACAGTGTTCGCCGAGCTACCAGGGCGCATCGAGCCGGTGCGTGTCGCCGAGGTGCGCGCGCGGGTGGCGGGGATCGTGCTCAAGCGCACCTTCGAGGAAGGGGCCGACGTGAAGGCCGGTGACGTGCTGTTCCAGATCGACCCTGCGCCGTTCAAGGCGGCCCTGTCGCGGGCGCAAGGTGAACTGGCTCGCGCCGAGGCGCAGCTGTTCCAGGCTCAGGCGATGGTTCGCCGTTACGAACCACTGGTGAAGATCGACGCCGTCAGCCAGCAGGATTTCGACAACGCCATGGCCGCTCTGCAGAGCGCCCAGGCCGACAAGCGCTCGGCCCAGGCCAATGTCGAAACTGCCCGCCTGGACCTGGGTTATGCCGAGGTTCGCGCCCCCATCGCCGGGCGTATCGGTCGCGCCCAGGTCACCGAAGGGGCTCTGGTAGGCCAGGGCGAAGCCACGCTGCTGGCACGTATCCAGCAACTCGATCCGGTGTACGCCGACTTCACCCAGCCTGCTGCCGATGCCCTGCGCCTGCGCGCGGCAATCGCCGAGGGCAAGGTTGCCGGTGCGAGCGACCAGCCGCTGTCGCTGCGTGTCGACGGTACCGATATCGAGCGCAAGGGCACGCTGCTGTTCACCGATATCTCGGTGGATCGCAGCACCGGGCAGATCGCCCTGCGAGGCCAGTTCGACAACCCCGAGGGCGTGCTGCTGCCGGGTATGTACGTGCGTGTGCGCACGCCGCAGGGGCTCAACCAGAACGCCATCCTGGTGCCGCAACGTGCCGTGCAGCGTTCGGCTGACGGCCAGGCCAGCGTGATGCTGCTGGGCGAGGGCGATACCGTCGAGGTGCGCCAGGTCACTACTGGCGCCATGCAAGGCTCGCGCTGGCAGATCAGCGAGGGCCTGCAGGCCGGCGACAAGGTGATCACCAGCTCGCTGGCGGCTATCCGTCCGGGCGCCAAGGTCATCCCACGCGAGCAAGGCGCCGCCGAAAAAGCTCCACAGTCCCAAGCCCAGTAA
|
Multi-drug resistance
|
Multi-drug RND efflux pumps
|
Drugs
| 1 |
MEG_8248|Multi-compound|Drug_and_biocide_resistance|Drug_and_biocide_RND_efflux_pumps|MEXD1
|
ATGCCCCTGTTTTTCATCCGACGCCCCAATTTTGCCTGGGTAGTCGCCCTGTTCATCTCGCTAGGTGGCCTGCTGGTCATTCCGTTCCTGCCGGTGGCACAGTACCCCAACGTGGCGCCGCCGCAGATTACCGTGACCGCCACCTATCCCGGCGCCTCGGCGCAGGTGCTGACCGACTCGGTGACCAGCGTCATCGAGGAAGAACTCAACGGCGCCAAGAACCTGCTGTACTTCGAGTCCACCAGCAACGCCAACGGCATAGCCGAGATCACCGTCACCTTCCAGCCGGGGACCGACCCCGAACTGGCCCAGGTCGACGTGCAGAACCGTCTGAAGAAGGCCGAGGCGCGCATGCCGCAGGCCGTGCTGACCCTCGGCATCCAGACCGAGCAGGCCACCGCCGGCTTTCTGCTGATCTATTCGCTGCGCTACAAGGATGGCGACAAGAACGCCAACACCACGGCACTGGCGGACTACGCGGTACGTAACGTCAACAACGAGATTCGCCGTCTGCCCGGTGTCGGCAAGCTGCAGTTCTTCGACTCCGAAGCCGCCATGCGCGTGTGGATCGACCCGCAGAAACTGGTCGGTTACGGCCTGTCCATCGACGACGTCAACAACGCCATCCGCACCCAGAACGTGCAGGTGCCGGCCGGCGCCTTCGGCAGCACGCCGGGCTCCAGCGAGCAGGAGCTGACCGCGACGCTGACCGTCAAGGGCACCCTGGACAACCCCGAGGAATTCGCCGCCATCGTGCTGCGTGCCAACCAGGACGGCTCGCGCCTGACCCTGGGCGACGTGGCACGCATCGAGGTCGGCAGCCAGGACTACAACTTCGGCTCGCGCCAGGACGGCAAGCCCGCCGTTGCCGCCGCCGTGCAGCTGTCGCCCGGTGCCAACGCGATCCAGACCGCCGAGGCGGTCAAGCAGCGTCTGACCGAGCTGTCGGCCAACTTCCCGGACAACGTCGAGTTCTCCGTGCCGTACGACACCTCGCGCTTCGTCGACGTGGCCATCGACAAGGTCATCATGACCCTCATCGAGGCCATGGTGCTGGTGTTCCTGGTGATGTTCCTGTTCCTGCAGAACGTGCGCTACACCCTGATCCCGTCCATCGTCGTGCCGGTGTGTCTGCTTGGTACCCTGACCTTCATGTACCTGCTTGGCTTCTCGGTGAACATGATGACCATGTTCGGCATGGTGCTGGCCATCGGCATCTTGGTGGACGACGCCATCGTGGTGGTGGAGAACGTCGAGCGGATCATGGCCGAGGAAGGCCTGGCGCCGGTGCCGGCGACCATCAAGGCGATGGGGCAGGTGTCCGGGGCGATCATCGGTATCACCCTGGTTCTGTCGGCGGTGTTCCTGCCGCTGGCCTTCATGGCGGGTTCGGTGGGGGTGATCTACCAGCAGTTCTCGCTGTCGCTGGCGGTGTCGATTCTGTTCTCGGGCTTTCTCGCGCTGACCTTCACCCCGGCGCTGTGCGCCACGCTGCTCAAGCCGATTCCTGTAGGCCATCACGAGAAGACTGGCTTCTTCGGCTGGTTCAACCGCAAGTTCACCAGCCTGACCAGCCGCTACACGAAGCTCAACGACAAGCTGGTGCCGCGAGCCGGGAGGGTGATGTTCATCTACCTGGGCGTGGTGGTGCTGATGGGCTTTCTCTACATGCGCCTGCCGGAATCCTTCGTGCCGGTGGAAGACCAGGGTTACATGATCGTCGACATCCAGCTGCCGCCCGGCGCCACCCGTGAGCGTACCTCGGCCGCTGGTGGAGAGCTGGAGTCATTTCTGATGGCCCGCGAGGCCGTGCAGACGACCTTCCTGGTGCTTGGCTTCAGCTTCTCCGGCATGGGCGAGAACGCGGCCATTGCCTTCCCGCTGCTCAAGGACTGGTCCGAGCGAGATTCTTCGCAGTCGCCGGAAGCCGAGTCGGCTGCGGTCAACCAGCACTTCGCCAACCTCGATGACGGCGCGATCATGGCGGTGCCGCCACCGCCGGTCGAAGGCCTGGGCAACTCGGGTGGTTTCGCCCTGCGCCTGCAGGACCGCGCCGGCCTTGGCCGCGATGCCCTGTTGGCAGCGCGCGATGAAGTGCTGGGCAAGGTCAACGGCAATCCGAAGTTCCTCTACGCCATGATGGAAGGTCTGGCCGAGGCGCCGCAGCTGCGCCTGGTGATCGACCGTGAGCAGGCGCGCACGCTGGGAGTCAGCTTCGAAGCGATCAGCAGCGCGCTGTCCACTGCGTTCGGCTCGTCGGTGATCAACGACTTCGCCAACGCCGGCCGCCAGCAGCGCGTGGTGGTACAGGCCGAACAGGCCGAGCGCATGACACCGGAAAGCGTCCTGCGCCTGCATGTGCCCAACGACAGCGGCAGCCTGGTACCGCTGAGTGCTTTCGTCACCACGAGCTGGGAAGAAGGCCCGGTGCAGGTCGCGCGTTACAACGGTTACCCGTCGATCCGCATTGCCGGTGACGCCGCGCCCGGCGTGAGCACTGGCGAGGCGATGCTCGAACTGGAGCGCATCGCTGCCGAGCTGCCCGAAGGTATCGGTTACGAGTGGACCGGGCTGTCGTATCAGGAGCGGGTCGCCAGCGGGCAGGCGACGATGCTGTTCGCCCTGGCCATCACCGTGGTGTTCCTGCTGCTGGTGGCGCTCTACGAGAGCTGGGCGATCCCGCTGACGGTGATGCTGATCGTGCCGGTCGGCGCACTCGGCGCGGTACTGGCGGTGACTGCTATCGGCCTGCCCAACGACGTGTACTTCAAGGTCGGCCTGATCACCGTGATCGGCCTGGCGGCGAAGAACGCCATTCTCATCGTCGAGTTCGCCAAGGACCTGTGGGAAGACGGCTACTCGCTGCGCGATGCTGCTGTCGAAGCCGCGCGCCTGCGTTTCCGCCCGATCATCATGACCTCCATGGCGTTCATGCTCGGCGTGGTGCCGCTGGCCATCGCCACTGGCGCCGGCGCTGCGAGCCAGCGCGCACTGGGCACCGGGGTGCTGGGCGGGATGCTCAGCGCGACCATGCTCGGGGTGATCTTCGTGCCGATCTTCTTCGTCTGGGTGCTGTCGCTGCTGCGCACCAAACCTCAGCAAACCGACAACCATCCCCTGCATAAAGCGGAGTAA
|
Drug and biocide resistance
|
Drug and biocide RND efflux pumps
|
Multi-compound
| 1 |
MEG_8420|Drugs|betalactams|Class_D_betalactamases|OXA
|
ATGCGCCCTCTCTTCTTCAGCGCCCTTCTCCTACTCTTCTCCGGGCATGCCCAGGCCAGCGAATGGAACGACAGCCAGGCTGTGGACAAGCTCTTCGGCGCGGCCGGGGTGAAAGGCACCTTCGTCCTCTACGATGTGCAGCGGCAGCGCTATGTCGGCCATGACCGGGGACGCGCGGAAACCCGCTTCGTTCCCGCTTCCACCTACAAGGTGGCGAACAGCCTGATCGGCTTATCCACAGGGGCGGTTAAATCCGCCGACGAGGTTCTTCCCTATGGCGGCAAGCCCCAGCGGTTCAAGGCCTGGGAACACGACATGAGCCTGCGCGACGCGATCAAGGCATCGAACGTACCGGTCTACCAGGAGCTGGCGCGACGCATCGGCCTGGAACGGATGCGCGCCAATGTTTCCCGCCTGGGTTACGGCAATGCGGAAATCGGCCAGGTTGTGGATAACTTCTGGCTGGTGGGACCGCTGAAGATCAGCGCGATGGAGCAGACCCGCTTTCTGCTCCGACTGGCACAGGGAGAATTGCCATTCCCCGCCCCGGTGCAGTCCACCGTGCGCGCCATGACCCTGCTGGAAAGCGGCCCGGGCTGGGAGCTGCACGGCAAGACCGGCTGGTGCTTCGACTGCACGCCGGAACTCGGCTGGTGGGTAGGCTGGGTGAAGCGCAACGAGCGGCTCTATGGCTTCGCCTTGAACATCGACATGCCCGGCGGCGAGGCCGACATCGGCAAGCGCGTCGAACTGGGCAAGGCCAGTCTCACGGCCCTCGGGATACTGCCCTGA
|
betalactams
|
Class D betalactamases
|
Drugs
| 1 |
MEG_8715|Drugs|Tetracyclines|Tetracycline_resistance_MFS_efflux_pumps|TET64
|
TTGAATCCTTCCATGATTGCCATCCTGACGACCGTCGTGCTTGACGCGATCGGCGTCGGGCTCGTGATGCCGATCCTGCCCGGGCTGCTGCGCACCCTCGCCGGCGCGGGCGGCGCCGACACGCACTACGGCATGCTGCTCGCGCTGTACGCGCTGGCGCAGTTCCTGTGCGCCCCCGTCCTTGGCGCGCTGAGCGACCGCTTCGGCCGCCGGCCCGTGCTGCTCGCGTCGCTCGCGGGCGCCGCGCTCGACTACCTGCTGATGGCGTATGCGCCGACGCTCGCGTGGCTCTATGCCGGGCGGCTGATCGCGGGCATCACGGGCGCGAACGTCGCGGTCGCGACCGCGTACGTCACCGACGTGACCGCGGAACCCGATCGCGCGCGCCGTTTCGGTCAATTGGGCGCCGCGATGGGGATCGGCTTCATCGCCGGCCCGGTGCTCGGCGGCCTGCTCGGCGCGTGGCATCTGCGCGCGCCGTTCGCCGCCGCGGCGCTGCTCAATGCGCTCAATCTCGCACTCGTCTGGCGGAGCCTGCCGGAATCGCGGCCGCCGGCCGCGCGCGCCGGCCGCGCCACGGTGAGCCTCAACGCGTTCGCGAGCCTGCGGCGGCTGCGCGGCGGCCCGGCGCTCGTCCCGCTGATCGGCGTCTACGTGATCGTGGCGCTGGTGTCGCAGGCGCCCGCGACGCTGTGGATCCTGTACGGACAGGCGCATTTCGGCTGGTCGACGCCGGTCGCGGGCCTGTCGCTCGCCGGCTACGGCGCGTGCCACGCGCTCGCGCAGGCGTTCGCGATCGGGCCGCTGATCGCGCGGCTCGGTGAGCGTCGCGCGCTCGCGCTGGGCCTCGCCGGCGACGCGCTCGGCCTCGTGGTCATCGCGTTCGCCAACGCGGCCTGGGTGCCGTTCGCGCTATTGCCGCTGTTCGCGGCGGGCGGCATGACGCTGCCGGCGCTGCAGGCGATGCTCGCGCGCCAGGTCGACGATGCCCGGCAGGGCGAGCTGCAGGGCACGCTCGCGAGCGTCGCGAGCCTGATCGGCGTCGCCGGGCCGCTCGTCGTCACCGCGGCCTATGCGGCAACCCGCGACGCGTGGCCCGGGCTCGTCTGGGCCGCGGCCGCGTTGCTCTACCTGCTGGTGCCGCCGCTGCTGGCCCACGCGCGGCCGGCGCGAGAAAGTCCGGCCGCGTAA
|
Tetracyclines
|
Tetracycline resistance MFS efflux pumps
|
Drugs
| 1 |
MEG_8653|Drugs|Fluoroquinolones|Quinolone_resistance_protein_Qnr|QNRB
|
ATGACGCTCGCGCTGACCGCCGAAAAAATCGAAAGAAACCGCTTCACTGGGCTGAAAGTTGAAAACAGCACATTTCATCACTGTGATTTCTCCGGGGCTGACCTGACCGGCACGGAGTTTATCGGCTGCCAGTTTTATGACCGCGAAAATCAAAAGGGCTGTAATTTCAGCCGCGCCATTTTGAAAGATGCGATTTTCAAAAACTGTGATTTATCGATGGCGGATTTCAGGAACGCCAGCGCGCTGGGCATCGAAATTCGTGGCTGTCGCGCGCAAGGTGCAGATTTTCGCGGCACCAGTTTTATGAATATGATCACCACACGCACCTGGTTTTGCAGCGCCTACATCACTAACACCAATCTTAGCTACGCCAATTTTTCGAAAGCGGTGCTGGAGAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGCACTCAGGTTCTTGGCGCGACGTTCAGTGGGTCAGATCTCTCCGGCGGGGAGTTTTCCTCATTCGACTGGCGCGCAGCCAACGTGACGCATTGCGATCTGACCAACTCAGAATTGGGTGATTTAGACGTGCGGGGCGTTGATTTACAGGGCGTCAAACTGGATAGCTATCAGGTGTCATTGATAATGGAGCGACTTGGTGTCGCGATTATCGGCTAG
|
Fluoroquinolones
|
Quinolone resistance protein Qnr
|
Drugs
| 1 |
MEG_8682|Drugs|betalactams|Class_C_betalactamases|RSC
|
ATGTACGGAAAAACCATAACCAGAGTGGGGGGCGTTGCCATTACCGCGCTGTTCCTCGGTGCCGGCAGCTGCGTCGCCGGGGATGATGTAGAAAAAAGGGTCAGGGCTGTCGTGGACGCAGCCATTCGGCCGGCTATGCAGGCGCATGCCATCCCTGGCATCGCGGTGGCGGTATCACTCAATGGGGAGCAGTATTACTTTAACTACGGCGTCGCCTCCAAAGAGAGTGGGCAGATGGTCACCGAGGATACGATTTTCGAGATCGGCTCGGTCAGTAAAACCTTCACGACGACCCTCGCATCCTACGCGCAGGAAAGTGGAGCGCTCTCCCTATCCGACCACGCAAGCCAATACCTGCCTTCGCTACGTGGCAGCAGTTTCGACAGCATCAGCCTGCTCGATCTTGCGACCTACACGCCCGGCGGTCTGCCGCTGCAGTTTCCGGACGCTGTGGACAGTCACGAAAAGATGATCGGTTATTACTACAACTGGAAACCGACCTATGCCGCCGGAACACACAGGCTCTACTCGAACCCGAGCATCGGCCTGCTCGGCTTTCTAACCGCTGAAAGCATGGGTGAGCCTTTCGAAGATCTACTGGAAAAGAAGCTGTTCCCGAAGCTCGGCCTAAGGCAGAGCTACATCAGGGTTCCACAAGAGCAGATGAGCCACTACGCGTACGGTTATAGCCGAGAGGACAAACCGATCAGGGTGGGCCCAGGCGTTCTGGATGCCGAGGCTTATGGCGTGAAATCCAGCTCGGCCGACATGATTCATTTCGTCGAGGCAAACATGCAGGCGGCTGATCTGGATGAGCCGCTGCAACATGCGATTGCCGCAACGCATAGGGGCTACTACAAGGTCGGCGACATGACTCAGGGGCTGGGATGGGAGTTTTACCCCTACCCGATAGAACTCGACCGTTTGCTTGCGGGCAACTCGGCCAAAATGATCCTTGAAGCGAATGAAATTACTCGACTCAACCCTCCGCTGATTCCGAAGGGCGACGTGCTCATTAACAAGACAGGCTCGACGAGCGGTTTTGGTGCATACGTGGCCTTTGTTCCAACCAAGGGTATCGGCATCGTGATGCTGGCGAACAAGAACTACCCCATCCCTGCAAGGGTGAAAGCCGCCCACCAAGTATTGACGGCCCTGGATGCTCGGACTGGATCTAATGCACACCATTGA
|
betalactams
|
Class C betalactamases
|
Drugs
| 1 |
MEG_8683|Drugs|betalactams|Class_D_betalactamases|RSD1
|
ATGAAAAGTTACGTAGACAAGAAATGGATGATAATCTTTCTTATAGTGTGTGTATCCTGTACTTCAAAGGCGATAAAAAAAGAAGCATTTCCTGGTTTTAAACCTTTCTTTGATGAATACGGCGTGCAGGGTTGTTTTATTCTCTACGACCTGAAGAATGATAATTACGAGATATATAACTCTCAACGATGTGAGCAGGGCTTTCTGCCCGCTTCTTCGTTTAAGATCCTTAACGCCATGATTGGACTGGAAACCGGTGTTGTGACCAGTAAAGACATGGTTATCCCCTGGGATGGGGTTACAAGGGAGGTGGAAAGCTGGAACAGGGACCATACACTGGCCTCAGCCATCCAGAATTCGGTGGTTCCTTATTTCCAGGAAATGGCCCGCCGCATAGGTCCTGAAAGGATGAAAAAGTATGTCAATGAAGCCGATTACGGGCAAATGGATGTAACGGCCCAGACTATTGATCATTTCTGGCTAAGGGGGAATTCCCGCATCACTCCCTGGGAACAGATGAACTTTCTGCTGAACTTCTACCAGAATAAGCTGCCCATTTCTGAAACCAACATTGATATTGTCAAGCAACTGATCATCCTTGAAGAAAATGAACGTTGGATCTTTAGGGGCAAGACAGGCTGGGCCAAACAGGATGGTCAGAACATTGGCTGGCTGATCGGTTATTATGAAAATGATAAAAATACCTGGCTTTATGTCTGCAACGTTGAGGCTTCAGATAACAATATCGAGAACTTCAAAGCCAGCAGACGCGGCATTACTGAAAAAGTGTTTAAATCAATGGGTTTGATGGAGTAG
|
betalactams
|
Class D betalactamases
|
Drugs
| 1 |
MEG_8102|Drugs|Aminoglycosides|Gentamicin-resistant_ATP-binding_protein|GAR
|
ATGATTATTCTGCTTAATGGACCGCTCGGAATCGGTAAATCCACGCTATCTGAGGCATTGACGGAACGGGTTGATTGGTGCGCCATGCTTGACGGCGACCACCTCATCGAACTCAATCCACCTCCTGCCAATGAGCAGGAAACGCTTCTTTCTGTGAGCACACTGCTCATTGCTCACTATCAGAGCGTCGGCTACCGCAACTTCGTTCTCAATCACCTGTGGACCGTTCCCGCCGACCTCAGTCAGTTTCGCGCCAAGCTTTCGGAGCTTGACTCAGACGTTCATTGCTTCCGTTTGACATTGCCGGTTGAGGAGAACCTCCGACGTATTGAGCGTAGAGCAAGTGCAACCGGACTTGACCGATCGTACGAGTTGGAGGTGTTTGCCGAGGAGCACACAGTTTTCTCTGGATGTTACGGACACGAACTTGGCGTTCCACTAGATGCATCGAGTTCGCCAGGCGAGCTTGCGAGCCAAGTTCTGGCGTTGCTTGGACTTCATTAG
|
Aminoglycosides
|
Gentamicin-resistant ATP-binding protein
|
Drugs
| 1 |
MEG_8431|Drugs|betalactams|Class_D_betalactamases|OXA
|
ATGAAAATTCTGATTTTACTGCTTTTAGTTAGTTGCTTGGGCCTGACGGCGTGTAGCCTGCCCGTTTCATCTTCCCCATCTCAAAGCACTTCAACTCAATCTACCCAAGCCATTGCCCAATTATTTGATCAGGCGCAAAGCGCAGGTGTTTTAGTGATTCAGCGTGATCAACAGATACAGGTCTATGGCAATGATTTAAGCCGTGCAGATACCGAATATGTTCCCGCCTCTACTTTTAAAATGCTCAATGCCCTGATTGGCCTGCAACATGGTAAAGCCACAACCAATGAAATTTTTAAATGGGATGGCAAGAAACGCAGTTTTTCAGCCTGGGAAAAAGACATGACTCTCGGCCAAGCCATGCAAGCTTCTGCTGTACCCGTCTATCAGGAACTGGCACGTCGCATTGGCCTTGAATTGATGGAACAGGAAGTGAGACGTATTCAATTCGGCAATCAACATATTGGGCAGCAGGTCGATAACTTCTGGTTGGTAGGCCCTTTGAAAATCACTCCAAAACAGGAAGTCGAATTTGTCTCTGCGCTTGCTCAAGAGCAGCTTGCCTTTGATCCTCAAGTCCAGCAACAAGTCAAAGCCATGTTACTTTTACAGGAACAGCAAGCTTATCGCCTATATGCCAAATCCGGTTGGGGCATGGATGTGGAACCGCAAGTCGGCTGGCTCACCGGCTGGGTTGAAACACCGCAGGCTGAAATCGTGGCATTTTCGCTGAATATGCAGATGCAAAATGGTATGGATCCGGCGATCCGCCTTGAGATTTTGCAGCAGGCTTTGGCCGAATTAGGGCTTTATCCAAAAGCTGAAGGATGA
|
betalactams
|
Class D betalactamases
|
Drugs
| 1 |
MEG_8007|Drugs|betalactams|Class_A_betalactamases|BLAPAM
|
ATGCGTTTGCTCGCCAGCCTCGCGCTGCCCCTGTTCGCCGCCAACCTGGCGGTCGCCGCCCCCGCCCAGCTGCCCCAGCTGGAGGCCTACAAGGGCCTCGACGCCTGGCTGGTGCCGGTGGAGCCCCTGCGCATCAGCGACCACGTGTGGCAGATCGGCACCGCCAGCATCAGCGCCCTGCTGGTGAAGACCGACGCCGGCGCGGTGCTCATTGACGGCGGCATGCCCCAGGTGGCCGACCACCTGCTGGCCAACATGAAGAAGCTCGGCGTGGCCCCGCAGGATGTGCGCCTGATCCTCCACAGCCACGCCCACATCGACCACGTCGGCCCGCTGGCGGCAATCAAGCGCGCCACCGGCGCCATGCTGGTGAGCAACGCCGAATCCGCCGTGCTGCTGCAGCGCGGCGGCGCCAACGACATCCACTTCGGCAGCGGCATGCTCTTCGAACCGATCCAGACCGACCGCCTGGTGCAGGACGGCGAGGCCGTGACCCTGGGCGACACCACCTTCACCGTGCACTTCACCCCGGGGCACACGCCCGGCAGCATGAGCTGGACCTGGGCCGACACCCGGGACGGCAAGCCCCTGCGCATCGCCTACAGCGACAGCCTCAGCGCGCCGGGCTACCAGCTGCGCCACAACGCCCGCTACCCGCACCTCGTGGAAGCCTTCCGCGCAAGCTTCGCCGCCGTCCGCGCCCTGCCCTGCGACCTGCTGCTCACGCCCCACGCCGAAGGCAGCGGCTGGGACTACGCCAACGCCGCCAGGCCGCACCCGCAGCCGGTCAGCTGCAAGGCCTACGCGGACAAGGCCGAGGCGAATCTCGACAAGATGCTCGCCGAGCAGGCGAACAAGCGCTGA
|
betalactams
|
Class A betalactamases
|
Drugs
| 1 |
MEG_8069|Drugs|Trimethoprim|Dihydrofolate_reductase|DFRA
|
TTGAAAATTTCATTAATCGCAGCGCAGTCAGAAAATGGCGTTATTGGTAATGGTCCAGAAATTCCATGGTCGGCGAAAGGTGAGCAGTTACTATTTAAAGCGCTAACATATAATCAGTGGCTTCTTGTTGGAAGAAAAACGTTTGAGTCTATGGGTATTCTTCCAAATAGAAAGTATGCTGTTATTTCAAAAAATGGAATTTCACCTCATCCTGAAAATGTACTAGTATTTTCGTCCATTGAAAATGCATTAAATGAATTGCCCAATATAACAGAGCATTTATATATTTCTGGCGGTGGTCAAATATATAATAGCCTTATTGAAAAGGCAGATACTATCCACTTATCTATTGTTCACACGGTGGTAGAAGGCAATGTAATATTTCCAAAAATACCTTCTAATTTCAATTTGGTATTTGAGCAATTCTATTCGTCAAATATTAATTATACTTATCAAATTTGGCAAAAAGGTTAA
|
Trimethoprim
|
Dihydrofolate reductase
|
Drugs
| 1 |
MEG_8034|Drugs|betalactams|Class_C_betalactamases|CMY
|
ATGATGAAAAAATCAATATGCTGCGCGTTGCTGCTGACAGCCTCTTTCTCAACGTTTGCCGCGTCAAAAACAGAACAACACATTGCCGATATCGTCAATCGCACCATCACACCGCTGATGCAAGAACAGGCTATTCCGGGTATGGCCGTGGCGATTATCTACCAGGGGAAACCGTATTACTTTACCTGGGGTAAAGCCGATATCGCCAATAACCGTCCCGTTACTCAGCAAACACTGTTTGAACTTGGCTCGGTCAGTAAGACGTTCAACGGCGTGTTGGGTGGCGATGCTATCGCCCGCGGCGAAATCAAGCTCAGCGATCCGGTCACGCAATACTGGCCAGAATTGACGGGCAAACAATGGCGGGGTATCAGCATGCTGCACTTAGCCACCTATACGGCGGGTGGTCTGCCGCTTCAGATCCCCGACGACGTTACGGATAAAGCCGCATTACTGCGCTTTTATCAAAACTGGCAGCCGCAATGGGCTCCAGGTGCTAAACGTCTCTATGCTAACTCCAGTATTGGCCTGTTTGGCGCACTAGCGGTGAAACCTTCAGGGATGAGCTATGAAGAGGCGCTAACCAGACGCGTCCTGCAGCCTTTAAAACTGGCGCATACCTGGATTACGGTTCCACAGAGCGAACAAAAAGATTATGCCTGGGGCTATCGCGAAGGAAAGCCAGTGCATGTTTCCCCCGGACAACTTGATGCCGAAGCCTATGGCGTGAAATCCAGCGTCGTCGATATGACTCGTTGGGTTCAGGCCAACATGGACGCCAGCCAGGTTAAGGAGAAAACGCTCCAGCAGGGCATTGAGCTTGCGCAATCACGTTACTGGCGTATTGGCGATATGTATCAGGGACTGGGCTGGGAGATGCTTAACTGGCCGGTGAAAGCCGACTCGATAATCAGCGGTAGCGACAGCAAAGTAGCGCTGGCAGCACTTCCCGCCGTTGAGGTAAATCCGCCAGCCCCGGCCGTGAAAGCCTCATGGGTGCATAAAACAGGGTCTACTGGCGGATTTGGCAGCTACGTTGCCTTCGTGCCAGAAAAAAAACTTGGCATCGTGATGCTGGCAAACAAAAGCTACCCTAACCCGGCTCGCGTAGAGGCCGCCTGGCGCATCCTGGAAAAGTTGCAATAA
|
betalactams
|
Class C betalactamases
|
Drugs
| 1 |
MEG_8655|Drugs|Fluoroquinolones|Quinolone_resistance_protein_Qnr|QNRB
|
ATGACGTTGTCATTAATTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTAAACTGTGATTTTTCGGGCGTCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAACCAGAAAGGGTGCAATTTCAGTCGCGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCAATGGCGGATTTTCGCAACGCCAGTGCGCTGGGCATTGAAATTCGTCACTGCCGCGCACAGGGTGCAGATTTTCGCAGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAACCGATGGATGGGAACTCAGGTGCTGGGTGCGACCTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGTCGTTCGACTGGCGGACTGCAAATTTTACGCATTGTGATTTGACCAATTCCGAACTGGGTAATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTACCAGGCCGCGTTGCTGATGGAGCGGCTTGGTATCGCTGTGATTGGTTAA
|
Fluoroquinolones
|
Quinolone resistance protein Qnr
|
Drugs
| 1 |
MEG_8239|Drugs|Lipopeptides|Colistin_phosphoethanolamine_transferase|MCR
|
ATGCCTTCCCTTATAAAAATAAAAATTGTTCCGCTTATGTTTTTTTTGGCACTGTATTTTGCATTTATGCTGAACTGGCGTGGAGTTCTCCATTTTTACGAAATCCTTTACAAATTAGAAGATTTTAAGTTTGGTTTCGCCATTTCATTACCAATATTGCTTGTTGCAGCGCTTAACTTTGTATTTGTTCCATTTTCGATACGGTATTTAATAAAGCCTTTTTTTGCACTTCTTATCGCACTTAGTGCAATCGTTAGTTACACAATGATGAAGTATAGAGTCTTGTTTGATCAAAACATGATTCAGAATATTTTTGAAACCAATCAAAATGAGGCGTTAGCATATTTAAGCTTACCAATTATAGGATGGGTTACTATTGCTGGCTTTATCCCTGCCATTTTACTTTTCTTTGTTGAAATTGAATATGAGGAAAAATGGTTCAAAGGGATTCTAACTCGTGCCCTATCGATGTTTGCATCACTTATAGTGATTGCGGTTATTGCAGCACTATACTATCAAGATTATGTGTCAGTGGGGCGCAACAATTCAAACCTCCAGCGTGAAATTGTTCCAGCCAATTTCGTTAATAGTACCGTTAAATACGTTTACAATCGTTATCTTGCTGAACCAATCCCATTTACAACTTTAGGTGATGATGCAAAACGGGATACTAATCAAAGTAAGCCCACGTTGATGTTTCTGGTCGTTGGTGAAACCGCTCGCGGTAAAAATTTCTCGATGAATGGCTATGAGAAAGACACCAATCCATTTACCAGTAAATCTGGTGGCGTGATCTCCTTTAATGATGTTCGTTCGTGTGGGACTGCAACCGCTGTATCTGTCCCCTGCATGTTCTCCAATATGGGGAGAAAGGAGTTTGATGATAATCTCGCTCGTAATAGCGAGGGTTTGTTAGATGTGTTGCAGAAAACGGGGGTCTCCATTTTTTGGAAGGAGAACGATGGCGGCTGCAAAGGCGTCTGCGACCGAGTTCCTAACATCGAGATCAAACCGAAGGATTACCCAAAGTTCTGCGATAAAAACACATGCTATGACGAGGTTGTCCTTCAAGACCTCGATAGTGAAATTGCTCAAATGAAAGGGGATAAGCTGGTTGGCTTCCACCTGATAGGTAGCCATGGCCCAACCTACTACAAACGCTACCCTGATGCTCATCGTCAGTTCACCCCTGATTGTCCACGCAGTGATATCGAAAACTGCACGGATGAAGAGCTCACCAACACCTATGACAACACCATCCGCTACACCGATTTCGTGATTGCAGAGATGATTGCCAAGTTGAAAACCTACGAAGATAAGTACAACACCGCATTGCTCTACGTCTCCGATCACGGTGAATCACTGGGAGCTATGGGGCTTTACCTGCACGGTACACCGTACAAGTTTGCACCGGATGATCAGACCCGCGTACCTATGCAGGTGTGGATGTCACCTGGTTTCATCAAAGAAAAAGGCATGAATATGGAATGTTTGCAGAAAAATGCCGCAGCCAATCGCTATTCTCATGACAACATATTTTCTTCTGTCCTGGGAATATGGGATGTGAAGACAGCTATCTACGAACAAGAATTAGATATCTTTAAGCAATGTCGGAATAATTGA
|
Lipopeptides
|
Colistin phosphoethanolamine transferase
|
Drugs
| 1 |
MEG_7904|Drugs|betalactams|Class_C_betalactamases|ACT
|
ATGAAGACAAAATCCCTTTGCAGTGCCCTGCTGCTCAGCACCTCCTGCTCTGTTCTCGCCGCGCCGATGTCAGAGAAACAGCTGTCTGACGTGGTGGAACGTACCGTTACCCCCCTGATGAAAGCGCAAGCCATTCCGGGCATGGCGGTAGCGGTGATTTATCAGGGTCAGCCGCACTACTTTACCTTCGGAAAGGCCGATGTTGCGGCGAACAAACCTGTCACCCCGCAAACCCTGTTTGAGCTGGGCTCTATAAGTAAAACCTTCACTGGCGTATTAGGTGGCGATGCGATTGCGCGCGGAGAAATATCGCTGGGCGACCCCGTGGCAAAGTACTGGCCCGAGCTAACAGGCAAGCAGTGGCAGGGTATTCGCATGTTGGATCTGGCGACCTACACCGCGGGTGGCCTGCCGCTACAGGTGCCGGATGAGGTCACGGATAACGCCTCCCTGCTGCGCTTCTATCAACACTGGCAACCGCAGTGGAAACCAGGCACAACGCGTCTTTATGCGAACGCCAGCATCGGGCTTTTTGGCGCCCTCGCGGTTAAACCCTCCGGTATGAGCTTTGAACAGGCCATGACGAAGCGGGTCTTCAAGCCACTCAAACTGGACCATACATGGATTAACGTTCCGAAAGAAGAAGAGGCGTATTACGCCTGGGGATACCGTGATGGTAAAGCGGTCCACGTTTCACCGGGAATGTTGGATGCCGAAGCGTATGGTGTCAAAACCAACGTCCAGGATATGGCGAGCTGGGTGAAGGCCAACATGAACCCTGCCGCTCTTCCGGATTCAACGCTGAAACAGGGTATTGCCCTGGCACAGTCTCGCTACTGGCGCGTGGGTGCCATGTATCAGGGTCTGGGCTGGGAGATGCTCAACTGGCCGGTAGAATCCAAAACCGTCGTGGAGGGCAGCGATAACAAGGTGGCTCTTGCACCGTTACCGGTGGCAGAAGTGAACCCTCCAGCTCCGCCAGTAAAAGCATCATGGGTACATAAAACAGGCTCGACGGGTGGATTCGGCAGCTATGTCGCATTTATTCCTGAGAAGGAACTCGGCATTGTTATGCTGGCGAACAAGAGCTACCCGAACCCGGCGCGCGTGGAAGCGGCATACCGTATTCTGAGCGCTCTGCAGTAA
|
betalactams
|
Class C betalactamases
|
Drugs
| 1 |
MEG_8713|Drugs|Tetracyclines|Tetracycline_resistance_MFS_efflux_pumps|TET62
|
ATGCAGACGGAAGCACGGATCAATAAATCTCTGGCCATTGTGCTCAGTGTCATTGTGCTGGATGCAATGGGGCTCGGGCTTGTGATGCCGGTTCTGCCGGAGTTGTTGCGCGGACTGGTGCCAGGCGGACAGGTAACAGGGCATTATGGTATGTTGCTGGCTGTCTATGCGCTGATGCAGGTGTTCTTTGCGCCGCTGCTAGGGCGATTGTCAGATCGCTATGGCCGCCGTCCGGTGCTGATTATGTCGCTTGCCGGTGCAGCAATTGACTATGCCGTCATGGCAGCAGCACCGGTGCTCTGGGTGATTTATATCGGCCGCATGATTGCCGGTATTACCGGAGCGACAGGTGCGGTTGCGGCATCGGCGATTGCCGATACGATGCCGTCAAACCAGCGGGCGCGCTGGTTCGGTTATATGGGCGCCTGTTACGGTGCCGGAATGATTGCGGGGCCTGCGATCGGCGGGCTGGCAGGCAGCCTGTCTGTGCACGCCCCCTTTATCGCGGCTGCTGTACTGAACGGAACCGGTTTTCTGCTGGCTTATCTTTTTCTCAAAGAGACACGTCCGGCAGGTTCGCAGCCGGCAGTTTCAGAAACATTCAGTTTGCGTGAGTTTCTGTTGCCGGTCAGCTTTCTCAAAGGGATGACCGCACTTGCGCTGGTGTTTTTCATTATCCAGCTGGTGGGGCAGCTTCCTGCAACATTGTGGGTGATCTATACGGAAGATCGTTTCGCGTGGGACACAACCATGGTCGGCTTTTCACTGGCGGCTTTCGGTGCCGTGCATACCGTGTTTCAGGCTTTTGTGACCGGCCCGCTCTCAGCCCGTTTTGGTGAGCGCCGCACATTGATCATCGGCATGGCTGCCGATGCCTGCGGTTTTCTGGCGCTGGCCATGATCACGCAAAGCTGGATGATACTGCCGGTACTATTGCTGCTGGCAACCGGCGGTGTCGGCATGCCCGCATTGCAGGCAATGTTGTCTGGGGCTGCCGGAGAGGATGAGCAGGGGAGTTTGCAGGGCACACTGACCAGCCTGACGAACCTGAGTTCGATTATCGGGCCCCTTGGTTTCTCGGCTTTCTACGCAATAACCGCAGTTGCATGGAATGGCTGGGTGTGGATTGGCGGTGCTGCGCTTTATTGCATCAGCTTCGCGATCCTGCGCCGGTCTTCATAA
|
Tetracyclines
|
Tetracycline resistance MFS efflux pumps
|
Drugs
| 1 |
MEG_8066|Drugs|Trimethoprim|Dihydrofolate_reductase|DFRA
|
TTGAAAGTATCATTGATGGCTGCAAGAGCGAAAAATGGCGTAATCGGTTGCGGTCCTAACATTCCTTGGTCTGCCAAAGGGGAACAGCTTCTTTTCAAAGCACTGACCTATAACCAATGGCTTTTGGTAGGGCGCAAAACATTTGAGTCTATGGGGCCGCTGCCCAATAGGAAATACGCGGTTGTTACCCGCTCAAACTGGACAGCGGCTAATGAAAACGTAGTGGTTTTCCCGTCGATTGACGAAGCGATGGGTAGATTAGGCGAGATCACTGACCATGTCATCGTCGCCGGTGGTGGAGAAATCTACCATGAAACGATACCCATGGCCTCTACTCTGCATGTGTCGACAATCGACGTTGAGCCAGAGGGAGACGTTTTCTTTCCGAACATTCCTGGGAAGTTTGATGTCGTTTTTGAGCAACAATTTACATCAAACATTAACTATTGCTATCAAATCTGGCAAAAGGGTTAA
|
Trimethoprim
|
Dihydrofolate reductase
|
Drugs
| 1 |
MEG_8068|Drugs|Trimethoprim|Dihydrofolate_reductase|DFRA
|
TTGTTTTTGAGTGTGGGTATGGCATTTCAGGATTTAGAAGTCGTTCATGTCGTTGCAATGGATCAGCAGCGCTGTATTGGTAAGGACAATGACCTGCCTTGGCATATCTCAGCAGATCTAAAACATTTTAAGGAAATCACCCAGGGCGGTGTAATTGTAATGGGACGTAAGACCCTTGAATCCATGGGACGTGCCTTGCCTAAACGTGTCAACTGGGTCATTACCCGTGATACAGACTGGTCTTTTGAAGGTACTAAAGTCGCACACACGATTGAAGATGCCTTGAACCAAGCTGTTGCAGATGTAAAAGCGTCAGAAAAACCGGAGTCTATTTATATTATTGGGGGTGGTGAAATCTTCAAACAGACAATGAGTATTGCTGACCGTCTGGAACTGACCCATGTCGAACTGGATGTACAAGGTCATGCCTTCTACCCGGAAATTCCTGCTGAATTCAAAAAAGTTTTTTCCGAACAACATATCGACGACAAAACTGGGATTGCTTTTGAGTTTGCAACTTATAGAAAATGA
|
Trimethoprim
|
Dihydrofolate reductase
|
Drugs
| 1 |
MEG_8719|Drugs|Tetracyclines|Tetracycline_inactivation_enzymes|TETX
|
ATGAGTTTATTAAACAATAAAAAAGTTGCAATTATCGGTGGCGGACCAGTTGGACTAACAATGGCAAACTTGTTACAACAAAACGGTATTGACATTACCGTTTACGAAAGAGATGAAAACCCAAAAGCACGAGTTTGGGGCGGAACGCTTGACCTTCACAAAAATTCAGGACAAGAAGCAATGAAAAAAGTAGGATTGTTGCAAACCTACTATGATTTGGCGCTACCTATGGGCGTAAACTTTGCTGATGAGAAGGGTAACATTATAGCAACAAGAAACCCGACACTCGAAAATAAGTTTGACAACCCCGAAATAAATAGAAACGCGTTGCGAAAAATGTTGCTTGGCAGCTTGAAAAATGACACAGTTGTTTGGGATAGAAAATCTATTGGGCTTGAACAAGAAAACGGAAAATGGCTGCTACATTTTGAAAATAAGCCAACTGCATTGGCCGACTTTATTATTGTTTCCAATGGTGGAATGTCTAAAATAAGAAATTTTGTTTCAGATAATGAAGTCGAAGAAACAGGTACTTTTATTATTCAGGGCGACATTCCTGAACCAGAAACGAACTGCCCTGAATTTTATAAGTTGTGCAACAACAATAGACTAATGACCGCACATCAAGGGAATTTATTAGTTGCGAATCCATTTAACAACGGAATGTTAACTTACGGTGTCATTTTCAAAAAGCCTGAAGAATGGAATAATGGAAAAGGATTAGATTTTAAGCCCACAAAAAGCGTTTCCGAGTTCTTGACAAACAGGTTTTCAAATTGGAGCAATGAATACAAGGAGTTAATTCGTTCAACAACTTTTTTCGTTGGTTTAACAATAAAAATATTTCCGCTAGACAAAAAGCCTTGGAAGAGTAATCGTCCGTTACCCATAACTTTAATTGGCGACACAGCTCACCTAATGCCACCTTTTGCAGGGCAGGGCGTAAACATTGGACTAATGGACGCTTTGATTTTGTCAGAAAATCTTACAAACGGGAAATTTGGAACGATACAAAGTGCTATTGATGACTATGAACAACGAATGTTTGTTTACGCAACAGAAGCACAAGCGGACTCGACAAAGAATGAAATAGAAATGCGAAATCCGAGCTTTACTTTTCAACAGCTAATGAATGTATAA
|
Tetracyclines
|
Tetracycline inactivation enzymes
|
Drugs
| 1 |
MEG_8658|Drugs|Fluoroquinolones|Quinolone_resistance_protein_Qnr|QNRVC
|
ATGGAAAAATCAAAGCAATTATATAATCAAGTAAACTTCTCACATCAGAATTTGCAAGAACATATCTTTAGCAATTGTACTTTTATACATTGTAATTTTAAGCGGTCAAACCTTCGAGATTCACAGTTCATTAACTGTACTTTCATAGAGCAGGGGGCACTGGAAGGGTGCGATTTTTCTTATGCTGATCTCCGAGATGCTTCATTTAAAGATTGTCAGCTTTCAATGTCCCATTTTAAGGGGGCAAATTGCTTTGGTATTGAACTGAGAGATTGTGATCTTAAAGGGGCAAATTTTAGCCAAGTTAGTTTTGTAAATCAGGTTTCGAATAAAATGTACTTTTGCTCTGCATACATAACAGGTTGTAACTTATCCTATGCCAATTTTGAGCAGCAACTTATTGAAAAGTGTGATCTGTTCGAAAATAGATGGATTGGTGCAAATCTTCGAGGCGCTTCATTTAAAGAATCAGATTTAAGTCGTGGCGTTTTTTCGGCAGACTGCTGGGAACAGTTTAGAGTACAAGGCTGTGATTTAAGTCATTCAGAACTTAATGGTTTAGATCCTCGAAAGATTGATCTTACAGGTGTAAAAATATGCTCGTGGCAACAGGAGCAGTTACTGGAGCAATTAGGGGTAATAATTGTTCCTGACTAA
|
Fluoroquinolones
|
Quinolone resistance protein Qnr
|
Drugs
| 1 |
MEG_8240|Drugs|Lipopeptides|Colistin_phosphoethanolamine_transferase|MCR
|
ATGCCCGTACTTTTCAGGATGAGGGTAATCCCCCTGGTTTTACTTCTGGCACTCGTTTTTGCATTCTTACTTAACTGGCCGGTGTTGCTGCATTTCTACGATATCCTGAGCCGTCTTGAACATGTGAGGGCGGGGTTCGTCATCTCCATTCCGTTTGTGCTGGTTGCAGCGCTTAACTTTGTGTTTATGCCCTTCTCGGTTCGCTACCTGCTTAAACCCTTCTTTGCCCTGTTGCTGGTCACCGGTTCGGTGGTGAGTTACGCCACACTGAAATATAAAGTGATGTTTGATCAGTCCATGATCGAAAATATACTGGAAACAAACCCACAGGAAGCGCATTCCTACCTGAATGGCTCACTGGTGCTGTGGCTGGTCTTTATGGGCATTCTTCCGGCTATCCTGTTGTTTTTGATTAAAATTGAATATACAGACAAATGGTACAAAGGGGTTGCCCACCGGCTGCTTTCCATGCTCGCTTCGCTGATCCTGATTGCAGGTGTTGCCGCTCTGTATTACCAGGATTATGCTTCTGTCGGGCGCAATAACCCGACGCTGAACAAAGAAATTATCCCGGCAAACTATGCGTACAGCACTTTCCATTACGTGAAGGATACCTATTTTACGACGAAAATGCCTTTCCGGACGCTGGGGGATGATGCAAGGCGCGTTACCCGGAATGGTAAACCCACGCTGATGTTCCTGGTAATTGGCGAAACGGCACGGAGCCAGAATTTCTCCATGAACGGCTACCCGCGTGACACAAATGCCTTTACCAGCAAAATCGATGGCGTTATTTCGTTCAGGAATATGCGTTCCTGCGGCACGGCGACCGCAGTCTCGGTGCCCTGTATGTTCTCGGATATGAACCGGACGGATTACGATGGTAAAAAGGCTGCCGGCAGTGAAAATGTCCTCGACATTGTGCAGAAAACGGGGGTTTCGCTGTTGTGGAAAGAAAACGATGGCGGGTGTAAAGGCGTATGCAGCCGTATCCCGACTGTCGAAATTAATCCCGGTATCAGTAAAAAACTGTGTGACGGTAAAACCTGCTATGACGATGTTATGCTGGAAAACCTGGATACCGAAATCGGCAAAATGGCCGGAGACAAGCTGATCGCCTTCCATATGATTGGCAGCCATGGACCGACCTATTACCAGCGTTATCCGGCAGAGCATCGTCACTTCATGCCGGAATGTGCGCGCAGCGATATCGAAAACTGCACGCAGGAACAGCTGGTTAATACCTACGACAATACCATTCGCCACACCGACTATGTGTTAGCGCAGATGATTGAAAAGCTTAAGCAATACAGCGAACAGTACAACACCGTACTGCTGTATGTGTCCGATCACGGCGAATCTCTGGGAGAGAGCGGACTGTATCTGCACGGTACCCCCTACAAACTGGCACCGGATCAGCAGACGCACATCCCGATGCAGCTCTGGATGTCGCCAGACTTCATTGCTGCTAAAAATATTAACGCCGCGTGTCTGCAGCATAATGCCGTTAACAGGACATATTCCCACGATAACCTTTTCGCGTCCGTACTGGGGCTCTGGGACATCACCACCGGGGCCTATCTTCCGGAAAGCGACCTGTTCCGCGAATGTCGTGGATAG
|
Lipopeptides
|
Colistin phosphoethanolamine transferase
|
Drugs
| 1 |
MEG_8638|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|POXT
|
ATGAAAGGTAAAAATATGAATTTAGCCTTTGGGTTGGAAGAAATTTATGAGGATGCTGAGTTTCAAATCGGAGATTTGGATAAGGTCGGTATTGTCGGCGTGAACGGAGCCGGAAAGACCACCTTGTTCCGCCTGCTGTTGGGAGAACTTGAACTTGATAATGGTTCACTGACCAGTGGAAATGCCCGTATTGGTTATCTCCCACAGGAAATTGTCTTGGAAGATGAGGATATTACCGTTTGGGATTTCCTTTTTGAGGGACGTCCGATTAAAAAGTATGAGCAGGAATTGGAAGAAATCTATAAAAAGCTTGAAACCGCAGTCAATGCAGAGCAGGAAGCACTGCTTGCCCGAATGGGAACATTGCAAGAACGCTTGGAGTATTTCGACTTCTATGAGGCAGAAACAATTCTGTTGGAGTTTGCAGATAAAATGAGCATTGATGCAGAATTATATCATCGTCCGATGAGAGAGCTTTCAGGCGGACAAAAATCCAAAATGGCATTTGCCAGACTACTATATTCAAAACCGGAAATTCTATTGTTGGATGAGCCTACCAACCATTTAGATGTCAGCACAAAGGATTTTGTTATAAAATACTTAAAGAATTATAGGGGTTCGGTACTGATTATCAGCCATGATATTGATTTTCTAAATCGGATTATCAACAAAATTATGTACATCAACAAAGCTACCCATAAAATATCTGTTTATGATGGAGACTACTACATCTACAAGAAAAAGTATGCAGAGGAACAGCGGATTCGTGAAATGGCGATTGTACAGCAGGAAAAAGAAATAAAGGAGCTTTCCGATTTTGTACAAAAAGCAAAACAAGCCAGTCAGACCAATCATCACCTCAAACGAATGGGTCAAGAGCGAGCCTTGCGGCTTGATAAAAAGCGTGGAGAGCTGCAAAAGAGAAATCGACTGTACAAGCGTGTGAAGATGGATATTCGCCCCAAGCGTGAAGGGGCACAAGTTCCCTTAGAGGTGGAAAATATCACCTTCCACTATTCGGGGTATCCCACCCTTTATCAGAACCTTTCCTTTCAGATTAACGGAAGAGAACGATTTCTTGTGGTGGGTGAAAACGGTGTCGGTAAATCCACCTTATTGAAATTGATGATGGGTATTCTCAGTCCAGATGAAGGATGCATTCGCTTTAACCAGAAAACTGATATTGCATATTATGCACAGGAACTCGAACAGCTTGATGAAAACAAAACGGTCATTGACAATGTGGAGTCTGAAGGATATACACCGTGGCAAATCAGAGCCGTACTGAGCAACTTCCTGTTTTATGATGACGATGTAAACAAGAAAGTATCTGTGCTGTCCCCTGGAGAAAAAGCAAGGGTTGCCCTTTGCAAAATCCTATTACAGAAAGCCAATCTTTTGATACTGGACGAGCCGACCAACCACCTTGACCCAGAAACGCAGAAAATCATTGGCGGCAACTTCAATTTGTTTGAGGGAACCATTATTGCCGTTAGCCATAACCCATCCTTTGTGGAACAAATCGGAATTAGCCGTATGCTTATTTTGCCCAGCGGTCGAATTGAACCCTATTCCCGTGAGCTGCTTGAGTATTATTATGAAATCAACACTCCCGAAGAAGAACAGAAATACTAA
|
Multi-drug resistance
|
Multi-drug ABC efflux pumps
|
Drugs
| 1 |
MEG_8207|Drugs|betalactams|Class_A_betalactamases|KPC
|
ATGTCACTGTATCGCCGTCTAGTTCTGCTGTCTTGTCTCTCATGGCCGCTGGCTGGCTTTTCTGCCACCGCGCTGACCAACCTCGTCGCGGAACCATTCGCTAAACTCGAACAGGACTTTGGCGGCTCCATCGGTGTGTACGCGATGGATACCGGCTCAGGCGCAACTGTAAGTTACCGCGCTGAGGAGCGCTTCCCACTGTGCAGCTCATTCAAGGGCTTTCTTGCTGCCGCTGTGCTGGCTCGCAGCCAGCAGCAGGCCGGCTTGCTGGACACACCCATCCGTTACGGCAAAAATGCGCTGGTTCCGTGGTCACCCATCTCGGAAAAATATCTGACAACAGGCATGACGGTGGCGGAGCTGTCCGCGGCCGCCGTGCAATACAGTGATAACGCCGCCGCCAATTTGTTGCTGAAGGAGTTGGGCGGCCCGGCCGGGCTGACGGCCTTCATGCGCTCTATCGGCGATACCACGTTCCGTCTGGACCGCTGGGAGCTGGAGCTGAACTCCGCCATCCCAGGCGATGCGCGCGATACCTCATCGCCGCGCGCCGTGACGGAAAGCTTACAAAAACTGACACTGGGCTCTGCACTGGCTGCGCCGCAGCGGCAGCAGTTTGTTGATTGGCTAAAGGGAAACACGACCGGCAACCACCGCATCCGCGCGGCGGTGCCGGCAGACTGGGCAGTCGGAGACAAAACCGGAACCTGCGGAGTGTATGGCACGGCAAATGACTATGCCGTCGTCTGGCCCACTGGGCGCGCACCTATTGTGTTGGCCGTCTACACCCGGGCGCCTAACAAGGATGACAAGGATGACAAGGATGACAAGTACAGCGAGGCCGTCATCGCCGCTGCGGCTAGACTCGCGCTCGAGGGATTGGGCGTCAACGGGCAGTAA
|
betalactams
|
Class A betalactamases
|
Drugs
| 1 |
MEG_8421|Drugs|betalactams|Class_D_betalactamases|OXA
|
ATGACAATCCGAATCTTTGCAATATTTTTCTCCACTCTTATTTTTGCCACTTTCGCGCATGCACAAGAAGGCACGCTAGAACGTTCTGACTGGAAGAAGTTCTTCGACGATTACCAAGCCAAAGGCACGATAGTTGTGGCAGACGAACGTCAAGCAGATCGCATCCTATCGGTTTTTGATCAAGCACGGGCGACAAAACGTTACTCGCCTGCATCAACATTCAAGATTCCACACACACTTTTTGCACTTGATGTAGGTGCTGTTCGTGATGAGTTCCAGGTTTTCCGATGGGACGGTATTAAACGAAGCTTTGCAGGACACAATCAAGACCAAAACTTGCGATCAGCTATGCGAAACTCTACGCTCTGGGTTTATGAGCTATTTGCAAGAGAGATCGGTGAGGAAAAAGCCAAACGCTATTTAAAGCAAATAGGTTATGGCAACGCCGACCCTTCGACAAGCAAAGGCGATTATTGGATAGATGGCACTCTAGAAATTTCTGCGTACGAACAGATTTCGTTTCTCAGAAAACTCTATCGAAATGAATTGCCATTTCGGGTAGAGCATCAGCGCTTGGTCAAAGATCTCATGATTACGGAAGCCGGGCGCAACTGGATTCTGCGCGCAAAGACTGGCTGGGAAGGTAGGTTTGGCTGGTGGGTGGGATGGGTTGAGTGGCCTACCGGCGCCGTATTCTTCGCATTGAATATCGATACGCCAAACAGAATGGATGATCTTTTCAAAAGAGAGGCAATCGTGCGGGCAATCCTCCACTCTATCGACGCGTTGCCGCCCAACTAGT
|
betalactams
|
Class D betalactamases
|
Drugs
| 1 |
MEG_7972|Drugs|betalactams|Class_B_betalactamases|AIM
|
ATGACGCTCCGCTCCACCCTGCTTTCCGCTCTGGTCGCGCTCGCGCTTCCCTCCGCCGCGCTCGCTTCCGACGCGACCACGGCCAAAGCCTGCGCCGACGATGCCGGCTGGAACGATCCCGCCACGCCGCTGAAGGTCTACGGCAACACCTGGTACGTCGGCACGTGCGGCATCAGCGCCTTGCTGGTGACCTCCGATGAAGGCCACATCCTGGTCGACGCCGCCACGCCGCAGGCCGGCCCGCAGATCCTCGCCAATATCCGCGCCCTCGGCTTCAAGCCGGAGGATGTGCGTGCCATCGTGTTCTCGCACGAGCACTTCGACCATGCCGGCAGCCTGGCCGAGTTGCAGCAGGCCACGGGCGCGCCTGTGTATGCGCGTGCGCCTGCCGTTGCCACGCTCAAGCGCGGCGCCAGCGATCGCAGCGATCCGCAGCATGAGGTACTCGATCCGTTCGCGCCGGTCCAGCAGGTGGTCGTACTCGACGACGACGGCGTGGTGCGTGTCGGTCCGCTCGCCCTGCAGGTCGTTTCCACGCCGGGACACACGCCCGGCGGCACCAGCTGGACCTGGCGCTCGTGCGAGGGCGACGACTGCCGGCAGATGGTCTACGCCGACAGCCTGACCGCGATCTCCGACGACGTGTACCGCTACAGCGACGATGCGGCGCACCCTGGTTACGTGGCGGCATTCCGCGAGACGCTGGCGCGGGTCGCGGCACTCGAGTGCGACATCCTGGTGACGCCACATCCGTCGGCCAGCCAACTCTGGTCCCGCATCGGTCCTCGCGCCGACCGCCCGCTGGTCGACACCAGCGCCTGCCGCACCTATGCACAGACCGCGACGCAGCGGCTGGACAAGCGGCTCGCGGACGAAGCGTCGAAGCCCCCCGTGCCTGCGCCTTGA
|
betalactams
|
Class B betalactamases
|
Drugs
| 1 |
MEG_8416|Drugs|betalactams|Class_D_betalactamases|OXA
|
ATGAATAAAGGTTTGCACAGAAAGCGCCTGAGTAAGCGTTTGCTGCTGCCCATGTTGTTGTGTTTATTGGCTCAGCAAACGCAGGCAGTGGCAGCGGCGCAGACCAAGGTCAGTGAAGTCGGCTCTGAGGTCACGGTCGAGGGTTGGCAAGAGGTACGCCGCTGGGACAAGTTGTTTGAATCTGCAGGTGTTAAAGGCTGTTTGCTGCTTTTGGATCAAAAGCGTTCTTTGGGGCTATCTAACAATCTAAGTCGCGCCGCCGAAGGCTTTATTCCTGCTTCTACCTTCAAGATCCCCTCTAGCCTGATTGCGTTGCAAACCGGGGCGGTGCGCGATGAAACCAGTCGTTTTAGCTGGGACGGAAAAGTTCGGGAAATTGCTGCCTGGAACCGGGATCAGAGTTTTCGCACCGCAATGAAGTACTCCGTGGTGCCTGTGTATCAGCAGCTGGCCAGGGAGATAGGCCCCAAAGTGATGGCAGCTATGGTGCGGCAACTGGAATATGGTAATCAGAATATCGGTGGCCAAGCGGACAGCTTCTGGCTCGACGGTCAACTTAGGATAACGGCGTTCCAACAAGTGGATTTTCTGCAGCAACTGCATGACAACAAGTTGCCTGTGTCTGAGCGCAGCCAGCGAATTGTCAAACAGATGATGCTGACCGAAGCGAGTACTGACTATATCATTCGCGCCAAGACAGGCTATGGTGTACAGCAAACGCCGGCCATAGGTTGGTGGGTCGGTTGGTTGGAGTTGGACGACAATACTGTCTATTTCGCCATTAATCTGGAGCTGACCTCCGCAAGCCAGTTACCGTTGCGCCAACAACTGGTGAAACAGGTGCTCAAGCAGGAACTGCTACTGCCTTGA
|
betalactams
|
Class D betalactamases
|
Drugs
| 1 |
MEG_8681|Drugs|betalactams|Class_A_betalactamases|RSA
|
ATGCAACTAGCTAGGTCGACGATCCTCACTGTTTTGCTCTGTCTGCCGATTGCTGTAACGGCTACGACTAAGGAGGAGATCCAAAAGATTGAGCGTCAGCGCAACCTCACGGTTGGCATCGCTCTTGTAGACGACGGGGGAACACTCCTGTTCGGTCATCGCGAAACGCAGCGCTTCGCCATGTGCTCGACATTTAAGTTGCCGCTGGCGGCTGCAACGCTTAAGCAAATCGAGAGCGGAAAGTGGTCTGCCGCCGAGCGGCTGAGCTATAGCGCTGGCCAATTAGATGCCTACGCGCCAGCTGCCAAGAGATATCTACCTACAGGCTACATCACGGTAGCTGAGGCTAACCAAGCCTCGGTCCAGCTCAGCGATAATACTGCTGCCAACTTGCTGCTTGACAAACTCGGAGGGCCATCGCAGCTCACATCCATGTTTCGCTCCCTCGGCGATTCCGTGAGTCGCCTGGATAGAAGAGAACCCGATTTGAACACCAACGTTTCGGGTGACCCGCGCGACACGACTACGCCGGGCGCGATGGCACGCATTGTCGCAAAGCTGGTATATGGAAACTATCTAAGTACAGCAGGCCGAGAGCAATTGCAGCGGCTTCTCATTGGCAATAACACAGGCGACTCGAGGATTCGCGCTGGAATCGCATCTGGCTGGACGACTGGCGACAAAACGGGTTCCTGCGACAATGGCGGACGAAATGACGCTGCGTTCCTGGTAAGCCCTGATGGCCGCAGATTTGCGCTGACAGTGTACCTGAACGCCCCATCGCTTGACGACAAGGCACGGAACGAGGTGGTCGCTACGGTAGCTCGCTTGGCGGTTGAGAGTATCCGCTAG
|
betalactams
|
Class A betalactamases
|
Drugs
| 1 |
MEG_8695|Drugs|betalactams|Class_C_betalactamases|SFDC
|
ATGCTGAAGAAATCCCTATCCTGTGTGCTGTTGCTCGCCACCTCAAGTTCAGTGTTTGCCGCACCGCAAACGGAAAAACAGATAGCCGACATTGTTAATCGCACCGTTGCGCCATTGATGCAAGAGCAGGGCATTCCCGGCATGGCCGTGGCGGTGATTTATCAGGGGCAGCCTTACTACTTCACCTGGGGATTGGCAGACGTTGCCGGCAAGCAACCCGTCACGCAGCAGACCTTATTCGAGCTGGGTTCGGTCAGTAAAACGTTCACAGGAGTGCTGGGCGGTGATGCCATTGCTCGCGGTGAAATCAACCTAAGCGATCCGGCGAGCAAGTACTGGCCAGCACTGTCTGGCAAGCAATGGCAGGGGATCACCTTGCTGCACCTGGCAACCTATACCGCCGGTGGCTTACCGCTGCAGATACCGGAAAATGTTACCGATGAAGCATCGCTGCAGAATTATTATCAAACCTGGCAACCGCAGTGGGCTCCGGGCACCAAGCGCCTATACTCGAACGCCAGTATTGGCCTGTTTGGCGCACTGATGGTCAAACCGTCAGGCATGAGTTTTGAACAGGCGATGACCCAACGCGTGTTCCAACCGTTGAAGCTATCGCAAACCTGGATAAACGTGCCGCAGCAGGAAGATAAGCACTACGCCTGGGGCTATCGCGATGGGAAAGCGGTTCGCGTTTCTCCGGGCATGTTTGATGCCGAAGCCTACGGCGTTAAGTCGTCGATAGAGGATATGGCAAGCTGGGTTCAGGCTAACATGGCGCCTGCTAAAGTGAAGGATGCCTCGCTGCAGAAGGGGATTACGCTTGCCCAGTCGCGCTACTGGCATGCCGGTGATATGTATCAAGGTCTGGGTTGGGAAATGCTGAACTGGCCGGTTAAAGAGAAAACTGTGGTCGAGGGTAGCGATAATAAAAACGCACTGGCAGCGCTGAGCGTCACAAAAATCACTCCGCCAGCGCCACTATCAAGCGCCTCTTGGGTACATAAAACTGGCTCAACCGGTGGATTTGGCAGCTATGTAGCCTTCATTCCTCAACAGGATCTCGGCATCGTGATGCTGGCTAACAAAAATTATCCTAATCCTGTGCGGGTTGAGGCGGCTTATCGCATTCTTGAAGCGTTACAGAAGTAA
|
betalactams
|
Class C betalactamases
|
Drugs
| 1 |
MEG_8417|Drugs|betalactams|Class_D_betalactamases|OXA
|
ATGAAACTTTTTTTTTGTTTCGCGCTTTTGATTTTAATCTCCGTAAAGGCTTTTGGACAGATCGATCTCCAGAGGCCTTTTCAAGATTGCGCGTTAGAGGGAAGCATCACCGTCTTTGATTACAAAAACAAAAAATGGACGTTCAGCGACCGGAGCGACGCGCGGCGCGAGACGCTGCCGGCTTCGACCTTTAAGGTCATCAATTCGCTGATCGCGCTCGAAACAGGCGCGGTCGAAGACGAAAAAGAGGTTTTCAAATGGGACGGCCGGCGGCGCGAGGTCGATGCGTGGAACGCCGACACCGATATGGAAAACGCTTTTCGAAATTCGACCGTCTGGTTTTATGAAGAATTGGCGAAACGCGCCGGCAAGGAAAAATACCGCGAGATTCTCAAAAAAAGCCGTTACGGAAACGGGAAAATCGACGGCGGCGAGGGCGTTAATTTCTGGGTTACCGGAGAGTTCGGCGTCACGCCGGAAAATCAGATAAAATTTTTGAAGGCGTTCTACGAAGAACGGCTTCCCTTTTCGCGCCGGAGTTTCGAGATCGTCAAACGCATCATGCTCGAAGAAAAAGCGGATAAATACACATTGCGCGCGAAAACCGGCTGGACGCGTTTCGGCGGAAAGGATACGGGCTGGTGGATCGGCTACGTCGAACGCAGCGACAATACATACTTTTTCGCCACGCGCGTAACGAAACCGCGCGAGACGCAAAACCCGCGCTTCGGCGAATGCCGCAAACTGATTACGCGCGACGTTTTGCGGCAAATGAAAATCATCGAATAG
|
betalactams
|
Class D betalactamases
|
Drugs
| 1 |
MEG_8212|Drugs|betalactams|Class_C_betalactamases|LAQ
|
ATGAAAAAATCCCTTTGCGCCGTGCTGCTGCTCACCGCTTCATGCTCTGCGCTTGCCGCGCCTCAAACTGAAAAACAGATCGCTGATACCGTCAATCGCATCATGACCCCGCTCATGAAAGAACAGGCGATTCCGGGCATGGCCGTCGCCGTGATTTATCAAGGAAAGACGCACTATTTTGTCTACGGCAAAGCAGATATCGCCGCGAATCAGCCCGTCACTCAGCACACCTTGTTTGAGCTGGGCTCCGTGAGCAAAACCTTTACCGGCGTTCTGGGCGGCGAAGCCATCGCACGCGGTGAAATCAGGCTTGACGATCCCGCCAGCAAATACTGGCCTGCGCTGACGGGTAAACAATGGAAAGGCATTACTCTGCTGCATCTGGCTACTTACACCGCAGGCGGTTTGCCGCTGCAAGTGCCGGATGAGGTAACCGATCAGGCGGCGCTTCTGCATTTCTACCAAAACTGGCAACCGCAGTGGACGCCGGGCGCAAAACGCCTGTACGCCAACGCCAGTATCGGTTTATTCGGCATGCTGGCGGTCAAGCCATCAGGGATGGATTTTGAACAGGCAATGACCTCACGCGTGTTCCAGCCGCTGGAACTCAATCACACCTGGATTAACGTCCCGGCAGCAGAGGAGAAGCATTACGCCTGGGGCTATCGTGACGGTAAACCGGTGCACGTTTCGCCCGGCATGCTTGATGCGGAATCTTACGGCGTCAAAACGACCATTGAAGATATGGCGAGCTGGGTTCGGGCCAATATGAATCCTGCGGGCGTTAAAGATGAAATGCTTAAGCAAGGAATCGAACTGGCACAGTCACGTTACTGGCGTATCGGGGAGATGTATCAGGGCTTAGGCTGGGAAATGCTGAACTGGCCGGTGAAAGCAAAAACCGTCGTCGACGGCAGCGATAACAAAATCGCACTGGCATCGCTGACGGCCGTCGAAGTGAATCCTCCCGCGCCCGCAGTTAAAGCCTCGTGGGTGCACAAGACGGGTTCAACCGGCGGATTTGGGAGCTACGTCGCCTTTATTCCTGAAAAGAACATCGGCATCGTGATGCTGGCGAATAAAAGCTATCCTAACCCTGCGCGTGTCGATGCGGCGTATCGTATCCTGGACACGTTGAAATAA
|
betalactams
|
Class C betalactamases
|
Drugs
| 1 |
MEG_8160|Drugs|betalactams|Class_A_betalactamases|IMI
|
ATGTTATTTAATTCGAAGCCAAGTAGAATATCCATCCTGTTAAGCTCTTTTTTGATTTCAATATCATTTTCCTCACAGGTCAATGCAAGTGGCATTGATGAGATTAAGAAACTTGAAACAGATTTCAATGGGAGGATTGGTGTGTATGCCTTAGATACCGGCTCTGGTAAATCATTTTCATACAAAGCGAATGAACGATTTCCTCTGTGTAGTTCTTTCAAAGGTTTTTTGGCTGCTGCTGTATTAAAGGGCTCTCAAGATAACCAACTTAATATTAATCAGGTTGTAAATTACAATACAAGAAGTTTAGAATTCCATTCCCCCATTACAACTAAATATAAAGAAAATGGAATGTCTTTAGGTGATATGGCTGCTGCTGCATTACAATATAGCGACAACGCTGCTACTAATATTATCCTTGAACGTTATATTGGTGGCCCTGAGGGCATGACTAAATTCATGCGGTCGATTGGAGATAAAGATTTTAGACTTGATCGTTGGGAGTTAGATCTTAACACAGCTATTCCTGGCGATGAACGTGACACATCCACACCCGCAGCAGTTGCTAAAAGTTTAAAAAACCTTGCTCTAGGTAATATACTTAACGACCATGAAAAGGAAATCTATCAGACATGGTTAAAGGGTAACACAACTGGCGCAGCGCGTATTCGTGCTAGCGTGCCAAACGATTGGGTAGTTGGCGATAAAACCGGTAGTTGCGGAGCATACGGTACGGCAAATGATTATGCTGTAGTCTGGCCAAAGAACAGGGCTCCTCTTATCATTTCTGTGTACACTACAAAAAATGAAAAAGAAGCCAAGCATAACGATAAGTTAATTGCAGAAACTTCAAGAATTGCAATTAAAAACCTTAAGTAA
|
betalactams
|
Class A betalactamases
|
Drugs
| 1 |
MEG_8274|Drugs|Aminoglycosides|16S_rRNA_methyltransferases|NPMB
|
ATGGTAAAGCAGATCCGCGGCAGCACCATCTGGCAACTAACGCGTGAAGAATTAGAGGAATGTATCAGCACGTATCGAGAGGTCGCTATCGACCTAGGTACGGGCGATGGGCGTTTTGTTTTGGACCTGGCCAAACTGGAAGCGGATACGTTCGTCATCGGAATAGATGCGAACGCGAAGCCGCTCGAAAAGCCCTCGGTCAAGATCACGCGAAAACCTGCCAAAGGCGGACTTCCGAACGCTCTCTTTGTTCAGGCCGCCGCTGAGGATCTTCCGAGTGAACTCGCCTCGGTTGCTGATAGTGTTACGGTCAATCTACCTTGGGGCAGCTTGCTCCGGGCGGTTCTTCTGCCCGATTCGGAAGTTCTTCGTGGTATTCGCCGGCTGGTAAAGCCCGGCGGCGAACTTGAGGTCGTGACCGCGATCGATCCGGTTCGCGATCTTCAGGAACTTGCCCGGCTCGGACTTTCACAGTTGACCGAGCAGCACTTCGAGACGGATCTCGTTCAGGCTTATCGAAACGCCGGATTAGAGAGGGGTAAAAACACTGGTTTCGCAAAGGCTGGTGCGCTTCCTATAGAGACGACCTGGGGCAAGCGTCTTTCCCGATCATCGGAGCGTTCGGTTCGCCGGCTAAGGTTCACCGCGGTATGA
|
Aminoglycosides
|
16S rRNA methyltransferases
|
Drugs
| 1 |
MEG_8424|Drugs|betalactams|Class_D_betalactamases|OXA
|
ATGCCGAAAAAATTAAAATTACTCGTTCTATCTGTAGTTGTGATGCCCTCAATAATATTATTGGGCTGCCAAAATATTCAGCCACACGTTCAAGCTTTAGTCACACAGAAACAGACTGAAGATCAGATCGCAACTGCATTTGAAAATATCCAGACCTCCGGTGTACTGGTCACTTATGATGGCAAAACTATTCAAACATATGGCAATGCGCTTAACCGGGCCGATCAGCGCTATATTCCGGCTTCTACTTTTAAAATGCTGAATGCTTTGATTGGTATCCAGCATCATAAGACTTCACCGAATGAAGTATTTAAATGGGATGGACAGAAGCGGGCTTTTACCAGCTGGGAAAAAGACTTAACCCTGGCAGAAGCCATGCAGGCTTCGGCTGTACCTGTGTATCAGGAACTGGCGCGCCGTATCGGTCTGGAATTAATGGCCAGTGAAGTAAAACGGGTCGGGTATGGCAATCAGTCGATTGGAACGCAAGTGGATAATTTCTGGTTAGTGGGACCTTTAGAAATTACCCCTGTTGAGGAAGTAAAATTTGCCTATGCCTTGGCGAAAAAACAACTTGCATTTGACTCATCAACCCAGCAACAAGTTAAAGATATGTTGCTGATTGAAGATATTCAGGGCACCAAAATCTATGCCAAAAGCGGATGGGGCATGGATGTAAATCCTCAGGTGGGATGGTGGACAGGTTGGGTAGAACAACCCAATGGACAGGTCACTGCATTTTCACTGAATATGGAAATGAAAAAGGCAGCACATGCAGAAGCACGTAAAGCCATTGTTTATCAGGCCCTGCAACAGCTCGGTTTAATTGGGCAATAA
|
betalactams
|
Class D betalactamases
|
Drugs
| 1 |
MEG_8425|Drugs|betalactams|Class_D_betalactamases|OXA
|
ATGTATAAAAAAGTCCTTGTCGTTGCGACAGCTACTCTATTTTTATCTGCCTGCTCCTCTAACACGGTAAAACAACATCAAATACATTCTATTTCCGCCAATAAAAATTCAGAAGAAATTAAATATCTGTTTGATCAGGCACAGACCACAGGAGTTTTAGTGATTAAGCGTGGGCAAACCGAAGAAATTTATGGCAATGATCTTAAAAGAGCATCAACCGCTTATGTTCCCGCCTCTACCTTTAAAATGTTAAATGCTTTAATTGGACTTGAACATCATAAGGCAACTACAACTGAAGTATTTAAATGGGATGGGCAAAAACGTTTATTTCCTGATTGGGAAAAGGACATGACACTGGGCGATGCCATGAAAGCTTCTGCGATTCCAGTTTACCAAGAATTAGCCCGACGAATTGGTCTAGATCTTATGTCTAAAGAGGTGAAACGAATTGGTTTTGGTAATGCTAACATTGGTTCAAAAGTAGATAATTTTTGGCTCGTTGGCCCTCTAAAAATTACACCTCAACAAGAAACCCAATTTGCTTATCAATTAGCCCTTAAAACGCTTCCATTTAGCCAAGATGTACAAGAACAAGTTCAATCAATGGTGTTCATAGAGGAAAAAAATGGAAGTAAAATTTATGCCAAAAGTGGTTGGGGGTGGGATGTTGAACCACAAGTTGGCTGGTTAACCGGTTGGGTCATTCAACCACAAGGAGAAATTGTGGCATTCTCGCTCAATTTAGAAATGAAAAAAGGAATTCCTAGTTCTATTCGAAAAGAAATTGCTTATAAAGGATTAGAACAACTCGGTGTTTTATAA
|
betalactams
|
Class D betalactamases
|
Drugs
| 1 |
MEG_8426|Drugs|betalactams|Class_D_betalactamases|OXA
|
ATGACTAAAAAAGCTCTTTTCTTTGCCATTGGTACGATGTTTTTGTCGGCATGTTCTTTTAATACCGTACAACAACATCAAATACAGTCAATTTCTACCAATAAAAACTCAGAGAAAATTAAATCATTGTTTGAACAAGCACAAACTGAAGGTGTTTTAGTTATAAAACGTGGGCAAACAGAGGAAATCTATGGCAATGATCTTAAAAGATCATCAACCGAATATGTTCCCGCCTCTACCTTTAAAATGTTAAATGCTTTGATAGGACTTGAGCATCATAAAGCAACACCAACTGAAGTGTTTAAATGGTATGGGCAAAAGCGTTTATTTCCCGATTGGGAAAAAGACATGACTCTAGGCGATGCGATGAAAGCTTCTGCTATTCCAGTTTATCAGGAACTAGCTCGACGAATTGGCCTTGATCTTATGTCTAAAGAGGTAAAACGCATTGGTTTCGGTAATGCTGATATTGGTTCAAAAGTAGATGATTTTTGGCTTGTTGGTCCACTTAAAATTACACCTCAACAAGAAGTACGGTTTGCTTATAAATTAGCCAACAAAACTCTTCCCTTTAGCAAAAATGTACAAGAACAAGTTCAATCTATGCTGTTCATTGAAGAAAAAAATGGACGAAAAATTTATGCCAAAAGTGGTTGGGGATGGGATGTGGATCCTCAAGTGGGTTGGTTTACAGGCTGGATCGTTCAACCTCAGGGAGAAATTATAGCTTTCTCACTTAATTTAGAAATGAAGAAAGGCATACCTAGTTCTATTCGAAAAGAAATTGCTTATAAAGGATTAGAGCAGCTAGGTATTTTATAG
|
betalactams
|
Class D betalactamases
|
Drugs
| 1 |
MEG_8427|Drugs|betalactams|Class_D_betalactamases|OXA
|
ATGAAAACTCTTATTTTGTTGCCTTTACTTAGTTGCTTGAGCCTGACAGCCTGTAGCTTGCCTGTTTCAAATTCGTCCTCTCAAATCACTTCAACTCAATCTATTCAAACCATTGCCAAATTATTTGATCAGGCACAAAGCTCTGGCGTTTTAGTAATTCAACGGGGCCCACATCTACAGGTCTATGGCAATGATTTGAGTCGTGCACATACCGAATATATTCCTGCTTCAACCTTTAAAATGCTCAATGCCCTGATTGGCCTGCAACATGGTAAAGCCACGACCAATGAAATCTTTAAATGGGATGGCAAGAAGCGCAGTTTTGCAGCCTGGGAAAAAGACATGACTCTCGGCCAAGCCATGCAAGCTTCTGCTGTACCCGTCTATCAGGAACTGGCACGTCGCATTGGTCTGGAACTAATGCAACAGGAAGTGCAACGCATTCGATTTGGTAATCAGCAGATTGGTCAGCATATCGACAACTTCTGGTTAGTCGGACCTTTGAAAGTTACTCCAAAACAGGAAGTCAAATTTGCCTCTGCGCTTGCTCAAGAGCAACTTGCCTTTGATCCTCAAGTCCAGCAACAAGTCAAAGCCATGTTACTGTTACAGGAGCGACAAGCTTATCGACTATATGCCAAATCTGGTTGGGGTATGGATGTGGAGCCGCAAGTCGGCTGGCTCACCGGCTGGATCGAAACACCTCAGGACGAAATCGTGGCATTTTCACTGAATATGCAGATGCAAAGTAATATGGATCCGGCGATCCGTCTTAAAATTTTGCAGCAGGCCTTGGCCGAATTAGGGCTTTATCCGAAAGCTGAAGGGTAA
|
betalactams
|
Class D betalactamases
|
Drugs
| 1 |
MEG_8428|Drugs|betalactams|Class_D_betalactamases|OXA
|
ATGTCTAAAAAATTAAAATTACTCGCGCTATGTGCAACTGTAATCTCAGCTGCAACACTGGTCGGTTGTCAAAATATTCAGTCCCAAGCTCAACCTCTAGTCTTAAAGAAACAGACGCAGGATCAGATCGCAACTGCATTCGAAAATATCCAGACAACTGGTGTATTGGTCACCTATGATGGCAAAAAATTTCAAAAATATGGCAATGATCTCAGCCGTGCAGATCAGCGTTACATTCCTGCCTCAACTTTTAAAATGCTCAATGCCTTGATTGGTATACAGCACCATAAAACCTCACCTAATGAAGTGTTTAAATGGGATGGACAGAAGCGGGCTTTTCGTAGCTGGGAGAAGGACTTAACGCTTGCTGAGGCAATGCAGGCTTCGGCTGTACCTGTCTATCAGGAGTTGGCGCGCCGTATCGGTCTAGAATTAATGGCAAGTGAAGTAAAGCGGGTTGGCTACGGTAATCAAAATATAGGGACGCAAGTTGATAATTTTTGGTTGGTGGGGCCTTTGGAGATTACGCCAGTTGAGGAAGTGAAATTTGCTTATGCCTTAGCCAAACAGCAACTTCCATTTGATCCCTCAACACAGCAGCAAGTCAGAGATATGTTGTTGATCGAAAATGTTCAGGGAACCAGAATCTATGCCAAAAGCGGTTGGGGAATGGATGTAAATCCTCAAGTCGGACGGTGGACAGGTTGGGTCGAACAACCAAATGGTCAAGTCACTGCATTTTCGCTGAATATGGAAATGAAAAAAGCAGAACATGCGGATGCGCGTAAAGCGATTGTTTATCAAGCTTTACAACAGTTAGGTTTATTACCTCAATAA
|
betalactams
|
Class D betalactamases
|
Drugs
| 1 |
MEG_8429|Drugs|betalactams|Class_D_betalactamases|OXA
|
ATGCCGAAAAAATTAAAATTACTCGCTCTATCTGTAGTTGTGATGCCCTCAATAATATTATTGGGCTGCCAAAATATTCAGCCACACGTTCAAACTTTAGTCGCGCAGAAACAGACTGAAGATCAGATCGCAACTGCATTTGAAAATATCCAGACCTCCGGTGTACTGGTTACCTATGATGGCAAAGCTATTCAAAAATATGGCAATGCGCTTAATCGGGCCGATCAGCGCTATATTCCTGCTTCCACCTTTAAAATGTTGAATGCCTTGATTGGTATCCAGCATCATAAGACTTCACCGAATGAAGTATTTAAATGGGATGGACAGAAGCGGGCATTTACCAGCTGGGAAAAAGACTTAACCCTGGCAGAAGCCATGCAGGCTTCGGCTGTACCTGTGTATCAGGAACTGGCGCGCCGTATCGGTCTGGAATTAATGGCCAGTGAAGTAAAACGGGTCGGGTATGGCAATCAGTCGATTGGAACGCAAGTGGATAATTTCTGGTTAGTGGGACCTTTAGAAATTACCCCTGTGGAGGAAGTAAAATTTGCCTATGCCTTGGCGAAAAAACAACTTGCATTTGACTCATCAACCCAGCAACAAGTTAAAGATATGTTGCTGATTGAAGATATTCAGGGCACCAAAATCTATGCCAAAAGTGGATGGGGCATGGATGTAAATCCTCAGGTGGGATGGTGGACAGGTTGGGTAGAACAACCCAATGGTCAGGTCACTGCATTTTCACTGAATATGGAAATGAAAAAGGCAGCACATGCAGAAGCACGTAAAGCTATTGTGTATCAGGCTTTACAACAACTGGGTCTATTGCCCCAATAA
|
betalactams
|
Class D betalactamases
|
Drugs
| 1 |
MEG_8432|Drugs|betalactams|Class_D_betalactamases|OXA
|
ATGAAAAAATTTGTACTCCCTTTACTTAGTATTTCAATTTTATTGTCTTTGACTGCATGCTCATCAGTTCAAACTACATTTCAAAATGTTTCATTGGTTTCAAATGAAAAAAATAAAGAGGCTATCAAAGGTTACTTTGATGAGGCCCAAACTCAAGGTGTAATTGTTATTAAGGATAATGAACACGTTGCTATGTATGGAAATAGTTTAACACGAGCACATACACAATATGTTCCAGCATCAACATTTAAAATTTTGAATGCTTTAATTGGATTAGAGAATAATAAAGTAACCACAGATGAGATGTTTAAGTGGGATGGTAACAAAAAAGCTTTCTCAATTTGGGAAAAAGATATGAACCTAGGGGAGGCAATGAAATTATCTGCAGTTCCTGTATATCAAGAGCTTGCAAGTCGTATTGGTTTAGATTTAATGCAGAAAGAAGTAAAACGGGTTAATTTTGGTAATGCTAATATTGGAACTCAAGTCGATAATTTTTGGTTAGTTGGTCCTTTGAAGATTTCACCTATACAAGAGGTTAAATTTGCTGATGATCTTGCACATAACAAATTACCATTCAAAATAGAGACACAAGAAACAGTTAAAAATATGCTTCTAATTAAAGAAATTAATGGAAGTAAAATTTATGCCAAAAGTGGTTGGGGGATGGACGTTAAACCTCAAGTAGGTTGGTTAACTGGTTGGGTGGAACAGCCTACAGGGAAGATAATTTCATTTTCATTAAATTTAGAAATGAAAAAAAATATGGCAGGTTCTATCCGTAATGAAATTACTTATAAAACATTAGCGAATCTTGGGATCATTTAA
|
betalactams
|
Class D betalactamases
|
Drugs
| 1 |
MEG_8433|Drugs|betalactams|Class_D_betalactamases|OXA
|
ATGTATAAAAAAGTCCTTGTCGTTGCAACAGCTACTCTATTTTTATCTGCCTGCTCTTCTAATACGGTAAAACAACACCAAATACACTCTATTTCCGCCAATAAAAATTCACAAGAAATTAAATCTCTGTTTGATCAGGCACACACCACGGGAGTTTTAGTGATTAAGCGTGGGCAGACCGAAGAAATTTTTGGCAATGATCTTAAAAGAGCATCAACAGAATATGTTCCCGCCTCTACATTTAAAATGCTAAATGCTTTAATTGGACTTGAACATCATAAAGCAACGACAGCTGAAGTATTTAAATGGGACCGGCAAAAGCGTTTGTTTCCTGATTGGGAAAAGGACATGACTTTAGGCGATGCAATGAAAGCTTCTGCTATTCCAGTTTATCAAGAACTAGCCCGAAGAATTGGACTTGATCTTATGGCTAAAGAGGTAAAACGTATTGGTTTCGGTAATGCGGACATTGGTTCAAAAGTAGATAATTTTTGGCTTGTCGGCCCACTTAAAATTACACCTGAACAAGAAACCCAATTTGCTTATGAATTAGCTAATAAAACTCTTCCATTTAGTAAAAATGTACAAGAACAAGTCCAATCAATGGTGTTCATAGAAGAAAAAAATGGACGTAAAATTTATGCTAAAAGTGGTTGGGGATGGGATGTTGAACCACAAGTTGGCTGGTTAACAGGCTGGGTCGTTCAACCGCAAGGAGAAATTGTGGCATTCTCGCTCAATTTAGAAATGAAAAAAGGAATTCCTAGTTCTATTCGAAAAGAAATTGCTTATAAAGGATTAGAACAACTCGGTGTTTTATAA
|
betalactams
|
Class D betalactamases
|
Drugs
| 1 |
MEG_8434|Drugs|betalactams|Class_D_betalactamases|OXA
|
ATGTCCCGCATTCTGTTGTCCGGCCTGCTTGCCGCCGGCCTCTTCTGTGCCTTGCCCGCCAGCGCCACCACGGGTTGCCTGCTGTTTGCCGATGGCAGCGGCAAACCCCTCAGCGCCCAGGGTGACTGCGCCAGCCAGCTGACGCCTGCCTCCACCTTCAAGATCCCACTCGCGCTGATGGGCTATGAGAGCGGCTTCCTGGTGGATGAACAGTTGCCCGCCCTGCCATTCAAAGCCGGTGACCCTGACTTCCTGCCGGAGTGGAAGCAGACCACCACCCCGAGCAACTGGATGAAATTCTCGGTGATCTGGTATTCCCAACGCCTCACCGAATGGCTGGGAGAGGCGCGCTTCCAGCAGTACGTCGACCGCTTCGACTACGGCAACCGGGAGCTCTCGGGCAACCCGGGCAAGCACGACGGTCTGACCCAGGCCTGGCTCAGCTCCAGCCTCGCCATCAGCCCCCAGGAACAGGCCCGCTTCCTCGGCAAGCTGGTGAGCGGCAAGCTGCCGGTCTCCGCCGAGGCGGTGCGCCGCACCAGCACGCTGCTGCGTCAGCCCGACATCGATGGCTGGCAGATCCACGGCAAGACCGGCATGGGCTACCCCAAGCTGCTGGATGGCAGCCTCAACCGGGATCAGCAGATCGGCTGGTTCGTCGGCTGGGCCAGCAAGCAGGACAAGAAGCTCATCTTCGTGCACACAGTGGTGCAAAAACCCGGCAAGCAGTTCGCGTCCCTCAGGGCAAAGGAAGAGGTGTTTGCCGCCTTGCCAACAGAGCTGAAGAAACTCTGA
|
betalactams
|
Class D betalactamases
|
Drugs
| 1 |
MEG_8208|Drugs|betalactams|Class_A_betalactamases|KPC
|
ATGTCACTGTATCGCCGTCTAGTTCTGCTGTCTTGTCTCTCATGGCCGCTGGCTGGCTTTTCTGCCACCGCGCTGACCAACCTCGTCGCGGAACCATTCGCTAAACTCGAACAGGACTTTGGCGGCTCCATCGGTGTGTACGCGATGGATACCGGCTCAGGCGCAACTGTAAGTTACCGCGCTGAGGAGCGCTTCCCACTGTGCAGCTCATTCAAGGGCTTTCTTGCTGCCGCTGTGCTGGCTCGCAGCCAGCAGCAGGCCGGCTTGCTGGACACACCCATCCGTTACGGCAAAAATGCGCTGGTTCCGTGGTCACCCATCTCGGAAAAATATCTGACAACAGGCATGACGGTGGCGGAGCTGTCCGCGGCCGCCGTGCAATACAGTGATAACGCCGCCGCCAATTTGTTGCTGAAGGAGTTGGGCGGCCCGGCCGGGCTGACGGCCTTCATGCGCTCTATCGGCGATACCACGTTCCGTCTGGACCGCTGGGAGCTGGAGCTGAACTCCGCCATCCCAGGCGATGCGCGCGATACCTCATCGCCGCGCGCCGTGACGGAAAGCTTACAAAAACTGACACTGGGCTCTGCACTGGCTGCGCCGCAGCGGCAGCAGTTTGTTGATTGGCTAAAGGGAAACACGACCGGCAACCACCGCATCCGCGCGGCGGTGCCGGCAGACTGGGCAGTCGGAGACAAAACCGGAACCTGCGGAGTGTATGGCACGGCAAATGACTATGCCGTCGTCTGGCCCACTGGGCGCGCACCTATTGTGTTGGCCGTCTACACCCGGGCGCCTAACAAGGATGACAAGCACAGCGAGGCCGTCATCGCCGCTAAGGATGACAAGCACAGCGAGGCCGTCATCGCCGCTGCGGCTAGACTCGCGCTCGAGGGATTGGGCGTCAACGGGCAGTAA
|
betalactams
|
Class A betalactamases
|
Drugs
| 1 |
MEG_8209|Drugs|betalactams|Class_A_betalactamases|KPC
|
ATGTCACTGTATCGCCGTCTAGTTCTGCTGTCTTGTCTCTCATGGCCGCTGGCTGGCTTTTCTGCCACCGCGCTGACCAACCTCGTCGCGGAACCATTCGCTAAACTCGAACAGGACTTTGGCGGCTCCATCGGTGTGTACGCGATGGATACCGGCTCAGGCGCAACTGTAAGTTACCGCGCTGAGGAGCGCTTCCCACTGTGCAGCTCATTCAAGGGCTTTCTTGCTGCCGCTGTGCTGGCTCGCAGCCAGCAGCAGGCCGGCTTGCTGGACACACCCATCCGTTACGGCAAAAATGCGCTGGTTCCGTGGTCACCCATCTCGGAAAAATATCTGACAACAGGCATGACGGTGGCGGAGCTGTCCGCGGCCGCCGTGCAATACAGTGATAACGCCGCCGCCAATTTGTTGCTGAAGGAGTTGGGCGGCCCGGCCGGGCTGACGGCCTTCATGCGCTCTATCGGCGATACCACGTTCCGTCTGGACCGCTGGGAGCTGGAGCTGAACTCCGCCATCCCAGGCGATGCGCGCGATACCTCATCGCCGCGCGCCGTGACGGAAAGCTTACAAAAACTGACACTGGGCTCTGCACTGGCTGCGCCGCAGCGGCAGCAGTTTGTTTCATCGCCGCGCGCCGTGACGGAAAGCTTACAAAAACTGACACTGGGCTCTGCACTGGCTGCGCCGCAGCGGCAGCAGTTTGTTGATTGGCTAAAGGGAAACACGACCGGCAACCACCGCATCCGCGCGGCGGTGCCGGCAGACTGGGCAGTCGGAGACAAAACCGGAACCTGCGGAGTGTATGGCACGGCAAATGACTATGCCGTCGTCTGGCCCACTGGGCGCGCACCTATTGTGTTGGCCGTCTACACCCGGGCGCCTAACAAGGATGACAAGCACAGCGAGGCCGTCATCGCCGCTGCGGCTAGACTCGCGCTCGAGGGATTGGGCGTCAACGGGCAGTAA
|
betalactams
|
Class A betalactamases
|
Drugs
| 1 |
MEG_8210|Drugs|betalactams|Class_A_betalactamases|KPC
|
ATGTCACTGTATCGCCGTCTAGTTCTGCTGTCTTGTCTCTCATGGCCGCTGGCTGGCTTTTCTGCCACCGCGCTGACCAACCTCGTCGCGGAACCATTCGCTAAACTCGAACAGGACTTTGGCGGCTCCATCGGTGTGTACGCGATGGATACCGGCTCAGGCGCAACTGTAAGTTACCGCGCTGAGGAGCGCTTCCCACTGTGCAGCTCATTCAAGGGCTTTCTTGCTGCCGCTGTGCTGGCTCGCAGCCAGCAGCAGGCCGGCTTGCTGGACACACCCATCCGTTACGGCAAAAATGCGCTGGTTCCGTGGTCACCCATCTCGGAAAAATATCTGACAACAGGCATGACGGTGGCGGAGCTGTCCGCGGCCGCCGTGCAATACAGTGATAACGCCGCCGCCAATTTGTTGCTGAAGGAGTTGGGCGGCCCGGCCGGGCTGACGGCCTTCATGCGCTCTATCGGCGATACCACGTTCCGTCTGGACCGCTGGGAGCTGGAGCTGAACTCCGCCATCCCAGGCGATGCGCGCGATACCTCATCGCCGCGCGCCGTGACGGAAAATACCTCATCGCCGCGCGCCGTGACGGAAAGCTTACAAAAACTGACACTGGGCTCTGCACTGGCTGCGCCGCAGCGGCAGCAGTTTGTTGATTGGCTAAAGGGAAACACGACCGGCAACCACCGCATCCGCGCGGCGGTGCCGGCAGACTGGGCAGTCGGAGACAAAACCGGAACCTGCGGAGTGTATGGCACGGCAAATGACTATGCCGTCGTCTGGCCCACTGGGCGCGCACCTATTGTGTTGGCCGTCTACACCCGGGCGCCTAACAAGGATGACAAGCACAGCGAGGCCGTCTACACCCGGGCGCCTAACAAGGATGACAAGCACAGCGAGGCCGTCATCGCCGCTGCGGCTAGACTCGCGCTCGAGGGATTGGGCGTCAACGGGCAGTAA
|
betalactams
|
Class A betalactamases
|
Drugs
| 1 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.